Log in Register

Login to your account

Username *
Password *
Remember Me

Create an account

Fields marked with an asterisk (*) are required.
Name *
Username *
Password *
Verify password *
Email *
Verify email *

Publications

Title Authors Journal Year
Separation of hemoglobin variants by capillary electrophoresis.Cotton F, Gulbis BMethods Mol. Biol.2013
Transcranial Doppler ultrasonography in sickle cell disease: a study in omani patients.Gujjar AR, Zacharia M, Al-Kindi S, William R, Al Lamki Z, Wali Y, Bashir W, Jain R, Al-Asmi A, Pathare A J. Pediatr. Hematol. Oncol.2013
Scaring athletes with sickle cell trait.Nelson SC Am. J. Cardiol.2013
Reactivity of the human hemoglobin Ascenzi P, Leboffe L, Polticelli F IUBMB Life2013
Quantitative analysis of murine terminal erythroid differentiation in vivo: novel method to study normal and disordered erythropoiesis.Liu J, Zhang J, Ginzburg Y, Li H, Xue F, De Franceschi L, Chasis JA, Mohandas N, An X Blood2013
Lactate dehydrogenase and hemolysis in sickle cell disease.Ballas SK Blood2013
Proteomic analysis of ERK1/2-mediated human sickle red blood cell membrane protein phosphorylation.Soderblom EJ, Thompson JW, Schwartz EA, Chiou E, Dubois LG, Moseley MA, Zennadi R Clin Proteomics2013
The Molecular Basis of α-Thalassemia.Higgs DR Cold Spring Harb Perspect Med2013
Identification and molecular characterization of a novel 55 kb deletion recurrent in Southern Italy: the Italian (G) γ((A) γδβ)°-thalassemia.Lacerra G, Prezioso R, Musollino G, Piluso G, Mastrullo L, De Angioletti M Eur. J. Haematol.2013
Outcomes using lower vs higher hemoglobin thresholds for red blood cell transfusion.Carson JL, Carless PA, Hébert PC JAMA2013
Remote monitoring of pain and symptoms using wireless technology in children and adolescents with sickle cell disease.Jacob E, Duran J, Stinson J, Lewis MA, Zeltzer L J Am Acad Nurse Pract2013
Hemoglobin sickle cell disease in Brazil.Cabañas-Pedro AC, Braga JA, Camilo-Araújo RF, Silva AI, Vicari P, Figueiredo M Haematologica2013
Use of portable x-ray fluorescence (pxrf) in vivo as an alternative technique for the assessment of iron levels in patients with thalassemia and hemochromatosis.Estevam M, Appoloni CR Health Phys2013
Left Ventricular Dyssynchrony Is an Early Manifestation of Heart Involvement in Sickle Cell Anemia.Karakaş MF, Büyükkaya E, Kurt M, Celik M, Karakaş E, Büyükkaya S, Akçay AB, Sen N Echocardiography2013
Parental information, motivation, and adherence behaviors among children with sickle cell disease.Raphael JL, Butler AM, Rattler TL, Kowalkowski MA, Mueller BU, Giordano TP Pediatr Blood Cancer2013
Mediastinal extramedullary hematopoiesis mimicking a neuroblastic tumor in a patient with beta-thalassemia.Montaruli E, Rosa FM, Paul A, Martelli H, Guettier C, Dufour C, Guérin F Pediatr Blood Cancer2013
Relationships between systemic vascular resistance, blood rheology and nitric oxide in children with sickle cell anemia or sickle cell-hemoglobin C disease.Lamarre Y, Hardy-Dessources MD, Romana M, Lalanne-Mistrih ML, Waltz X, Petras M, Doumdo L, Blanchet-Deverly A, Martino J, Tressières B, Maillard F, Tarer V, Etienne-Julan M, Connes P Clin. Hemorheol. Microcirc.2013
A Case of Recurrent Psychosis during Sickle Cell Disease Crisis Treated Successfully with Ziprasidone.Spiegel DR, Messerschmidt C, Morewitz J, Akintola M Clin Schizophr Relat Psychoses2013
Morbidities and Mortality in Transfusion-Dependent Beta-Thalassemia Patients (Single-Center Experience).Mokhtar GM, Gadallah M, El Sherif NH, Ali HT Pediatr Hematol Oncol2013
Beta-thalassemia major: does it confer particularities to the breast?Bletsa G, Zagouri F, Gounaris A, Chrysikos D, Theodoropoulos G, Lymperi M, Koulocheri D, Menenakos E, Zografos GC, Sergentanis TN Breast J2013
Continuous Measurement of Hemoglobin: Methodological Approach and Lessons for the Future.Riou B Anesthesiology2013
Endocrinopathies in beta-thalassemia major. Prevalence, risk factors, and age at diagnosis in Northwest Saudi Arabia.Habeb AM, Al-Hawsawi ZM, Morsy MM, Al-Harbi AM, Osilan AS, Al-Magamsi MS, Zolaly MA Saudi Med J2013
Spectrum of α-Thalassemia Mutations in Transfusion-Dependent β-Thalassemia Patients from the Eastern Province of Saudi Arabia.Akhtar MS, Qaw F, Borgio JF, Albuali W, Suliman A, Nasserullah Z, Al-Jarrash S, Al-Ali A Hemoglobin2013
The Clinical and Laboratory Spectrum of Hb C [β6(A3)Glu→Lys, GAG>AAG] Disease.Cook CM, Smeltzer MP, Mortier NA, Kirk SE, Despotovic JM, Ware RE, Hankins JS Hemoglobin2013
A non-electrolyte haemolysis assay for diagnosis and prognosis of sickle cell disease.Milligan C, Rees DC, Ellory JC, Osei A, Browning JA, Hannemann A, Gibson JS J. Physiol. (Lond.)2013
Sickle hemoglobin disturbs normal coupling between erythrocyte O2 content, glycolysis and antioxidant capacity.Rogers SC, Ross JG, d'Avignon A, Gibbons LB, Gazit V, Hassan MN, McLaughlin D, Griffin S, Neumayr T, Debaun M, Debaun MR, Doctor A Blood2013
Developmental Function in Toddlers With Sickle Cell Anemia.Armstrong FD, Elkin TD, Brown RC, Glass P, Rana S, Casella JF, Kalpatthi RV, Pavlakis S, Mi Z, Wang WC, Pediatrics2013
Echocardiography in thalassemic patients on blood transfusions and chelation without heart failure.Rodrigues A, Guimarães-Filho FV, Braga JC, Rodrigues CS, Waib P, Fabron-Junior A, Tan DM, França AC, Okoshi MP, Okoshi K Arq. Bras. Cardiol.2013
How i manage priapism due to sickle cell disease.Olujohungbe A, Burnett AL Br. J. Haematol.2013
Hepatocellular carcinoma in hepatitis-negative patients with thalassemia intermedia: a closer look at the role of siderosis.Maakaron JE, Cappellini MD, Graziadei G, Ayache JB, Taher AT Ann Hepatol2013
Liver fibrosis in young Egyptian beta-thalassemia major patients: relation to hepatitis C virus and compliance with chelation.Elalfy M, Esmat G, Matter RM, Abdel Aziz HE, Massoud WA Ann Hepatol2013
Thalassemia bone disease: the association between nephrolithiasis, bone mineral density and fractures.Wong P, Fuller PJ, Gillespie MT, Kartsogiannis V, Strauss BJ, Bowden D, Milat F Osteoporos Int2013
Identification of KAP-1-associated complexes negatively regulating the Ey and β-major globin genes in the β-globin locus.Yang D, Ma Z, Lin W, Yang J, Tian C, Wei H, Jiang Y, He F J Proteomics2013
Molecular and clinical evaluation of the acute human parvovirus B19 infection: comparison of two cases in children with sickle cell disease and discussion of the literature.Slavov SN, Kashima S, Silva-Pinto AC, Amarilla AA, Aquino VH, Covas DT Braz J Infect Dis2013
Evidence of Differential Selection for the -α(3.7) and -α(4.2) Single α-Globin Gene Deletions within the Same Population.Yap ZM, Sun KM, Teo CR, Tan AS, Chong SS Eur. J. Haematol.2013
Alpha thalassemia/mental retardation syndrome X-linked gene product ATRX is required for proper replication restart and cellular resistance to replication stress.Leung JW, Ghosal G, Wang W, Shen X, Wang J, Li L, Chen J J. Biol. Chem.2013
High prevalence of adrenal insufficiency in patients with sickle cell disease: results from a community hospital in the u.s.Makino J, Ndzengue A, Adekolujo S, Tipu A, Dogar UM, Mezher H, Sivasambu B, Trauber D, Guillaume E, Jaffe EA, Shiferaw-Deribe Z Exp. Clin. Endocrinol. Diabetes2013
Use of Serum Iron Status and Hemoglobin A2 Levels for Discrimination Between Iron Deficiency and Thalassemia Minor.Aslan D Pediatr Hematol Oncol2013
Sickle erythrocytes target cytotoxics to hypoxic tumor microvessels and potentiate a tumoricidal response.Terman DS, Viglianti BL, Zennadi R, Fels D, Boruta RJ, Yuan H, Dreher MR, Grant G, Rabbani ZN, Moon E, Lan L, Eble J, Cao Y, Sorg B, Ashcraft K, Palmer G, Telen MJ, Dewhirst MW PLoS ONE2013
Cardiac and hepatic iron and ejection fraction in thalassemia major: Multicentre prospective comparison of combined Deferiprone and Deferoxamine therapy against Deferiprone or Deferoxamine Monotherapy.Pepe A, Meloni A, Rossi G, Cuccia L, D Ascola GD, Santodirocco M, Cianciulli P, Caruso V, Romeo MA, Filosa A, Pitrolo L, Putti MC, Peluso A, Campisi S, Missere M, Midiri M, Gulino L, Positano V, Lombardi M, Ricchi P J Cardiovasc Magn Reson2013
Locus of control, depression and quality of life among persons with sickle cell disease in Jamaica.Gibson RC, Morgan KA, Abel WD, Sewell CA, Martin JS, Lowe GA, Haye WD, Edwards CL, O'Garo KN, Reid ME, Asnani MR Psychol Health Med2013
Craniofacial bone infarcts in sickle cell disease: clinical and radiological manifestations.Watanabe M, Saito N, Nadgir RN, Liao JH, Flower EN, Steinberg MH, Sakai O J Comput Assist Tomogr2013
The spectrum of β-thalassemia mutations in Gaza Strip, Palestine.Sirdah MM, Sievertsen J, Al-Yazji MS, Tarazi IS, Al-Haddad RM, Horstmann RD, Timmann C Blood Cells Mol. Dis.2013
Comparison of discriminative indices for iron deficiency anemia and β thalassemia trait in a Brazilian population.Matos JF, Dusse LM, Stubbert RV, Ferreira MR, Coura-Vital W, Fernandes AP, de Faria JR, Borges KB, Carvalho MD Hematology2013
Association between Sickle Cell Anemia and Pulp Necrosis.Costa CP, Thomaz EB, Souza Sde F J Endod2013
Systematic review of current and emerging strategies for reducing morbidity from malaria in sickle cell disease.Aneni EC, Hamer DH, Gill CJ Trop. Med. Int. Health2013
Hydroxyurea treatment in β-thalassemia patients: to respond or not to respond?Banan M Ann. Hematol.2013
Management of Hepatocellular Carcinoma in Homozygous β-Thalassemia Cirrhotic Patients.Gomatos IP, Alexakis N, Koskinas J, Smparounis SA, Katsaragakis S, Konstadoulakis MM, Zografos GC Am Surg2013
Induction of human fetal hemoglobin expression by denosine-2[prime],3[prime]-dialdehyde.He Y, Rank G, Zhang M, Ju J, Liu R, Xu Z, Brown F, Cerruti L, Ma C, Tan R, Jane SM, Zhao Q J Transl Med2013
Sickle Cell Disease in Pregnancy: Maternal Complications in a Medicaid-Enrolled Population.Boulet SL, Okoroh EM, Azonobi I, Grant A, Craig Hooper W Matern Child Health J2013
Clinical experience with fetal hemoglobin induction therapy in patients with β-thalassemia.Musallam KM, Taher AT, Cappellini MD, Sankaran VG Blood2013
Hypoxia Biomarkers, Oxidative Stress, and Circulating Microparticles in Pediatric Patients With Thalassemia in Upper Egypt.Elsayh KI, Zahran AM, El-Abaseri TB, Mohamed AO, El-Metwally TH Clin. Appl. Thromb. Hemost.2013
Hemoglobin variants and high-performance liquid chromatography.Nair S, Nadkarni AH, Ghosh K, Colah R Int J Lab Hematol2013
Genetic Heterogeneity of Beta Globin Mutations among Asian-Indians and Importance in Genetic Counselling and Diagnosis.Kumar R, Singh K, Panigrahi I, Agarwal S Mediterr J Hematol Infect Dis2013
Beta thalassemia major in a developing country: epidemiological, clinical and evolutionary aspects.Bejaoui M, Guirat N Mediterr J Hematol Infect Dis2013
Age at diagnosis of sickle cell anaemia in lagos, Nigeria.Akodu S, Diaku-Akinwumi I, Njokanma O Mediterr J Hematol Infect Dis2013
Characterization of Adult α- and β-Globin Elevated by Hydrogen Peroxide in Cervical Cancer Cells That Play A Cytoprotective Role Against Oxidative Insults.Li X, Wu Z, Wang Y, Mei Q, Fu X, Han W PLoS ONE2013
Erythrocyte NADPH oxidase activity modulated by Rac GTPases, PKC, and plasma cytokines contributes to oxidative stress in sickle cell disease.George A, Pushkaran S, Konstantinidis DG, Koochaki S, Malik P, Mohandas N, Zheng Y, Joiner CH, Kalfa TA Blood2013
Hair-on-end appearance in a case of thalassemia intermedia.Balikar R, Redkar NN, Patil MA, Pillai R BMJ Case Rep2013
Hemodynamic Predictors of Mortality in Adults with Sickle Cell Disease.Mehari A, Alam S, Tian X, Cuttica MJ, Barnett CF, Miles G, Xu D, Seamon C, Adams-Graves P, Castro OL, Minniti CP, Sachdev V, Taylor Vi JG, Kato GJ, Machado RF Am. J. Respir. Crit. Care Med.2013
Care Seeking for Pain in Young Adults with Sickle Cell Disease.Jenerette CM, Brewer CA, Ataga KI Pain Manag Nurs2013
Sickle Cell Disease with Double Stroke in a Moroccan Family.Hamzi K, Itto AB, Jouhadi Z, Slassi I, Nadifi S J. Mol. Neurosci.2013
Epidemiology of Bloodstream Infections in Children with Sickle Cell Disease.Ellison AM, Ota KV, McGowan KL, Smith-Whitley K Pediatr. Infect. Dis. J.2013
Triplex-forming Peptide Nucleic Acids Induce Heritable Elevations in Gamma-globin Expression in Hematopoietic Progenitor Cells.Chin JY, Reza F, Glazer PM Mol. Ther.2013
Successful Unrelated Cord Blood Transplantation For Homozygous α-Thalassemia.Gumuscu B, Thompson EI, Grovas AC, Zach TL, Warkentin PI, Coccia PF J. Pediatr. Hematol. Oncol.2013
Gene therapy for hemoglobinopathies: progress and challenge.Dong A, Rivella S, Breda L Transl Res2013
Serial echocardiographic left ventricular ejection fraction measurements: A tool for detecting thalassemia major patients at risk of cardiac death.Maggio A, Vitrano A, Calvaruso G, Barone R, Rigano P, Mancuso L, Cuccia L, Capra M, Pitrolo L, Prossomariti L, Filosa A, Caruso V, Gerardi C, Campisi S, Cianciulli P, Elefteriou A, Angastiniotis M, Hamza H, Telfer P, Walker JM, Phrommintikul A, Chattipakorn N Blood Cells Mol. Dis.2013
Age-related treatment patterns in sickle cell disease patients and the associated sickle cell complications and healthcare costs.Blinder MA, Vekeman F, Sasane M, Trahey A, Paley C, Duh MS Pediatr Blood Cancer2013
Thirty years experience in preventing haemoglobinopathies in Greece: achievements and potentials for optimization.Ladis V, Karagiorga-Lagana M, Tsatra I, Chouliaras G Eur. J. Haematol.2013
Incidence, Risk Factors, and Outcome of Portal Vein Thrombosis After Laparoscopic-Assisted Splenectomy in β-Thalassemia Patients: A Prospective Exploratory Study.Alexakis N, Dardamanis D, Albanopoulos K, Ptohis N, Skalistira M, Karagiorga M, Zografos G, Leandros E J Laparoendosc Adv Surg Tech A2013
Redox Reactions of Hemoglobin: Mechanisms of Toxicity and Control.Mollan T, Alayash AI Antioxid. Redox Signal.2013
In vivo comparison of myocardial T1 with T2 and T2* in thalassaemia major.Feng Y, He T, Carpenter JP, Jabbour A, Alam MH, Gatehouse PD, Greiser A, Messroghli D, Firmin DN, Pennell DJ J Magn Reson Imaging2013
1,25-Dihydroxyvitamin D(3) -induced intestinal calcium transport is impaired in β-globin knockout thalassemic mice.Charoenphandhu N, Kraidith K, Teerapornpuntakit J, Thongchote K, Khuituan P, Svasti S, Krishnamra N Cell Biochem. Funct.2013
Doppler Ultrasound Velocimetry of Middle Cerebral Arteries of Patients With Sickle Cell Disease at Aminu Kano Teaching Hospital: A Preliminary Report.Tabari AM, Ismail A Ultrasound Q2013
Moyamoya syndrome with sickle cell trait.Agrawal R, Berube C, Steinberg G, George TI Int J Lab Hematol2013
Stem cell transplantation after reduced intensity conditioning for sickle cell disease.Matthes-Martin S, Lawitschka A, Fritsch G, Lion T, Grimm B, Breuer S, Boztug H, Karlhuber S, Holter W, Peters C, Minkov M Eur. J. Haematol.2013
Hb Plasencia [α125(H8)Leu→Arg (α2)] is a Frequent Cause of α(+)-Thalassemia in the Portuguese Population.Cunha E, Bento C, Oliveira A, Relvas L, Neves J, Gameiro M, Barros C, Araújo A, Macedo A, Rocha P, Costa R, Maia T, Ribeiro ML Hemoglobin2013
Comparative Assessment of Deferiprone and Deferasirox in Thalassemia Major Patients in the First Two Decades-Single Centre Experience.Zachariah M, Tony S, Bashir W, Al Rawas A, Wali Y, Pathare A Pediatr Hematol Oncol2013
Strokes and hemoglobinopathies in Burkina Faso.Napon C, Kaboré A, Ouédraogo M, Dravé A, Lompo L, Kaboré J Med Sante Trop2013
Changes of Bone Density in Pediatric Patients with β-thalassemia Major after Allogenic Hematopoietic Stem Cell Transplantation.Hamidieh AA, Hamidi Z, Nedaeifard L, Heshmat R, Alimoghaddam K, Larijani B, Ghavamzadeh A, Mohajeri-Tehrani MR Arch Iran Med2013
Microdeletion Of Exon 3 In The HBA2 Gene Associated With Mild α-Thalassemia Trait.Lambert A, Wong AY, Kominami Y, Smith VC, Reddy S, Wadsworth LD, Au NH, Macgillivray RT Hemoglobin2013
Influence of Lime Juice on the Severity of Sickle Cell Anemia.Adegoke SA, Shehu UA, Mohammed LO, Sanusi Y, Oyelami OA J Altern Complement Med2013
Combined iron deficiency and thalassemia minor.Burdick C Am. J. Clin. Pathol.2013
The Transfusion Alternatives Preoperatively in Sickle Cell Disease (TAPS) study: a randomised, controlled, multicentre clinical trial.Howard J, Malfroy M, Llewelyn C, Choo L, Hodge R, Johnson T, Purohit S, Rees DC, Tillyer L, Walker I, Fijnvandraat K, Kirby-Allen M, Spackman E, Davies SC, Williamson LM Lancet2013
Preoperative transfusion in patients with sickle-cell disease.Goldsmith JC, Wang WC Lancet2013
Hb Treviso [α91(FG3)Leu→Phe (α2)]: A New Slightly Unstable Hemoglobin Variant with Moderately Decreased Oxygen Affinity.Barberio G, Leone D, Ivaldi G, Giordano PC Hemoglobin2013
Low cost biosensor-based molecular differential diagnosis of α-thalassemia (Southeast Asia deletion).Wangmaung N, Promptmas C, Chomean S, Sanchomphu C, Ittarat W Clin. Chem. Lab. Med.2013
Detection of Hb Constant Spring [α142, Term→Gln, TAA>CAA (α2)] in Heterozygotes Combined With β-Thalassemia.Li YQ, Li R, Li DZ Hemoglobin2013
Gγ-Xmn I Polymorphism: A Significant Determinant of β-Thalassemia Treatment Without Blood Transfusion.Ansari SH, Shamsi TS, Munzir S, Khan MT, Erum S, Perveen K, Farzana T, Ashraf M, Mehboob T, Moinuddin M J. Pediatr. Hematol. Oncol.2013
Hemoglobin Variants: Biochemical Properties and Clinical Correlates.Thom CS, Dickson CF, Gell DA, Weiss MJ Cold Spring Harb Perspect Med2013
Fetal Myocardial Performance (Tei) Index in Fetal Hemoglobin Bart's Disease.Luewan S, Tongprasert F, Srisupundit K, Tongsong T Ultraschall Med2013
Automated capillary electrophoresis in the screening for hemoglobinopathies.Cotton F, Wolff F, Gulbis B Methods Mol. Biol.2013
Trends in hospital admissions for sickle cell disease in England.Aljuburi G, Majeed A J Public Health (Oxf)2013
Trends in hospital admissions for sickle cell disease in England.Latinovic R, Streetly A J Public Health (Oxf)2013
Protection from sickle cell retinopathy is associated with elevated HbF levels and hydroxycarbamide use in children.Estepp JH, Smeltzer MP, Wang WC, Hoehn ME, Hankins JS, Aygun B Br. J. Haematol.2013
Hemoglobinopathy: molecular epidemiological characteristics and health effects on hakka people in the meizhou region, southern china.Lin M, Wen YF, Wu JR, Wang Q, Zheng L, Liu GR, Huang Y, Yang H, Lin F, Zhan XF, Lin CP, Yang HT, Weng QQ, Huang FT, Wang Y, Yao MQ, Chen HZ, Wu DH, Zeng JB, Zeng RX, Yang H, Li GC, Lu M, Zhu JJ, Xie LX, Wang JL, Yang LY PLoS ONE2013
Protection against Oxidative Stress in Beta Thalassemia/Hemoglobin E Erythrocytes by Inhibitors of Glutathione Efflux Transporters.Muanprasat C, Wongborisuth C, Pathomthongtaweechai N, Satitsri S, Hongeng S PLoS ONE2013
Effects of adenotonsillectomy on polysomnographic parameters in children with sickle cell disease.Finch P, Stocks RM, Smeltzer MP, Kimble A, Schoumacher R, Hankins JS Pediatr Blood Cancer2013
The impact of race and disease on sickle cell patient wait times in the emergency department.Haywood C, Tanabe P, Naik R, Beach MC, Lanzkron S Am J Emerg Med2013
Cost utility analysis of reduced intensity hematopoietic stem cell transplantation in adolescence and young adult with severe thalassemia compared to hypertransfusion and iron chelation program.Sruamsiri R, Chaiyakunapruk N, Pakakasama S, Sirireung S, Sripaiboonkij N, Bunworasate U, Hongeng S BMC Health Serv Res2013
Visual Diagnosis: A 31/2-year-old Boy With Sickle β-Thalassemia and a Groin Mass.Bagchi A, Elnawawi A, Sadanandan S Pediatr Rev2013
The prevention of thalassemia.Cao A, Kan YW Cold Spring Harb Perspect Med2013
Classification of the disorders of hemoglobin.Forget BG, Bunn HF Cold Spring Harb Perspect Med2013
Prevalence of hypoxemia among children with sickle cell anemia during steady state and crises: A cross-sectional study.Chinawa JM, Ubesie AC, Chukwu BF, Ikefuna AN, Emodi IJ Niger J Clin Pract2013
Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson.Field JJ, Lin G, Okam MM, Majerus E, Keefer J, Onyekwere O, Ross A, Campigotto F, Neuberg D, Linden J, Nathan DG Blood2013
Effect of a Congolese herbal medicine used in sickle cell anemia on the expression of plasminogen activators in Human Coronary Aortic Endothelial Cells culture.Nsimba MM, Yamamoto C, Lami JN, Hayakawa Y, Kaji T J Ethnopharmacol2013
Hepatitis C in patients with β-thalassemia major. A single-centre experience.Triantos C, Kourakli A, Kalafateli M, Giannakopoulou D, Koukias N, Thomopoulos K, Lampropoulou P, Bartzavali C, Fragopanagou H, Kagadis GC, Christofidou M, Tsamandas A, Nikolopoulou V, Karakantza M, Labropoulou-Karatza C Ann. Hematol.2013
Abnormal myocardial perfusion-fibrosis pattern in sickle cell disease assessed by cardiac magnetic resonance imaging.Bratis K, Kattamis A, Athanasiou K, Hautemann D, van Wijk K, Reiber H, Mavrogeni S Int. J. Cardiol.2013
Human T-cell lymphotropic virus type 1 Infection among U.S. Thalassemia Patients.Switzer W, Shankar A, Trimble S, Thompson AA, Giardina PJ, Cohen AR, Coates TD, Vichinsky E, Neufeld EJ, Boudreaux JM, Heneine PW AIDS Res. Hum. Retroviruses2013
Candidate sequence variants and fetal hemoglobin in children with sickle cell disease treated with hydroxyurea.Green NS, Ender KL, Pashankar F, Driscoll C, Giardina PJ, Mullen CA, Clark LN, Manwani D, Crotty J, Kisselev S, Neville KA, Hoppe C, Barral S PLoS ONE2013
Genetic determinants of haemolysis in sickle cell anaemia.Milton JN, Rooks H, Drasar E, McCabe EL, Baldwin CT, Melista E, Gordeuk VR, Nouraie M, Kato GR, Minniti C, Taylor J, Campbell A, Luchtman-Jones L, Rana S, Castro O, Zhang Y, Thein SL, Sebastiani P, Gladwin MT, , Steinberg MH Br. J. Haematol.2013
Fetal hemoglobin and hydroxycarbamide modulate both plasma concentration and cellular origin of circulating microparticles in sickle cell anemia children.Nébor D, Romana M, Santiago R, Vachiery N, Picot J, Broquere C, Chaar V, Doumdo L, Odièvre MH, Benkerrou M, Elion J Haematologica2013
Busulfan, Fludarabine and Alemtuzumab Conditioning and Unrelated Cord Blood Transplantation in Children with Sickle Cell Disease.Radhakrishnan K, Bhatia M, Geyer MB, Del Toro G, Jin Z, Baker C, Harrison L, Morris E, Baxter-Lowe LA, Cairo MS Biol. Blood Marrow Transplant.2013
Results of hematopoietic stem cell transplantation in hemoglobinopathies: Thalassemia major and sickle cell disease.Hladun R, Elorza I, Olivé T, Dapena JL, Llort A, Sánchez de Toledo J, Díaz de Heredia C An Pediatr (Barc)2013
Novel Mutations Responsible for α-Thalassemia in Iranian Families.Bayat N, Farashi S, Hafezi-Nejad N, Faramarzi N, Ashki M, Vakili S, Imanian H, Khosravi M, And AA, Najmabadi H Hemoglobin2013
Thyroid function status and echocardiographic abnormalities in patients with Beta thalassemia major in bahrain.Garadah TS, Mahdi NA, Jaradat AM, Hasan ZA, Nagalla DS Clin Med Insights Cardiol2013
Normal Hb A(2) β-Thalassemia Trait: Frameshift Mutation (HBB: c.187_251dup) in Cis with the Hb A(2') δ-Globin Gene Missense Mutation (HBD: c.49G>C).Waye JS, Eng B, Hellens L, Hohenadel BA, Nakamura LM, Walker L Hemoglobin2013
Breast cancer in patients with sickle cell disease can be treated safely with weekly paclitaxel.Al Zaman AS Saudi Med J2013
Molecular and hematological characteristics of a novel form of α-globin gene triplication: The hemoglobin St. Luke's-Thailand [α95(G2)Pro→Arg] or Hb St. Luke's [A2] HBA2.Singha K, Fucharoen G, Jetsrisuparb A, Fucharoen S Clin. Biochem.2013
Subarachnoidal hemorrhage and multiple vascular cerebral abnormalities in β-thalassemia major.Svahn J, Cho TH, Derex L, Mechtouff L, Nighoghossian N Rev. Neurol. (Paris)2013
Evolutionary constraints in the β-globin cluster: the signature of purifying selection at the δ-globin (HBD) locus and its role in developmental gene regulation.Moleirinho A, Seixas S, Lopes AM, Bento C, Prata MJ, Amorim A Genome Biol Evol2013
Michelangelo's John the Baptist and thalassemia.Tan M, Goh S, Ashrafian H Ann. Hematol.2013
A simple, rapid, low-cost diagnostic test for sickle cell disease.Yang X, Kanter J, Piety NZ, Benton MS, Vignes SM, Shevkoplyas SS Lab Chip2013
High Throughput Molecular Confirmation of β-Thalassemia Mutations Using Novel TaqMan Probes.Kho SL, Chua KH, George E, Tan JA Sensors (Basel)2013
Disruption of the Hbsl1-Myb Locus Causes Hereditary Persistence of Fetal Hemoglobin in Mouse.Suzuki M, Yamazaki H, Mukai HY, Motohashi H, Shi L, Tanabe O, Engel JD, Yamamoto M Mol. Cell. Biol.2013
Iron overload in β-thalassemia intermedia: an emerging concern.Musallam KM, Cappellini MD, Taher AT Curr. Opin. Hematol.2013
Evaluation of the 5mg/g liver iron concentration threshold and its association with morbidity in patients with β-thalassemia intermedia.Musallam KM, Cappellini MD, Taher AT Blood Cells Mol. Dis.2013
Association in Cis of the Mutations +20 (C>T) in the 5' Untranslated Region and IVS-II-745 (C>G) on the β-Globin Gene.Ropero P, González FA, Cela E, Beléndez C, Cervera A, Martínez-Nieto J, Fuente-Gonzalo FD, Vinuesa L, Villegas A, Díaz-Mediavilla J Hemoglobin2013
Misdiagnosis of Hb D-Punjab/β-Thalassemia is a Potential Pitfall in Hemoglobinopathy Screening Programs: A Case Report.Belhoul KM, Bakir ML, Abdulrahman M Hemoglobin2013
Prevalence and Molecular Characterization of β-Thalassemia in the State of Bahia, Brazil: First Identification of Mutation HBB: c.135delC in Brazil.Fonseca SF, Moura Neto JP, Goncalves MS Hemoglobin2013
Risk Adopted Allogeneic Hematopoietic Stem Cell Transplantation Using a Reduced Intensity Regimen for Children with Thalassemia Major.Hussein AA, Al-Zaben A, Ghatasheh L, Natsheh A, Hammada T, Abdel-Rahman F, Abu-Jazar H, Sharma S, Najjar R, Frangoul H Pediatr Blood Cancer2013
Genetic mapping and exome sequencing identify two mutations associated with stroke protection in pediatric patients with sickle cell anemia.Flanagan JM, Sheehan V, Linder H, Howard TA, Wang YD, Hoppe CC, Aygun B, Adams RJ, Neale GA, Ware RE Blood2013
Wandering Pneumonia, Recurrent Hemoptysis, and Anemia in a Child With Sickle Cell Trait.Chauhan A, Urrego F, Warrier R Clin Pediatr (Phila)2013
Spectrum of α-thalassemia mutations including first observation of - -(FIL) deletion in Hatay Province, Turkey.Celik MM, Gunesacar R, Oktay G, Duran GG, Kaya H Blood Cells Mol. Dis.2013
Cerebral blood flow abnormalities in children with sickle cell disease: a systematic review.Behpour AM, Shah PS, Mikulis DJ, Kassner A Pediatr. Neurol.2013
Low flow nocturnal oxygen therapy does not suppress haemoglobin levels or increase painful crises in sickle cell disease.Ip H, Kesse-Adu R, Howard J, Hart N Br. J. Haematol.2013
Sickle cell disease in pregnancy: trend and pregnancy outcomes at a tertiary hospital in Tanzania.Muganyizi PS, Kidanto H PLoS ONE2013
Retinal changes in children and adolescents with sickle cell disease attending a paediatric hospital in Cairo, Egypt: risk factors and relation to ophthalmic and cerebral blood flow.Tantawy AA, Andrawes NG, Adly AA, El Kady BA, Shalash AS Trans. R. Soc. Trop. Med. Hyg.2013
Exploring barriers and facilitators to clinical trial enrollment in the context of sickle cell anemia and hydroxyurea.Lebensburger JD, Sidonio RF, Debaun MR, Safford MM, Howard TH, Scarinci IC Pediatr Blood Cancer2013
Long Term Outcome and Evaluation of Organ Function in Pediatric Patients Undergoing Haploidentical and Matched Related Hematopoietic Cell Transplantation for Sickle Cell Disease.Dallas M, Triplett B, Shook D, Hartford C, Srinivasan A, Laver J, Ware R, Leung W Biol. Blood Marrow Transplant.2013
Wandering Spleen Associated With β-Thalassemia: A Case Report.Akhter MQ, Authoy F, Nabi J, Rahman MR, Hossain I, Hossain MM, Mamun AA, Chakrabarty P Mymensingh Med J2013
Lysine-specific demethylase 1 is a therapeutic target for fetal hemoglobin induction.Shi L, Cui S, Engel JD, Tanabe O Nat. Med.2013
A double-blind, randomized, multicenter phase 2 study of prasugrel versus placebo in adult patients with sickle cell disease.Wun T, Soulieres D, Frelinger AL, Krishnamurti L, Novelli EM, Kutlar A, Ataga KI, Knupp CL, McMahon LE, Strouse JJ, Zhou C, Heath LE, Nwachuku CE, Jakubowski JA, Riesmeyer JS, Winters KJ J Hematol Oncol2013
Natural history of hepatitis C in thalassemia major : a long-term prospective study.Eliana LM, Raffaella O, Fabrice D, Battista LG, Stefania V, Franco A, Claudia C, Patrizia F, Giovanna C, Renzo G Eur. J. Haematol.2013
Pseudoxanthoma elasticum-like lesions in beta-thalassemia/hemoglobin E patient: A case report.Kasemsarn P, Boonchai W J. Dermatol.2013
Mortality rates and age at death from sickle cell disease: u.s., 1979-2005.Lanzkron S, Carroll CP, Haywood C Public Health Rep2013
Acquired hemoglobin variants and exposure to glucose-6-phosphate dehydrogenase deficient red blood cell units during exchange transfusion for sickle cell disease in a patient requiring antigen-matched blood.Raciti PM, Francis RO, Spitalnik PF, Schwartz J, Jhang JS J Clin Apher2013
Assessment of communication modes in patients and families with sickle cell disease.Anderson C, Torres S, Gokuli S, Brandow AM, Panepinto JA Pediatr Blood Cancer2013
Mi2β-mediated silencing of the fetal γ-globin gene in adult erythroid cells.Amaya M, Desai M, Gnanapragasam MN, Wang SZ, Zhu SZ, Williams DC, Ginder GD Blood2013
PML bodies provides an important platform for the maintenance of telomeric chromatin integrity in embryonic stem cells.Chang FT, McGhie JD, Chan FL, Tang MC, Anderson MA, Mann JR, Andy Choo KH, Wong LH Nucleic Acids Res.2013
Haemoglobin variants among voluntary blood donors in Jos, Nigeria: the implications on blood transfusion.Damulak OD, Bolorunduro SA, Egesie JO, Yakubu K, Godit P, Smith OA Niger J Med2013
Value of magnetic resonance imaging T2* tests in detecting heart and liver iron overload in patients with β-thalassemia major.Wu XD, Jing YF, Pei FY, Chen JQ, Feng XQ, He YL, Zhang YM, Li CF Nan Fang Yi Ke Da Xue Xue Bao2013
PedsQL™ Sickle Cell Disease Module: Feasibility, Reliability, and Validity.Panepinto JA, Torres S, Bendo CB, McCavit TL, Dinu B, Sherman-Bien S, Bemrich-Stolz C, Varni JW Pediatr Blood Cancer2013
Antibiotics for treating acute chest syndrome in people with sickle cell disease.Martí-Carvajal AJ, Conterno LO, Knight-Madden JM Cochrane Database Syst Rev2013
Phytomedicines (medicines derived from plants) for sickle cell disease.Oniyangi O, Cohall DH Cochrane Database Syst Rev2013
Sistani Population: a Different Spectrum oF β-Thalassemia Mutations From other Ethnic Groups of Iran.Miri-Moghaddam E, Zadeh-Vakili A, Nikravesh A, Sanei Sistani S, Naroie-Nejad M Hemoglobin2013
Daytime pulse oximetry measurements may not predict nocturnal desaturations in adult sickle cell patients.Mehta H, Efird JT, Kadali RA, Boettger P, Liles D, Knupp C, Sharma S Ann. Hematol.2013
Sickle cell disease and venous thromboembolism: what the anticoagulation expert needs to know.Naik RP, Streiff MB, Lanzkron S J. Thromb. Thrombolysis2013
Sickle Cell Disease and Perioperative Considerations: Review and Retrospective Report.Stanley AC, Christian JM J. Oral Maxillofac. Surg.2013
Renal tubular dysfunction in children with sickle cell heamoglobinopathy.Badr M, El Koumi MA, Ali YF, Almonem NA, Hassan T, El-Morshedy S, El Rahman RA, Afify M Nephrology (Carlton)2013
Codon 62 (GTG>GCG, Val→Ala) (α1) (HBA1: c.188T>C) Causing Nondeletional α-Thalassemia in a Chinese Family.Liao C, Tang HS, Li R, Li DZ Hemoglobin2013
Identification of the First Mutation in a Bre Motif of the β-Globin Gene and its Inheritance with two Other α-Globin Gene Mutations in a Lebanese Family.Inati A, Abbas HA, Al-Danaf J, Souaid M, Kahale M, Koussa S, Nasr TA, Davis L, Luo HY, Chui DH Hemoglobin2013
Thalassemia and premarital screening: potential for implementation of a screening program among young people in pakistan.Mirza A, Ghani A, Pal A, Sami A, Hannan S, Ashraf Z, Iqbal S, Malik UZ, Hayat U, Fatmi Z Hemoglobin2013
Secular trends in the national and provincial births of new thalassemia cases in iran from 2001 to 2006.Hadipour Dehshal M, Ahmadvand A, Yousefi Darestani S, Manshadi M, Abolghasemi H Hemoglobin2013
Platelet Activation and Inhibition iN Sickle cell disease (PAINS) study.Frelinger AL, Jakubowski JA, Brooks JK, Carmichael SL, Berny-Lang MA, Barnard MR, Heeney MM, Michelson AD Platelets2013
Two decades of pre-marital screening for beta-thalassemia in central Iran.Zeinalian M, Nobari RF, Moafi A, Salehi M, Hashemzadeh-Chaleshtori M J Community Genet2013
Fetal hemoglobin in sickle cell anemia: Genetic studies of the Arab-Indian haplotype.Ngo D, Bae H, Steinberg MH, Sebastiani P, Solovieff N, Baldwin CT, Melista E, Safaya S, Farrer LA, Al-Suliman AM, Albuali WH, Al Bagshi MH, Naserullah Z, Akinsheye I, Gallagher P, Luo HY, Chui DH, Farrell JJ, Al-Ali AK, Alsultan A Blood Cells Mol. Dis.2013
Diminishing bias in sickle cell disease.Stewart R, Whiteman L Med Teach2013
Weight Status of Children With Sickle Cell Disease.Chawla A, Sprinz PG, Welch J, Heeney M, Usmani N, Pashankar F, Kavanagh P Pediatrics2013
Hemoglobin Shady Grove: A Novel Fetal Methemoglobin Variant.Marks A, Luo HY, Chui DH, Greenberg J Pediatr Blood Cancer2013
"You Just Have to Live With It": Coping With Sickle Cell Disease in Jamaica.Anderson M, Asnani M Qual Health Res2013
Predictors of Academic Achievement for School Age Children with Sickle Cell Disease.Smith KE, Patterson CA, Szabo MM, Tarazi RA, Barakat LP Adv Sch Ment Health Promot2013
Distinct sonographic features of acute appendicitis in sickle cell disease.Monib S, Donkol RH, Hassan A, Riaz AA Ann Saudi Med2013
Prevalence of iron overload complications among patients with b-thalassemia major treated at Dubai Thalassemia Centre.Belhoul KM, Bakir ML, Kadhim AM, Dewedar HE, Eldin MS, Alkhaja FA Ann Saudi Med2013
A review of acute chest syndrome in pediatric sickle cell disease.Abbas HA, Kahale M, Hosn MA, Inati A Pediatr Ann2013
Determining and Surveying the Role of Carnitine and Folic Acid to Decrease Fatigue in β-Thalassemia Minor Subjects.Tabei SM, Mazloom M, Shahriari M, Zareifar S, Azimi A, Hadaegh A, Karimi M Pediatr Hematol Oncol2013
Daily changes in pain, mood and physical function in children hospitalized for sickle cell disease pain.Zempsky WT, Palermo TM, Corsi JM, Lewandowski AS, Zhou C, Casella JF Pain Res Manag2013
Understanding the experiences of youth living with sickle cell disease: a photovoice pilot.Valenzuela JM, Vaughn LM, Crosby LE, Strong H, Kissling A, Mitchell MJ Fam Community Health2013
Multifocal osteoarticular infection caused by Salmonella non typhi in a child with sickle cell disease.Cabaret B, Couëc ML, Lorrot M, Launay E, Gras-Le Guen C Arch Pediatr2013
Sudden death in a case of sickle cell anemia: Post-mortem computed tomography and autopsy correlation from a radiologist's perspective.Abdul Rashid SN, Krauskopf A, Vonlanthen B, Thali MJ, Ruder TD Leg Med (Tokyo)2013
Hematological and hemorheological determinants of resting and exercise-induced hemoglobin oxygen desaturation in children with sickle cell disease.Waltz X, Romana M, Lalanne-Mistrih ML, Machado RF, Lamarre Y, Tarer V, Hardy-Dessources MD, Tressieres B, Divialle-Doumdo L, Petras M, Maillard F, Etienne-Julan M, Connes P Haematologica2013
Bone Mineral Density Patterns in Vitamin D Deficient African American Men With Sickle Cell Disease.Adams-Graves P, Daniels AB, Womack CR, Freire AX Am. J. Med. Sci.2013
Evaluation of h3 histone methylation and colony formation in erythroid progenitors treated with thalidomide and sodium butyrate.Fard AD, Kaviani S, Noruzinia M, Soleimani M, Abroun S, Chegeni R, Hajifathali A, Zonoubi Z, Ahmadvand M, Mohammadi MM, Saki N Lab Hematol2013
A pharmaco-economic evaluation of deferasirox for treating patients with iron overload caused by transfusion-dependent thalassemia in Taiwan.Ho WL, Chung KP, Yang SS, Lu MY, Jou ST, Chang HH, Yang YL, Lin DT, Lin KH J. Formos. Med. Assoc.2013
Novel Single Cell Functional Analysis of Red Blood Cells using Laser Tweezers Raman Spectroscopy: Application for Sickle Cell Disease.Liu R, Mao Z, Matthews DL, Li CS, Chan JW, Satake N Exp. Hematol.2013
The acute chest syndrome of sickle cell disease.Desai PC, Ataga KI Expert Opin Pharmacother2013
Updated role of nitric oxide in disorders of erythrocyte function.Kahn MJ, Maley JH, Lasker GF, Kadowitz PJ Cardiovasc Hematol Disord Drug Targets2013
Establishment of immortalized human erythroid progenitor cell lines able to produce enucleated red blood cells.Kurita R, Suda N, Sudo K, Miharada K, Hiroyama T, Miyoshi H, Tani K, Nakamura Y PLoS ONE2013
Thrombin Generation in Children with Sickle Cell Disease: Relationship with Age, Hemolysis, Transcranial Doppler Velocity and Hydroxyurea Treatment.Noubouossie DC, Lê PQ, Rozen L, Ziereisen F, Willems D, Demulder A, Ferster A Eur. J. Haematol.2013
Sickle cell disease--the American saga.Siddiqi AE, Jordan LB, Parker CS Ethn Dis2013
Erythropoiesis in the absence of adult hemoglobin.Liu S, McConnell SC, Ryan TM Mol. Cell. Biol.2013
Factors affecting hemoglobin measurement.Berkow L J Clin Monit Comput2013
Bacteremia in Febrile Children With Sickle Cell Disease.Ozgönenel B, Mushrif SK, McGrath E, Roy S, Sarnaik S J. Pediatr. Hematol. Oncol.2013
Generation of Transgene-free Induced Pluripotent Stem Cells with Non-viral Methods.Wang T, Zhao HS, Zhang QL, Xu CL, Chang-Bai Liu A Chin. Med. Sci. J.2013
Pilot Study of Human Recombinant Hyaluronidase-Enhanced Subcutaneous Hydration and Opioid Administration for Sickle Cell Disease Acute Pain Episodes.Sandoval M, Coleman P, Govani R, Siddiqui S, Todd KH J Pain Palliat Care Pharmacother2013
Among emergency physicians, use of the term 'Sickler' is associated with negative attitudes towards people with sickle cell disease.Jeffrey G, Paula T, Lynne R, Michael D Am. J. Hematol.2013
Phenotypic and molecular changes of hemoglobinopathies in cancer.Abaza H, Gara Y, Ben Chaabene A, Douik H, Harzallah L, Boussen H, Guemira F Tunis Med2013
Problems in determining thalassemia carrier status in a program for prevention and control of severe thalassemia syndromes: a lesson from Thailand.Viprakasit V, Limwongse C, Sukpanichnant S, Ruangvutilert P, Kanjanakorn C, Glomglao W, Sirikong M, Utto W, Tanphaichitr VS Clin. Chem. Lab. Med.2013
Detection of fetal mutations causing hemoglobinopathies by non-invasive prenatal diagnosis from maternal plasma.D'Souza E, Sawant PM, Nadkarni AH, Gorakshakar A, Ghosh K, Colah RB J Postgrad Med2013
Reducing TMPRSS6 ameliorates hemochromatosis and β-thalassemia in mice.Guo S, Casu C, Gardenghi S, Booten S, Aghajan M, Peralta R, Watt A, Freier S, Monia BP, Rivella S J. Clin. Invest.2013
Striking the target in iron overload disorders.Finberg KE J. Clin. Invest.2013
Tertiary and quaternary effects in the allosteric regulation of animal hemoglobins.Ronda L, Bruno S, Bettati S Biochim. Biophys. Acta2013
Erythroid transcription factor EKLF/KLF1 mutation causing congenital dyserythropoietic anemia type IV in a patient of Taiwanese origin: Review of all reported cases and development of a clinical diagnostic paradigm.Jaffray JA, Mitchell WB, Gnanapragasam MN, Seshan SV, Guo X, Westhoff CM, Bieker JJ, Manwani D Blood Cells Mol. Dis.2013
Complex neonatal hemoglobin pattern due to co-inheritance of Hb Q-Thailand and Hb E.van Gammeren AJ, Jonkers M, Harteveld CL Int J Lab Hematol2013
Macrophages support pathological erythropoiesis in polycythemia vera and β-thalassemia.Ramos P, Casu C, Gardenghi S, Breda L, Crielaard BJ, Guy E, Marongiu MF, Gupta R, Levine RL, Abdel-Wahab O, Ebert BL, Van Rooijen N, Ghaffari S, Grady RW, Giardina PJ, Rivella S Nat. Med.2013
Prevalence of HBsAg and anti-HCV antibodies in homozygous sickle cell patients at Yaounde Central Hospital.Sack FN, Noah DN, Zouhaïratou H, Mbanya D Pan Afr Med J2013
Blood transfusion among thalassemia patients: A single Egyptian center experience.Ragab LA, Hamdy MM, Shaheen IA, Yassin RN Asian J Transfus Sci2013
Prevalence of common hemoglobin variants in an afro-descendent Ecuadorian population.Domínguez Y, Zurita C, Calvopiña D, Villacís J, Mora M BMC Res Notes2013
Genetic compound heterozygosity for Southeast Asian ovalocytosis and thalassemia in Thailand: prevalence and phenotypic analysis.Ngouprommin L, Sae-Ung N, Fucharoen S, Fucharoen G, Sanchaisuriya K, Jetsrisuparb A Clin. Genet.2013
Genomic variation in the MAP3K5 gene is associated with β-thalassemia disease severity and hydroxyurea treatment efficacy.Tafrali C, Paizi A, Borg J, Radmilovic M, Bartsakoulia M, Giannopoulou E, Giannakopoulou O, Stojiljkovic-Petrovic M, Zukic B, Poulas K, Stavrou EF, Lambropoulou P, Kourakli A, Felice AE, Papachatzopoulou A, Philipsen S, Pavlovic S, Georgitsi M, Patrinos GP Pharmacogenomics2013
Relationship between Malaria Incidence and IgG Levels to Plasmodium falciparum Merozoite Antigens in Malian Children: Impact of Hemoglobins S and C.Miura K, Diakite M, Diouf A, Doumbia S, Konate D, Keita AS, Moretz SE, Tullo G, Zhou H, Lopera-Mesa TM, Anderson JM, Fairhurst RM, Long CA PLoS ONE2013
Haptoglobin Preferentially Binds β but Not α Subunits Cross-Linked Hemoglobin Tetramers with Minimal Effects on Ligand and Redox Reactions.Jia Y, Wood F, Buehler PW, Alayash AI PLoS ONE2013
Biomarkers of hypochromia: the contemporary assessment of iron status and erythropoiesis.Urrechaga E, Borque L, Escanero JF Biomed Res Int2013
Deferasirox demonstrates a dose-dependent reduction in liver iron concentration and consistent efficacy across subgroups of non-transfusion-dependent thalassemia (NTDT) patients.Taher AT, Porter JB, Viprakasit V, Kattamis A, Chuncharunee S, Sutcharitchan P, Siritanaratkul N, Galanello R, Karakas Z, Lawniczek T, Habr D, Ros J, Zhang Y, Cappellini MD Am. J. Hematol.2013
Left ventricular hypertrabeculation / noncompaction in beta-thalassemia.Finsterer J, Stöllberger C Am. J. Hematol.2013
Effectiveness of the model for prenatal control of severe thalassemia.Tongsong T, Charoenkwan P, Sirivatanapa P, Wanapirak C, Piyamongkol W, Sirichotiyakul S, Srisupundit K, Tongprasert F, Luewan S, Ratanasiri T, Komwilaisak R, Saksiriwuttho P, Vuthiwong C, Punpuckdeekoon P, Panichkul P, Rueangchainikhom W, Choowong J, Orungrote N, Sarapak S, Kovavisarach E, Jaruyawongs P, Tansathit T, Phadungkiatwattana P, Rujiwetpongstorn J, Kor-Anantakul O, Suwanrath C, Hanprasertpong T, Pranpanus S Prenat. Diagn.2013
Asymmetric Dimethylarginine levels in Children with Sickle Cell Disease and its Correlation to Tricuspid Regurgitant Jet Velocity.El-Shanshory M, Badraia I, Donia A, Abd El-Hameed F, Mabrouk M Eur. J. Haematol.2013
Preimplantation genetic diagnosis, an alternative to conventional prenatal diagnosis of the hemoglobinopathies.Traeger-Synodinos J Int J Lab Hematol2013
New insights into sickle cell disease: a disease of hypoxia.Sun K, Xia Y Curr. Opin. Hematol.2013
Intra-Abdominal Umbilical Vein Varix Associated with Fetal Cardiac Failure: A Pitfall to the Prenatal Diagnosis of Alpha-Zero-Thalassemia.Rosenblatt J, Loberstajn A, Coulomb A, Stos B, Garel C, Abarah B, Bénifla JL, Jouannic JM Fetal. Diagn. Ther.2013
Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease.Sasongko TH, Nagalla S, Ballas SK Cochrane Database Syst Rev2013
Clinical Manifestations of α-Thalassemia.Vichinsky EP Cold Spring Harb Perspect Med2013
Intrafamilial Transmission of Hepatitis C Infection in Egyptian Multitransfused Thalassemia Patients.Said F, El Beshlawy A, Hamdy M, El Raziky M, Sherif M, Abdel Kader A, Ragab L J. Trop. Pediatr.2013
Fetal Haemoglobin and β-globin Gene Cluster Haplotypes among Sickle Cell Patients in Chhattisgarh.Bhagat S, Patra PK, Thakur AS J Clin Diagn Res2013
The influence of the BCL11A polymorphism on the phenotype of patients with beta thalassemia could be affected by the beta globin locus control region and/or the Xmn1-HBG2 genotypic background.Neishabury M, Zamani F, Keyhani E, Azarkeivan A, Abedini SS, Eslami MS, Kakroodi ST, Vesiehsari MJ, Najmabadi H Blood Cells Mol. Dis.2013
Next generation sequencing of SNPs for non-invasive prenatal diagnosis: challenges and feasibility as illustrated by an application to β-thalassaemia.Papasavva T, van Ijcken WF, Kockx CE, van den Hout MC, Kountouris P, Kythreotis L, Kalogirou E, Grosveld FG, Kleanthous M Eur. J. Hum. Genet.2013
A randomized phase I/II trial of HQK-1001, an oral fetal globin gene inducer, in β-thalassaemia intermedia and HbE/β-thalassaemia.Fucharoen S, Inati A, Siritanaratku N, Thein SL, Wargin WC, Koussa S, Taher A, Chaneim N, Boosalis M, Berenson R, Perrine SP Br. J. Haematol.2013
Treating iron overload in patients with non-transfusion-dependent thalassemia.Taher AT, Viprakasit V, Musallam KM, Cappellini MD Am. J. Hematol.2013
Potential mechanisms for renal damage in beta-thalassemia.Mallat NS, Mallat SG, Musallam KM, Taher AT J. Nephrol.2013
A liver mass in an iron-overloaded thalassaemia intermedia patient.Maakaron JE, Musallam KM, Ayache JB, Jabbour M, Tawil AN, Taher AT Br. J. Haematol.2013
Efficacy and safety of deferasirox at low and high iron burdens: results from the EPIC magnetic resonance imaging substudy.Porter JB, Elalfy MS, Taher AT, Aydinok Y, Chan LL, Lee SH, Sutcharitchan P, Habr D, Martin N, El-Beshlawy A Ann. Hematol.2013
Beta-S globin haplotypes in patients with sickle cell anemia: one approach to understand the diversity in Brazil.Okumura JV, Lobo CL, Bonini-Domingos CR Rev Bras Hematol Hemoter2013
Protective effect of flavonoids against reactive oxygen species production in sickle cell anemia patients treated with hydroxyurea.Henneberg R, Otuki MF, Furman AE, Hermann P, do Nascimento AJ, Leonart MS Rev Bras Hematol Hemoter2013
Molecular matching of red blood cells is superior to serological matching in sickle cell disease patients.da Costa DC, Pellegrino J, Guelsin GA, Ribeiro KA, Gilli SC, Castilho L Rev Bras Hematol Hemoter2013
Impact of iron overload on interleukin-10 levels, biochemical parameters and oxidative stress in patients with sickle cell anemia.Barbosa MC, Dos Santos TE, de Souza GF, de Assis LC, Freitas MV, Gonçalves RP Rev Bras Hematol Hemoter2013
Oxidative stress in sickle cell disease.Queiroz RF, Lima ES Rev Bras Hematol Hemoter2013
Comments on: molecular matching of red blood cells is superior to serological matching in sickle cell disease patients.Nance ST, Keller MA Rev Bras Hematol Hemoter2013
Does increased red blood cell deformability raise the risk for osteonecrosis in sickle cell anemia?Lemonne N, Lamarre Y, Romana M, Mukisi-Mukaza M, Hardy-Dessources MD, Tarer V, Mougenel D, Waltz X, Tressières B, Lalanne-Mistrih ML, Etienne-Julan M, Connes P Blood2013
Umbilical Cord Blood: An Evolving Stem Cell Source for Sickle Cell Disease Transplants.Shenoy S Stem Cells Transl Med2013
Application of Multiplex Ligation-Dependent Probe Amplification to Screen for β-Globin Cluster Deletions: Detection of Two Novel Deletions in a Multi Ethnic Population.Cui J, Azimi M, Baysdorfer C, Vichinsky EP, Hoppe CC Hemoglobin2013
Neuropathic pain in sickle cell disease triggered by Pain-Ease™.Rastogi S, Bird L, Karsli C Paediatr Anaesth2013
Hemoglobin A2 Lowered by Iron Deficiency and α -Thalassemia: Should Screening Recommendation for β -Thalassemia Change?Denic S, Agarwal MM, Al Dabbagh B, El Essa A, Takala M, Showqi S, Yassin J ISRN Hematol2013
The impact of migrations on the health services for rare diseases in europe: the example of haemoglobin disorders.Angastiniotis M, Vives Corrons JL, Soteriades ES, Eleftheriou A ScientificWorldJournal2013
Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A.Xu J, Bauer DE, Kerenyi MA, Vo TD, Hou S, Hsu YJ, Yao H, Trowbridge JJ, Mandel G, Orkin SH Proc. Natl. Acad. Sci. U.S.A.2013
Evaluation of the SCKnowIQ Tool and Reproductive CHOICES Intervention Among Young Adults With Sickle Cell Disease or Sickle Cell Trait.Gallo AM, Wilkie DJ, Wang E, Labotka RJ, Molokie RE, Stahl C, Hershberger PE, Zhao Z, Suarez ML, Johnson B, Pullum C, Angulo R, Thompson A Clin Nurs Res2013
What's New in the Pathophysiology of Sickle Cell Disease?Adekile AD Med Princ Pract2013
Prevalence of Pneumococcal Bacteremia in Children with Sickle Cell Disease.Patel A, Zuzo A, Imran H, Siddiqui AH Pediatr Hematol Oncol2013
Changes in the quality of life of people with thalassemia major between 2001 and 2009.Gollo G, Savioli G, Balocco M, Venturino C, Boeri E, Costantini M, Forni GL Patient Prefer Adherence2013
Analysis of clinical phenotypes of compound heterozygotes of Hb J-Bangkok and β-thalassemia.Zhao Y, Shang X, Xiong F, Liu Y, Lou J, Xu X Zhonghua Yi Xue Yi Chuan Xue Za Zhi2013
Red blood cell alloimmunization: lessons from sickle cell disease.Treml A, King KE Transfusion2013
Low-dose ketamine as a potential adjuvant therapy for painful vaso-occlusive crises in sickle cell disease.Neri CM, Pestieau SR, Darbari DS Paediatr Anaesth2013
Effect of Antioxidant Therapy on Hepatic Fibrosis and Liver Iron Concentrations in β-Thalassemia Major Patients.Elalfy MS, Adly AA, Attia AA, Ibrahim FA, Mohammed AS, Sayed AM Hemoglobin2013
Coagulation profile of children with sickle cell anemia in steady state and crisis attending the university of Nigeria teaching hospital, Ituku-Ozalla, Enugu.Chinawa JM, Emodi IJ, Ikefuna AN, Ocheni S Niger J Clin Pract2013
Emergency Provider Analgesic Practices and Attitudes Toward Patients With Sickle Cell Disease.Glassberg JA, Tanabe P, Chow A, Harper K, Haywood C, Debaun MR, Richardson LD Ann Emerg Med2013
Clinical correlates of acute pulmonary events in children and adolescents with sickle cell disease.Paul R, Minniti CP, Nouraie M, Luchtman-Jones L, Campbell A, Rana S, Onyekwere O, Darbari DS, Ajayi O, Arteta M, Ensing G, Sable C, Dham N, Kato GJ, Gladwin MT, Castro OL, Gordeuk VR Eur. J. Haematol.2013
Genome-wide analysis shows that Ldb1 controls essential hematopoietic genes/pathways in mouse early development and reveals novel players in hematopoiesis.Mylona A, Andrieu-Soler C, Thongjuea S, Martella A, Soler E, Jorna R, Hou J, Kockx C, van Ijcken W, Lenhard B, Grosveld F Blood2013
Side effects of Deferasirox Iron Chelation in Patients with Beta Thalassemia Major or Intermedia.Al-Khabori M, Bhandari S, Al-Huneini M, Al-Farsi K, Panjwani V, Daar S Oman Med J2013
Transfusion and sickle cell disease.Boulat C Transfus Clin Biol2013
The Current Status of β-Thalassemia Major in Mainland China.Xu LH, Fang JP Hemoglobin2013
Interplay between coagulation and vascular inflammation in sickle cell disease.Sparkenbaugh E, Pawlinski R Br. J. Haematol.2013
A case of X-linked alpha-thalassemia/mental retardation (ATR-X) syndrome with repeated apnea attacks due to laryngomalacia.Ebishima Y, Misaki T, Owa K, Okuno T, Wada T, Suehiro Y No To Hattatsu2013
Routine Paediatric Sickle Cell Disease (SCD) Outpatient Care in a Rural Kenyan Hospital: Utilization and Costs.Amendah DD, Mukamah G, Komba A, Ndila C, Williams TN PLoS ONE2013
Expression of Regulatory Platelet MicroRNAs in Patients with Sickle Cell Disease.Jain S, Kapetanaki MG, Raghavachari N, Woodhouse K, Yu G, Barge S, Coronnello C, Benos PV, Kato GJ, Kaminski N, Gladwin MT PLoS ONE2013
MicroRNA-486-3p Regulates γ-Globin Expression in Human Erythroid Cells by Directly Modulating BCL11A.Lulli V, Romania P, Morsilli O, Cianciulli P, Gabbianelli M, Testa U, Giuliani A, Marziali G PLoS ONE2013
Apolipoprotein E gene polymorphism and the risk of left ventricular dysfunction among Egyptian β-thalassemia major.El-Tagui MH, Hamdy MM, Shaheen IA, Agha H, Abd-Elfatah HA Gene2013
Association between the genetic polymorphisms of glutathione S-transferase (GSTM1 and GSTT1) and the clinical manifestations in sickle cell anemia.de Oliveira Filho RA, Silva GJ, de Farias Domingos I, Hatzlhofer BL, da Silva Araújo A, de Lima Filho JL, Bezerra MA, Martins DB, de Araújo RF Blood Cells Mol. Dis.2013
The effect of hydroxcarbamide therapy on survival of children with sickle cell disease.Lopes de Castro Lobo C, Pinto JF, Nascimento EM, Moura PG, Cardoso GP, Hankins JS Br. J. Haematol.2013
Diagnostic testing for α-globin gene disorders in a heterogeneous North American population.Waye JS, Eng B Int J Lab Hematol2013
Prenatal and newborn screening for hemoglobinopathies.Hoppe CC Int J Lab Hematol2013
Maternal Complications and The Association with Baseline Variables in Pregnant Women with Sickle Cell Disease.Al-Farsi SH, Al-Riyami NM, Al-Khabori MK, Al-Hunaini MN Hemoglobin2013
Paradoxical protection from atherosclerosis and thrombosis in a mouse model of sickle cell disease.Wang H, Luo W, Wang J, Guo C, Wolffe SL, Wang J, Sun EB, Bradley KN, Campbell AD, Eitzman DT Br. J. Haematol.2013
Biologic complexity in sickle cell disease: implications for developing targeted therapeutics.Gee BE ScientificWorldJournal2013
A Case of Invasive Streptococcus pneumoniae in an Afebrile Adolescent With Sickle Cell Disease.Santoro JD, Case AE, El-Dahr J, Kanter J Clin Pediatr (Phila)2013
Plastrum testudinis induces γ-globin gene expression through epigenetic histone modifications within the γ-globin gene promoter via activation of the p38 MAPK signaling pathway.Qian X, Chen J, Zhao D, Guo L, Qian X Int. J. Mol. Med.2013
Predictors for Bacteremia in Febrile Sickle Cell Disease Children in the Post-7-Valent Pneumococcal Conjugate Vaccine Era.Chang TP, Kriengsoontorkij W, Chan LS, Wang VJ J. Pediatr. Hematol. Oncol.2013
Benefits of Delayed Fetal Hemoglobin (HbF) Switching in Sickle Cell Disease (SCD): A Case Report and Review of the Literature.Pack-Mabien AV, Imran H J. Pediatr. Hematol. Oncol.2013
Deferiprone-induced seizures in a patient with β-thalassemia major.Mallat NS, Beydoun A, Musallam KM, Koussa S, Taher AT Blood Cells Mol. Dis.2013
Silent β-Thalassemia Mutations at -101 (C>T) and -71 (C>T) and Their Coinheritance with the Sickle Cell Mutation in Bahrain.Al Moamen NJ, Mahdi F, Salman E, Thabet A, Abbas R, Al Arrayed S, Sanad H, Al Alawi A Hemoglobin2013
Sildenafil therapy in thalassemia patients with doppler-defined risk for pulmonary hypertension.Morris CR, Kim HY, Wood JC, Porter JB, Klings ES, Trachtenberg FL, Sweeters N, Olivieri NF, Kwiatkowski JL, Virzi L, Singer ST, Taher A, Neufeld EJ, Thompson AA, Sachdev V, Larkin S, Suh JH, Kuypers FA, Vichinsky EP Haematologica2013
Venous Thromboembolism in Adults with Sickle Cell Disease: A Serious and Under-recognized Complication.Naik RP, Streiff MB, Haywood C, Nelson JA, Lanzkron S Am. J. Med.2013
Evaluation and Comparison of Soluble Transferrin Receptor in Thalassemia Carriers and Iron Deficient Patients.Khatami S, Dehnabeh SR, Mostafavi E, Kamalzadeh N, Yaghmaei P, Saeedi P, Shariat F, Bagheriyan H, Zeinali S, Akbari MT Hemoglobin2013
Hydrodynamics of hemostasis in sickle-cell disease.Cohen SI, Mahadevan L Phys. Rev. Lett.2013
Assessment and management of iron overload in β-thalassaemia major patients during the 21st century: a real-life experience from the Italian Webthal project.Piga A, Longo F, Musallam KM, Cappellini MD, Forni GL, Quarta G, Chiavilli F, Commendatore F, Mulas S, Caruso V, Galanello R Br. J. Haematol.2013
Early complication in Sickle Cell Anemia children due to A(TA)_n TAA polymorphism at the promoter of UGT1A1 gene.Chaouch L, Talbi E, Moumni I, Ben Chaabene A, Kalai M, Chaouachi D, Mallouli F, Ghanem A, Abbes S Dis. Markers2013
Hemoglobin - source of reactive oxygen species .Zapora E, Jarocka I Postepy Hig Med Dosw (Online)2013
Cytochrome P450 2D6 Polymorphisms and Predicted Opioid Metabolism in African American Children With Sickle Cell Disease.Yee MM, Josephson C, Hill CE, Harrington R, Castillejo MI, Ramjit R, Osunkwo I J. Pediatr. Hematol. Oncol.2013
Hyperhemolysis in Sickle Cell Disease.Aragona E, Kelly MJ J. Pediatr. Hematol. Oncol.2013
Pain in Sickle Cell Disease #270.Minniti CP, Lu K, Groninger H J Palliat Med2013
Interaction of Hb Adana (HBA2: c.179G>A) with Deletional and Nondeletional α(+)-Thalassemia Mutations: Diverse Hematological and Clinical Features.Nainggolan IM, Harahap A, Ambarwati DD, Liliani RV, Megawati D, Swastika M, Setianingsih I Hemoglobin2013
Detection of β-globin Gene Mutations Among β-thalassaemia Carriers and Patients in Malaysia: Application of Multiplex Amplification Refractory Mutation System-Polymerase Chain Reaction.Hassan S, Ahmad R, Zakaria Z, Zulkafli Z, Abdullah WZ Malays J Med Sci2013
Prenatal diagnosis of haemoglobinopathies: our experience of 523 cases.Grosso M, Puzone S, Storino MR, Sessa R, Izzo P Clin. Chem. Lab. Med.2013
Barriers to Hematopoietic Cell Transplantation Clinical Trial Participation of African American and Black Youth With Sickle Cell Disease and Their Parents.Omondi NA, Ferguson SE, Majhail NS, Denzen EM, Buchanan GR, Haight AE, Labotka RJ, Rizzo JD, Murphy EA J. Pediatr. Hematol. Oncol.2013
Therapeutic potential of hematopoietic cells derived from pluripotent stem cells.Bouhassira EE Expert Opin Biol Ther2013
Alpha-(1,6)-fucosyltransferase (FUT8) inhibits hemoglobin production during differentiation of murine and K562 human erythroleukemia cells.Sasaki H, Toda T, Furukawa T, Mawatari Y, Takaesu R, Shimizu M, Wada R, Kato D, Utsugi T, Ohtsu M, Murakami Y J. Biol. Chem.2013
Effects of Antiretroviral Drugs for Prevention of HIV-Mother-to-Child Transmission on Hematological Parameters and Hemoglobin Synthesis in HIV-Uninfected Newborns With and Without Thalassemia Carrier.Wongnoi R, Oberdorfer P, Sirivatanapa P, Phanpong C, Pornprasert S Curr. HIV Res.2013
Assessment of hepatic and pancreatic iron overload in pediatric Beta-thalassemic major patients by t2* weighted gradient echo magnetic resonance imaging.Youssef DM, Fawzy Mohammad F, Ahmed Fathy A, Aly Abdelbasset M ISRN Hematol2013
Prevalence of High Blood Pressure, Heart Disease, Thalassemia, Sickle-Cell Anemia, and Iron-Deficiency Anemia among the UAE Adolescent Population.Barakat-Haddad C J Environ Public Health2013
Ineffective Erythropoiesis in β -Thalassemia.Ribeil JA, Arlet JB, Dussiot M, Cruz Moura I, Courtois G, Hermine O ScientificWorldJournal2013
Testosterone replacement therapy does not promote priapism in hypogonadal men with sickle cell disease: 12-month safety report.Morrison BF, Reid M, Madden W, Burnett AL Andrology2013
Genetic modifiers of sickle cell anemia in the BABY HUG cohort: Influence on laboratory and clinical phenotypes.Sheehan VA, Luo Z, Flanagan JM, Howard TA, Thompson BW, Wang WC, Kutlar A, Ware RE, Am. J. Hematol.2013
Usefulness of Pulsed Wave Tissue Doppler Imaging in Assessment of Left Ventricular Functions in Children with Beta-Thalassemia Major.Abdelmoktader AM, Azer HY Indian J Pediatr2013
Sirolimus and post transplant Cy synergistically maintain mixed chimerism in a mismatched murine model.Fitzhugh CD, Weitzel RP, Hsieh MM, Phang OA, Madison C, Luznik L, Powell JD, Tisdale JF Bone Marrow Transplant.2013
Erythrocyte deformability and aggregation in homozygous sickle cell disease.Vayá A, Collado S, Dasí MA, Pérez ML, Hernandez JL, Barragán E Clin. Hemorheol. Microcirc.2013
β-Thalassemia in Abu Dhabi: Consanguinity and Tribal Stratification are Major Factors Explaining the High Prevalence of the Disease.Denic S, Aden B, Nagelkerke N, Al Essa A Hemoglobin2013
A New β(0)-Thalassemia Mutation (codon 102, AAC>ATCAC) in Coexistence with a Heterozygous P4.2 Nippon Gene.Adhiyanto C, Yamashiro Y, Hattori Y, Nitta T, Hino M, Matar M, Takagi F, Kimoto M Hemoglobin2013
Thalassemia and Hemoglobinopathies in Thua Thien Hue Province, Central Vietnam.Nguyen HV, Sanchaisuriya K, Nguyen D, Phan HT, Siridamrongvattana S, Sanchaisuriya P, Fucharoen S, Fucharoen G, Schelp FP Hemoglobin2013
Elevated Serum Levels Of Cell Death Circulating Biomarkers, M30 And M65, In Patients With β-Thalassemia Major.Esmaeil N, Moayedi B, Gharagozloo M, Maracy MR Hemoglobin2013
Leg Ulcers in Sickle Cell Disease: Current Patterns and Practices.Delaney KM, Axelrod KC, Buscetta A, Hassell KL, Adams-Graves PE, Seamon C, Kato GJ, Minniti CP Hemoglobin2013
Longitudinal monitoring of cardiac siderosis using cardiovascular magnetic resonance (CMR) T2* in patients with thalassemia major on various chelation regimens: A 6 year study.Ambati SR, Randolph RE, Mennitt K, Kleinert DA, Weinsaft JW, Giardina PJ Am. J. Hematol.2013
Relationship between myocardial T2* values and cardiac volumetric and functional parameters in β-thalassemia patients evaluated by cardiac magnetic resonance in association with serum ferritin levels.Liguori C, Pitocco F, Di Giampietro I, de Vivo AE, Schena E, Cianciulli P, Zobel BB Eur J Radiol2013
Molecular and hematological studies in a large cohort of α(0)-thalassemia in northeast Thailand: Data from a single referral center.Chaibunruang A, Prommetta S, Yamsri S, Fucharoen G, Sae-Ung N, Sanchaisuriya K, Fucharoen S Blood Cells Mol. Dis.2013
Improved Clinical Outcomes of High Risk β Thalassemia Major Patients Undergoing a HLA Matched Related Allogeneic Stem Cell Transplant with a Treosulfan Based Conditioning Regimen and Peripheral Blood Stem Cell Grafts.Mathews V, George B, Viswabandya A, Abraham A, Ahmed R, Ganapule A, Sindhuvi E, Lakshmi KM, Srivastava A PLoS ONE2013
The Molecular Basis of β-Thalassemia.Thein SL Cold Spring Harb Perspect Med2013
Prenatal control of nondeletional α-thalassemia: first experience in mainland China.Li J, Li R, Zhou JY, Xie XM, Liao C, Li DZ Prenat. Diagn.2013
Sickle Cell Disease Related Mortality in the United States (1999-2009).Hamideh D, Alvarez O Pediatr Blood Cancer2013
The Emergency Department Sickle Cell Assessment of Needs and Strengths (ED-SCANS): Reliability and Validity.Tanabe P, Thornton VL, Martinovich Z, Todd KH, Wun T, Lyons JS Adv Emerg Nurs J2013
Adrenal insufficiency is prevalent in HbE / β thalassaemia paediatric patients irrespective of their clinical severity and transfusion requirement.Nakavachara P, Viprakasit V Clin. Endocrinol. (Oxf)2013
Extramedullary haematopoiesis presented as intrathoracic tumour in a patient with alpha-thalassaemia.Bobylev D, Zhang R, Haverich A, Krueger M J Cardiothorac Surg2013
Conservative management of Beta-thalassemia major cases in the sub-division level hospital of rural West Bengal, India.Bandyopadhyay U, Kundu D, Sinha A, Banerjee K, Bandyopadhyay R, Mandal T, Ray D J Nat Sci Biol Med2013
To respond or not to respond to hydroxyurea in thalassemia: a matter of stress adaptation?Ronchi A, Ottolenghi S Haematologica2013
Acute Care of Pediatric Patients With Sickle Cell Disease: A Simulation Performance Assessment.Burns TL, Debaun MR, Boulet JR, Murray GM, Murray DJ, Fehr JJ Pediatr Blood Cancer2013
The use of extracorporeal membrane oxygenation in pediatric patients with sickle cell disease.Kuo K, Cornell T, Shanley T, Odetola F, Annich G Perfusion2013
Thermal Pain and Sensory Processing in Children With Sickle Cell Disease.O'Leary JD, Crawford MW, Odame I, Shorten GD, McGrath PA Clin J Pain2013
Long-term treatment with deferiprone enhances left ventricular ejection function when compared to deferoxamine in patients with thalassemia major.Filosa A, Vitrano A, Rigano P, Calvaruso G, Barone R, Capra M, Cuccia L, Gagliardotto F, Pitrolo L, Prossomariti L, Casale M, Caruso V, Gerardi C, Campisi S, Cianciulli P, Rizzo M, D'Ascola G, Ciancio A, Maggio A Blood Cells Mol. Dis.2013
Transcranial Doppler Velocity and Brain MRI/MRA Changes in Children With Sickle Cell Anemia on Chronic Transfusions to Prevent Primary Stroke.Sheehan VA, Hansbury EN, Smeltzer MP, Fortner G, McCarville MB, Aygun B Pediatr Blood Cancer2013
Normalized Transcranial Doppler Velocities, Stroke Prevention and Improved Pulmonary Function after Stem Cell Transplantation in Children with Sickle Cell Anemia.Mynarek M, Bettoni da Cunha Riehm C, Brinkmann F, Weißenborn K, Tell-Lüersen M, Heuft HG, Maecker-Kolhoff B, Sykora KW Klin Padiatr2013
Immunomodulatory effects of silymarin in patients with β-thalassemia major.Gharagozloo M, Karimi M, Amirghofran Z Int. Immunopharmacol.2013
Prolongation of QTc Intervals and Risk of Death Among Patients with Sickle Cell Disease.Upadhya B, Ntim W, Brandon Stacey R, Henderson R, Leedy D, O'Brien FX, Knovich MA Eur. J. Haematol.2013
Interpreting elevated fetal hemoglobin in pathology and health at the basic laboratory level: new and known γ- gene mutations associated with hereditary persistence of fetal hemoglobin.Amato A, Cappabianca MP, Perri M, Zaghis I, Grisanti P, Ponzini D, Di Biagio P Int J Lab Hematol2013
Detection of Rare Beta Globin Gene Mutation [+22 5UTR(G>A)] in an Infant, Despite Prenatal Screening.Mahdavi MR, Karami H, Akbari MT, Jalali H, Roshan P Case Rep Hematol2013
Incidence of Serious Bacterial Infections in Febrile Children With Sickle Cell Disease.Bansil NH, Kim TY, Tieu L, Barcega B Clin Pediatr (Phila)2013
Morbidity among child travellers with sickle-cell disease visiting tropical areas: an observational study in a French tertiary care centre.Sommet J, Missud F, Holvoet L, Ithier G, Lorrot M, Benkerrou M, Faye A Arch. Dis. Child.2013
Tardive hip disease diagnosis in a young adult with sickle cell disease.Bokolombe A, Samato F, Lukinu T, Ekila M, Aloni M Afr Health Sci2013
Outcome of cholelithiasis in Sudanese children with Sickle Cell Anaemia (SCA) after 13 years follow-up.Attalla B, Karrar Z, Ibnouf G, Mohamed A, Abdelwahab O, Nasir EM, El Seed MA Afr Health Sci2013
Acute splenic sequestration in a pregnant woman with homozygous sickle-cell anemia.Maia CB, Nomura RM, Igai AM, Fonseca GH, Gualandro SM, Zugaib M Sao Paulo Med J2013
Transfusion suppresses erythropoiesis and increases hepcidin in adult patients with beta-thalassemia major: a longitudinal study.Pasricha SR, Frazer DM, Bowden DK, Anderson GJ Blood2013
Mild β(+)-Thalassemia Associated With Two Linked Sequence Variants: IVS-II-839 (T>C) and IVS-II-844 (C>A).Waye JS, Eng B, Hellens L, Hohenadel BA, Nakamura LM, Walker L Hemoglobin2013
Hb Grove City [β38(C4)Thr→Ser, ACC>AGC; HBB: c.116C>G]: A New Low Oxygen Affinity β Chain Variant.Taliercio RM, Ashton RW, Horwitz L, Swanson KC, Wendt PC, Hoyer JD, Oliveira JL Hemoglobin2013
Comparison of right and left side heart functions in patients with thalassemia major, patients with thalassemia intermedia, and control group.Noori N, Mohamadi M, Keshavarz K, Alavi SM, Mahjoubifard M, Mirmesdagh Y J Tehran Heart Cent2013
Cell-Free Hemoglobin and Its Scavenger Proteins: New Disease Models Leading the Way to Targeted Therapies.Schaer DJ, Buehler PW Cold Spring Harb Perspect Med2013
A randomized, placebo-control trial of arginine therapy for the treatment ofchildren with sickle cell disease hospitalized with vaso-occlusive pain episodes.Morris CR, Kuypers FA, Lavrisha L, Ansari M, Sweeters N, Stewart M, Gildengorin G, Neumayr L, Vichinsky EP Haematologica2013
Sepsis caused by Mycobacterium terrae complex in a patient with sickle cell disease.Esnakula AK, Mummidi SK, Oneal PA, Naab TJ BMJ Case Rep2013
Isolated cortical vein thrombosis in a patient with sickle cell disease: Treatment with decompressive craniotomy and anticoagulation and literature review.Hamamoto Filho PT, Gabarra RC, Braga GP, Ruiz E Resende LS, Bazan R, Zanini MA Neurol India2013
Natural antiband 3 antibodies in patients with sickle cell disease.Villaescusa R, Arce AA, Lalanne-Mistrih ML, Lamarre Y, Hierso R, Hernández C, Hardy-Dessources MD, C. R. Biol.2013
Post-transfusional iron overload in the haemoglobinopathies.Thuret I C. R. Biol.2013
Nutrition and sickle cell disease.Reid M C. R. Biol.2013
Relevance of blood groups in transfusion of sickle cell disease patients.Noizat-Pirenne F C. R. Biol.2013
Autonomic nervous system dysfunction: Implication in sickle cell disease.Connes P, Coates TD C. R. Biol.2013
KLF10 gene expression is associated with high fetal hemoglobin levels and with response to hydroxyurea treatment in β-hemoglobinopathy patients.Borg J, Phylactides M, Bartsakoulia M, Tafrali C, Lederer C, Felice AE, Papachatzopoulou A, Kourakli A, Stavrou EF, Christou S, Hou J, Karkabouna S, Lappa-Manakou C, Ozgur Z, van Ijcken W, von Lindern M, Grosveld FG, Georgitsi M, Kleanthous M, Philipsen S, Patrinos GPPharmacogenomics2012
The spine in β-thalassemia syndromes.Haidar R, Mhaidli H, Musallam KM, Taher ATSpine2012
Peroxiredoxin II is essential for preventing hemolytic anemia from oxidative stress through maintaining hemoglobin stability.Han YH, Kim SU, Kwon TH, Lee DS, Ha HL, Park DS, Woo EJ, Lee SH, Kim JM, Chae HB, Lee SY, Kim BY, Yoon do Y, Rhee SG, Fibach E, Yu DYBiochem. Biophys. Res. Commun.2012
Noninvasive Prenatal Diagnosis of Monogenic Diseases by Targeted Massively Parallel Sequencing of Maternal Plasma: Application to β-Thalassemia.Lam KW, Jiang P, Liao GJ, Chan KC, Leung TY, Chiu RW, Lo YMClin. Chem.2012
Association of xmn I polymorphism and hemoglobin e haplotypes on postnatal gamma globin gene expression in homozygous hemoglobin e.Ekwattanakit S, Monteerarat Y, Riolueang S, Tachavanich K, Viprakasit VAdv Hematol2012
Left ventricular rotational dynamics in Beta thalassemia major: a speckle-tracking echocardiographic study.Monte I, Buccheri S, Bottari V, Blundo A, Licciardi S, Romeo MAJ Am Soc Echocardiogr2012
Silent cerebral infarct in child patients with beta thalassaemia intermedia.Leblebisatan G, Bay A, Sirikci A, Kilincaslan H, Sonmezisik S, Leblebisatan S, Baspinar O, Dogan M, Yis UBlood Coagul. Fibrinolysis2012
High dose vitamin D therapy for chronic pain in children and adolescents with sickle cell disease: results of a randomized double blind pilot study.Osunkwo I, Ziegler TR, Alvarez J, McCracken C, Cherry K, Osunkwo CE, Ofori-Acquah SF, Ghosh S, Ogunbobode A, Rhodes J, Eckman JR, Dampier C, Tangpricha VBr. J. Haematol.2012
β-Thalassemia: New Therapeutic Modalities, Genetics, Complications, and Quality of Life.Karimi M, Haghpanah S, Taher AT, Cappellini MDAnemia2012
Dynamic dyssynchrony and impaired contractile reserve of the left ventricle in Beta-thalassaemia major: an exercise echocardiographic study.Cheung YF, Yu W, Li SN, Lam WW, Ho YC, Wong SJ, Chan GC, Ha SYPLoS ONE2012
Gene Expression Profiling Identifies HOXB4 as a Direct Downstream Target of GATA-2 in Human CD34+ Hematopoietic Cells.Fujiwara T, Yokoyama H, Okitsu Y, Kamata M, Fukuhara N, Onishi Y, Fujimaki S, Takahashi S, Ishizawa K, Bresnick EH, Harigae HPLoS ONE2012
A Single Nucleotide Polymorphism in the HBBP1 Gene in the Human β-Globin Locus is Associated with a Mild β-Thalassemia Disease Phenotype.Giannopoulou E, Bartsakoulia M, Tafrali C, Kourakli A, Poulas K, Stavrou EF, Papachatzopoulou A, Georgitsi M, Patrinos GPHemoglobin2012
No improvement in suboptimal vitamin A status with a randomized, double-blind, placebo-controlled trial of vitamin A supplementation in children with sickle cell disease.Dougherty KA, Schall JI, Kawchak DA, Green MH, Ohene-Frempong K, Zemel BS, Stallings VAAm. J. Clin. Nutr.2012
Unmasking Hb Paksé (codon 142, TAA>TAT, α2) and its Combinations in Patients also Carrying Hb Constant Spring (codon 142, TAA>CAA, α2) in Northern Thailand.Pornprasert S, Panyasai S, Treesuwan KHemoglobin2012
A New Frameshift Mutation on the α2-Globin Gene Causing α(+)-Thalassemia: Codon 43 (TTC>-TC or TTC>T-C).Joly P, Lacan P, Garcia C, Barro C, Francina AHemoglobin2012
MicroRNAs: Allies or foes in erythropoiesis?Byon JC, Papayannopoulou TJ. Cell. Physiol.2012
Carbon-fiber microelectrode amperometry reveals sickle-cell-induced inflammation and chronic morphine effects on single mast cells.Manning BM, Hebbel RP, Gupta K, Haynes CLACS Chem. Biol.2012
Alternative options for DNA-based experimental therapy of β-thalassemia.Gambari RExpert Opin Biol Ther2012
Early non-invasive detection of fetal Y chromosome sequences in maternal plasma using multiplex PCR.Kolialexi A, Tounta G, Apostolou P, Vrettou C, Papantoniou N, Kanavakis E, Antsaklis A, Mavrou AEur. J. Obstet. Gynecol. Reprod. Biol.2012
An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports.Rifai N, Annesley TM, Berg JP, Brugnara C, Delvin E, Lamb EJ, Ness PM, Plebani M, Wick MR, Wu A, Joris Delanghe Clin. Biochem.2012
Prenatal diagnosis of hemoglobinopathies by pyrosequencing: a more sensitive and rapid approach to fetal genotyping.Timbs AT, Rugless MJ, Gallienne AE, Haywood AM, Henderson SJ, Old JMHemoglobin2012
GATA-3 regulates hematopoietic stem cell maintenance and cell-cycle entry.Ku CJ, Hosoya T, Maillard I, Engel JDBlood2012
Neonatal cyanosis due to a new (G)γ-globin variant causing low oxygen affinity: Hb F-Sarajevo [(G)γ102(G4)Asn→Thr, AAC>ACC].Zimmermann-Baer U, Capalo R, Dutly F, Saller E, Troxler H, Kohler M, Frischknecht HHemoglobin2012
A rare Hb H disease due to the - -(SEA) and 16.6 kb α-thalassemia-2 deletions.Sroymora S, Jindadamrongwech S, Butthep P, Chuncharunee SHemoglobin2012
Is the poly A (T>C) mutation a causative factor for misdiagnosis in second trimester prenatal diagnosis of β-thalassemia by fetal blood analysis on high performance liquid chromatography?Italia KY, Sawant PM, Nadkarni AH, Ghosh K, Colah RBHemoglobin2012
A new β chain hemoglobin variant with increased oxygen affinity: Hb Santa Giusta Sardegna [β93(F9)Cys→Trp; HBB c.282T>G].Fais A, Sollaino MC, Barella S, Perseu L, Era B, Corda MHemoglobin2012
α(+)-Thalassemia trait caused by a frameshift mutation in exon 2 of the α2-globin gene [HBA2 c.244delT].Waye JS, Walker L, Eng BHemoglobin2012
Comparison of two known chromosomal rearrangements in the δβ-globin complex with identical DNA breakpoints but causing different Hb A(2) levels.Saller E, Moradkhani K, Dutly F, Vinatier I, Préhu C, Frischknecht H, Goossens MHemoglobin2012
Effects of experimental asthma on inflammation and lung mechanics in sickle cell mice.Pritchard KA, Feroah TR, Nandedkar SD, Holzhauer SL, Hutchins W, Schulte ML, Strunk RC, Debaun MR, Hillery CAAm. J. Respir. Cell Mol. Biol.2012
Semi-nested Taqman real-time quantitative PCR for noninvasive prenatal diagnosis of Bart's hydrops fetalis.Pornprasert S, Sukunthamala K, Kunyanone N, Sittiprasert S, Thungkham K, Junorse S, Pongsawatkul K, Pattanaporn W, Jitwong CJ Med Assoc Thai2012
Vitamin E supplement improves erythrocyte membrane fluidity of thalassemia: an ESR spin labeling study.Sutipornpalangkul W, Morales NP, Unchern S, Sanvarinda Y, Chantharaksri U, Fucharoen SJ Med Assoc Thai2012
Relation between NT-proBNP levels, iron overload, and early stage of myocardial dysfunction in β-thalassemia major patients.Balkan C, Tuluce SY, Basol G, Tuluce K, Ay Y, Karapinar DY, Gurgun C, Bayindir O, Kavakli KEchocardiography2012
A new tool for the assessment of satisfaction with iron chelation therapy (ICT-Sat) for patients with β-thalassemia major.Elalfy MS, Massoud W, Elsherif NH, Labib JH, Elalfy OM, Elaasar S, von Mackensen SPediatr Blood Cancer2012
Increased serum ferritin predicts the development of hypertension among middle-aged men.Kim MK, Baek KH, Song KH, Kang MI, Choi JH, Bae JC, Park CY, Lee WY, Oh KWAm. J. Hypertens.2012
Arterial spin labeling measurement of cerebral perfusion in children with sickle cell disease.Gevers S, Nederveen AJ, Fijnvandraat K, van den Berg SM, van Ooij P, Heijtel DF, Heijboer H, Nederkoorn PJ, Engelen M, van Osch MJ, Majoie CBJ Magn Reson Imaging2012
Acute splenic sequestration crisis in sickle cell disease: cohort study of 190 paediatric patients.Brousse V, Elie C, Benkerrou M, Odièvre MH, Lesprit E, Bernaudin F, Grimaud M, Guitton C, Quinet B, Dangiolo S, de Montalembert MBr. J. Haematol.2012
Compliance of deferoxamine injection in beta-thalassaemia major patients in Iran.Rashid M, Karimi MTransfus Med2012
Bone marrow transplant options and preferences in a sickle cell anemia cohort on chronic transfusions.Hansbury EN, Schultz WH, Ware RE, Aygun BPediatr Blood Cancer2012
A study on gene mutation spectrums of α- and β-thalassemias in populations of Yunnan Province and the prenatal gene diagnosisZhu BS, He J, Zhang J, Zeng XH, Su J, Xu XH, Li SY, Chen H, Zhang YHZhonghua Fu Chan Ke Za Zhi2012
Hydroxycarbamide alters erythroid gene expression in children with sickle cell anaemia.Flanagan JM, Steward S, Howard TA, Mortier NA, Kimble AC, Aygun B, Hankins JS, Neale GA, Ware REBr. J. Haematol.2012
Mortality in adults with sickle cell disease and pulmonary hypertension.Mehari A, Gladwin MT, Tian X, Machado RF, Kato GJJAMA2012
Spectrum of gene deletion in 471 children with α-thalassemiaLin YH, Fan L, Zhang Z, Pan ZW, Song CLZhongguo Dang Dai Er Ke Za Zhi2012
Prenatal screening for β-thalassemia major reveals new and rare mutations in the Pakistani population.Moatter T, Kausar T, Aban M, Ghani S, Pal JAInt. J. Hematol.2012
To SWiTCH or not to SWiTCH?de Montalembert MBlood2012
Hemoglobin Showa-Yakushiji: a common β thalassemia mutation among the Agri community from western India.Gorakshakar A, Sathe P, Colah R, Nadkarni A, Ghosh KGenet Test Mol Biomarkers2012
The hypersensitive sites of the murine β-globin locus control region act independently to affect nuclear localization and transcriptional elongation.Bender MA, Ragoczy T, Lee J, Byron R, Telling A, Dean A, Groudine MBlood2012
Pneumococcal bacteremia in a vaccinated pediatric sickle cell disease population.Ellison AM, Ota KV, McGowan KL, Smith-Whitley KPediatr. Infect. Dis. J.2012
Australian Paediatric Surveillance Unit study of haemoglobinopathies in Australian children.Argent E, Emder P, Monagle P, Mowat D, Petterson T, Russell S, Sachdev R, Stone C, Ziegler DSJ Paediatr Child Health2012
Thalassemic DNA-Containing Red Blood Cells Are under Oxidative Stress.Dana M, Prus E, Fibach EAnemia2012
Clinical management of adult sickle-cell disease.Bartolucci P, Galactéros FCurr. Opin. Hematol.2012
Anemia in the elderly.Pang WW, Schrier SLCurr. Opin. Hematol.2012
Extended scrapie incubation time in goats singly heterozygous for PRNP S146 or K222.White SN, Reynolds JO, Waldron DF, Schneider DA, O'Rourke KIGene2012
Nonsense β-thalassemia mutation at codon 37 (TGG>TGA), detected for the first time in three Turkish cases.Bozdogan ST, Unsal C, Erkman H, Genc A, Yuregir OO, Muslumanoglu MH, Aslan HHemoglobin2012
A novel case of Hb Phnom Penh: codons 117/118 (+ATC) as a cause of α+ -thalassemia.Zhai YS, Tang HS, Zhou JY, Li DZHemoglobin2012
Microsatellite markers within the α-globin gene cluster for robust preimplantation genetic diagnosis of severe α-thalassemia syndromes in Mediterranean populations.Destouni A, Christopoulos G, Vrettou C, Kakourou G, Kleanthous M, Traeger-Synodinos J, Kanavakis EHemoglobin2012
Serum ferritin and total units transfused for assessing iron overload in adults with sickle cell disease.Drasar E, Vasavda N, Igbineweka N, Awogbade M, Allman M, Thein SLBr. J. Haematol.2012
Inter-site validations of the Pixel-Wise method for cardiac T2* analysis in transfusion-dependent Thai thalassemia patients.Saiviroonporn P, Viprakasit V, Maneesai A, Siritanaratkul N, Pongtanakul B, Wood JC, Krittayaphong RJ Med Assoc Thai2012
Genotyping of β-globin gene mutations in single lymphocytes: a preliminary study for preimplantation genetic diagnosis of monogenic disorders.Durmaz B, Ozkinay F, Onay H, Karaca E, Aydinok Y, Tavmergen E, Vrettou C, Traeger-Synodinos J, Kanavakis EHemoglobin2012
Contemporary approaches to treatment of beta-thalassemia intermedia.Taher AT, Musallam KM, Karimi M, Cappellini MDBlood Rev.2012
Serum ferritin levels and endocrinopathy in medically treated patients with β thalassemia major.Belhoul KM, Bakir ML, Saned MS, Kadhim AM, Musallam KM, Taher ATAnn. Hematol.2012
Physiopathology of Bone Modifications in β-Thalassemia.Perisano C, Marzetti E, Spinelli MS, Callà CA, Graci C, Maccauro GAnemia2012
Genetic origin and interaction of the Filipino β⁰-thalassemia with Hb E and α-thalassemia in a Thai family.Yamsri S, Sanchaisuriya K, Fucharoen G, Fucharoen STransl Res2012
Effect of α-thalassaemia on exercise-induced oxidative stress in sickle cell trait.Faёs C, Martin C, Chirico EN, Féasson L, Oyonno-Enguelle S, Dubouchaud H, Francina A, Thiriet P, Pialoux V, Messonnier LActa Physiol (Oxf)2012
First case of Hb Fontainebleau with sickle haemoglobin and other non-deletional α gene variants identified in neonates during newborn screening for sickle cell disorders.Upadhye DS, Jain D, Nair SB, Nadkarni AH, Ghosh K, Colah RBJ. Clin. Pathol.2012
Newborn screening shows a high incidence of sickle cell anemia in Central India.Jain DL, Sarathi V, Upadhye D, Gulhane R, Nadkarni AH, Ghosh K, Colah RBHemoglobin2012
Hb Stanleyville-II [α78(EF7)Asn→Lys (α2); HbA2: c.237C>A]: incidence of 1:11,500 in a newborn screening program in Brazil.Silva MR, Sendin SM, Pimentel FS, Velloso-Rodrigues C, Romanha ÁJ, Viana MBHemoglobin2012
Partial radiofrequency ablation of the spleen in thalassemia.Hashemieh M, Akhlaghpoor S, Azarkeivan A, Azizahari A, Shirkavand A, Sheibani KDiagn Interv Radiol2012
A combined approach for β-thalassemia based on gene therapy-mediated adult hemoglobin (HbA) production and fetal hemoglobin (HbF) induction.Zuccato C, Breda L, Salvatori F, Breveglieri G, Gardenghi S, Bianchi N, Brognara E, Lampronti I, Borgatti M, Rivella S, Gambari RAnn. Hematol.2012
β-Thalassemia Intermedia: A Clinical Perspective.Musallam KM, Taher AT, Rachmilewitz EACold Spring Harb Perspect Med2012
Report of haemoglobin J-Toronto and alpha thalassemia in a family from North of Iran.Mahdavi MR, Bayat N, Hadavi V, Karami H, Roshan P, Najmabadi H, Rohanizadeh HJ Pak Med Assoc2012
Neridronate improves bone mineral density and reduces back pain in β-thalassaemia patients with osteoporosis: results from a phase 2, randomized, parallel-arm, open-label study.Forni GL, Perrotta S, Giusti A, Quarta G, Pitrolo L, Cappellini MD, D'Ascola DG, Borgna Pignatti C, Rigano P, Filosa A, Iolascon G, Nobili B, Baldini M, Rosa A, Pinto V, Palummeri EBr. J. Haematol.2012
Restrictive pulmonary dysfunction and its predictors in young patients with β-thalassaemia major.Bourli E, Dimitriadou M, Economou M, Vlachaki E, Christoforidis A, Maratou E, Stanopoulos I, Argyropoulou P, Aivazis VPediatr. Pulmonol.2012
Allogeneic hematopoietic stem cell transplantation in thalassemia major: results of a reduced-toxicity conditioning regimen based on the use of treosulfan.Bernardo ME, Piras E, Vacca A, Giorgiani G, Zecca M, Bertaina A, Pagliara D, Contoli B, Pinto RM, Caocci G, Mastronuzzi A, La Nasa G, Locatelli FBlood2012
Inhaled bronchodilators for acute chest syndrome in people with sickle cell disease.Knight-Madden JM, Hambleton IRCochrane Database Syst Rev2012
Non-invasive measurements of carboxyhemoglobin and methemoglobin in children with sickle cell disease.Caboot JB, Jawad AF, McDonough JM, Bowdre CY, Arens R, Marcus CL, Mason TB, Smith-Whitley K, Ohene-Frempong K, Allen JLPediatr. Pulmonol.2012
Drugs for preventing red blood cell dehydration in people with sickle cell disease.Nagalla S, Ballas SKCochrane Database Syst Rev2012
Use of fat suppression in R₂ relaxometry with MRI for the quantification of tissue iron overload in beta-thalassemic patients.Papakonstantinou O, Foufa K, Benekos O, Alexopoulou E, Mademli M, Balanika A, Economopoulos N, Kelekis NLMagn Reson Imaging2012
Intersite validations of the pixel-wise method for liver R2* analysis in transfusion-dependent thalassemia patients: a more accessible and affordable diagnostic technology.Saiviroonporn P, Viprakasit V, Sanpakit K, Wood JC, Krittayaphong RHematol Oncol Stem Cell Ther2012
Effect of ANXA2 gene single nucleotide polymorphism (SNP) on the development of osteonecrosis in Indian sickle cell patient: a PCR-RFLP approach.Pandey S, Ranjan R, Pandey S, Mishra RM, Seth T, Saxena RIndian J. Exp. Biol.2012
Prenatal diagnosis for thalassaemia in Egypt: what changed parents' attitude?El-Beshlawy A, El-Shekha A, Momtaz M, Said F, Hamdy M, Osman O, Meshaal S, Gafaar T, Petrou MPrenat. Diagn.2012
International network on endocrine complications in thalassaemia (I-CET): an opportunity to grow.De Sanctis V, Soliman AT, Angastiniotis M, Eleftheriou A, Kattamis Ch, Karimi M, El Kholy M, Elsedfy H, Yassin MA, El Awwa A, Stoeva I, Skordis N, Raiola G, Fiscina BGeorgian Med News2012
Detection of deletions/duplications in α-globin gene cluster by multiplex ligation-dependent probe amplification.Nezhat N, Akbari MTGenet Test Mol Biomarkers2012
A quantitative assay to detect α-thalassemia deletions and triplications using multiplex nested real-time quantitative polymerase chain reaction.Zhou WJ, Liu WY, Liu D, Jiang JH, Zhou DM, Zhong ZY, Xu XMAnal. Biochem.2012
Genetic modifiers of β-thalassemia and clinical severity as assessed by age at first transfusion.Danjou F, Anni F, Perseu L, Satta S, Dessì C, Lai ME, Fortina P, Devoto M, Galanello RHaematologica2012
A functional promoter polymorphism of the δ-globin gene is a specific marker of the Arab-Indian haplotype.Alsultan A, Ngo DA, Farrell JJ, Akinsheye I, Solovieff N, Ghabbour HA, Al-Ali A, Alsuliman A, Al-Baghshi M, Albu-Ali W, Alabdulaali M, Baldwin CT, Farrer LA, Luo H, Melista E, Safaya S, Nwaru M, Chui DH, Steinberg MHAm. J. Hematol.2012
Identification of a New HBA1 Gene Mutation (HBA1:c.301-2A>T) in Cis with Hb Riccarton (HBA1:c.154G>A) [α51(CE9)Gly→Ser].Scheps KG, Binaghi A, Varela VHemoglobin2012
Genetic modifiers of sickle cell disease.Steinberg MH, Sebastiani PAm. J. Hematol.2012
World distribution, population genetics, and health burden of the hemoglobinopathies.Williams TN, Weatherall DJCold Spring Harb Perspect Med2012
Quantitative T2* Magnetic Resonance Imaging for Evaluation of Iron Deposition in the Brain of β-Thalassemia Patients.Akhlaghpoor S, Ghahari A, Morteza A, Khalilzadeh O, Shakourirad A, Alinaghizadeh MRClin Neuroradiol2012
A novel deletion of β-globin promoter causing high HbA2 in an Indian population.Mayuranathan T, Rayabaram J, Edison ES, Srivastava A, Velayudhan SRHaematologica2012
Sickle cell disease: genetics, cellular and molecular mechanisms, and therapies.Pace BS, Ofori-Acquah SF, Peterson KRAnemia2012
Population pharmacokinetics of cyclophosphamide in patients with thalassemia major undergoing HSCT.Balasubramanian P, Desire S, Panetta JC, Lakshmi KM, Mathews V, George B, Viswabandya A, Chandy M, Krishnamoorthy R, Srivastava ABone Marrow Transplant.2012
Hydroxyurea is associated with reductions in hypercoagulability markers in sickle cell anemia.Colella MP, De Paula EV, Conran N, Machado-Neto JA, Annicchino-Bizzacchi JM, Costa FF, Saad ST, Traina FJ. Thromb. Haemost.2012
Renal function in patients with β-thalassaemia major: a long-term follow-up study.Lai ME, Spiga A, Vacquer S, Carta MP, Corrias C, Ponticelli CNephrol. Dial. Transplant.2012
Status of 25-hydroxyvitamin D deficiency and effect of vitamin D receptor gene polymorphisms on bone mineral density in thalassemia patients of North India.Singh K, Kumar R, Shukla A, Phadke SR, Agarwal SHematology2012
Altered vascular function, arterial stiffness, and antioxidant gene responses in pediatric thalassemia patients.Detchaporn P, Kukongviriyapan U, Prawan A, Jetsrisuparb A, Greenwald SE, Kukongviriyapan VPediatr Cardiol2012
Severe fetal and neonatal hemolytic anemia due to a 198 kb deletion removing the complete β-globin gene cluster.Verhovsek M, Shah NR, Wilcox I, Koenig SC, Barros T, Thornburg CD, Steinberg MH, Luo HY, Chui DHPediatr Blood Cancer2012
CTCF-mediated transcriptional regulation through cell type-specific chromosome organization in the β-globin locus.Junier I, Dale RK, Hou C, Képès F, Dean ANucleic Acids Res.2012
The relation of fragmented QRS with tissue Doppler derived parameters in patients with b-thalassaemia major.Buyukkaya E, Karakas MF, Kurt M, Bilen P, Yalcın F, Celik M, Helvacı R, Kaya H, Ertekin F, Sökmen E, Sen N, Akcay ABClin Invest Med2012
Transcription factor binding at enhancers: shaping a genomic regulatory landscape in flux.Palstra RJ, Grosveld FFront Genet2012
Magnetic resonance angiography-defined intracranial vasculopathy is associated with silent cerebral infarcts and glucose-6-phosphate dehydrogenase mutation in children with sickle cell anaemia.Thangarajh M, Yang G, Fuchs D, Ponisio MR, McKinstry RC, Jaju A, Noetzel MJ, Casella JF, Barron-Casella E, Hooper WC, Boulet SL, Bean CJ, Pyle ME, Payne AB, Driggers J, Trau HA, Vendt BA, Rodeghier M, Debaun MRBr. J. Haematol.2012
Platelet activation and platelet-leukocyte interaction in β-thalassemia/hemoglobin E patients with marked nucleated erythrocytosis.Keawvichit R, Khowawisetsut L, Chaichompoo P, Polsrila K, Sukklad S, Sukapirom K, Khuhapinant A, Fucharoen S, Pattanapanyasat KAnn. Hematol.2012
Development of a fast LC-MS/MS assay for the determination of deferiprone in human plasma and application to pharmacokinetics.Song TS, Hsieh YW, Peng CT, Liu CH, Chen TL, Hour MJBiomed. Chromatogr.2012
Cerebral infarction in β-thalassemia intermedia: Breaking the silence.Musallam KM, Taher AT, Karimi M, Rachmilewitz EAThromb. Res.2012
NF-Y Recruits Both Transcription Activator and Repressor to Modulate Tissue- and Developmental Stage-Specific Expression of Human γ-Globin Gene.Zhu X, Wang Y, Pi W, Liu H, Wickrema A, Tuan DPLoS ONE2012
Genetic Evidence of an Evolutionarily Conserved Role for Nrf2 in the Protection against Oxidative Stress.Mukaigasa K, Nguyen LT, Li L, Nakajima H, Yamamoto M, Kobayashi MMol. Cell. Biol.2012
Methemoglobinemia and ascorbate deficiency in hemoglobin E β thalassemia: metabolic and clinical implications.Allen A, Fisher C, Premawardhena A, Bandara D, Perera A, Allen S, St Pierre T, Olivieri N, Weatherall DBlood2012
Reawakening fetal hemoglobin: prospects for new therapies for the β-globin disorders.Bauer DE, Kamran SC, Orkin SHBlood2012
Erythrocyte density in sickle cell syndromes is associated with specific clinical manifestations and hemolysis.Bartolucci P, Brugnara C, Teixeira-Pinto A, Pissard S, Moradkhani K, Jouault H, Galacteros FBlood2012
Interference of Hemoglobin D on Measurements of Hemoglobin A1c by the High-Performance Liquid Chromatography HA-8160 in 27 Patients.Lorenzo-Medina M, De-La-Iglesia S, Ropero P, Martin-Alfaro R, Quintana-Hidalgo LJ Diabetes Sci Technol2012
A phase 1/2 trial of HQK-1001, an oral fetal globin inducer, in sickle cell disease.Kutlar A, Ataga K, Reid M, Vichinsky EP, Neumayr L, Blair-Britt L, Labotka R, Glass J, Keefer JR, Wargin WA, Berenson R, Perrine SPAm. J. Hematol.2012
The Short Isoform of NF-YA Belongs to the Embryonic Stem Cell Transcription Factor Circuitry.Dolfini D, Minuzzo M, Pavesi G, Mantovani RStem Cells2012
Prevalence of β-Thalassemia Trait and Abnormal Hemoglobin in Premarital Screening in the Province of Izmir, Turkey.Uysal A, Genc A, Taşyürek N, Türkyilmaz B Pediatr Hematol Oncol2012
Glutathionylation induced structural changes in oxy human hemoglobin analyzed by backbone amide hydrogen/deuterium exchange and MALDI-mass spectrometry.Mitra G, Muralidharan M, Narayanan S, Pinto J, Srinivasan K, Mandal AK Bioconjug. Chem.2012
Interventions for treating leg ulcers in people with sickle cell disease.Martí-Carvajal AJ, Knight-Madden JM, Martinez-Zapata MJ Cochrane Database Syst Rev2012
Gene therapy for sickle cell disease.Olowoyeye A, Okwundu CI Cochrane Database Syst Rev2012
Mental health disorders influence admission rates for pain in children with sickle cell disease.Myrvik MP, Burks LM, Hoffman RG, Dasgupta M, Panepinto JA Pediatr Blood Cancer2012
National trends in incidence rates of hospitalization for stroke in children with sickle cell disease.McCavit TL, Xuan L, Zhang S, Flores G, Quinn CT Pediatr Blood Cancer2012
Combined chelation therapy with deferasirox and deferoxamine in thalassemia.Lal A, Porter J, Sweeters N, Ng V, Evans P, Neumayr L, Kurio G, Harmatz P, Vichinsky E Blood Cells Mol. Dis.2012
Relationship between Plasma Ferritin Level and Siderocyte Number in Splenectomized β-Thalassemia/HbE Patients.Tripatara A, Srichana N, Lamool P, Amnuaykan S, Hongart P, Jetsrisuparb A Anemia2012
Mortality, Asthma, Smoking and Acute Chest Syndrome in Young Adults with Sickle Cell Disease.Knight-Madden JM, Barton-Gooden A, Weaver SR, Reid M, Greenough A Lung2012
Initial Development of a Questionnaire Evaluating Perceived Benefits and Barriers to Pediatric Clinical Trials Participation.Barakat LP, Patterson CA, Mondestin V, Chavez V, Austin T, Robinson MR, Li Y, Smith-Whitley K, Cohen R Contemp Clin Trials2012
Assessment of leucoreduction of sickle cell trait blood: quality of the filtered product.Amar KO, Bourdonné O, Bruneau S, Sellami F, Richard P Blood Transfus2012
Haplo-BMT: cure or back to sickle cell?Bernaudin F, Kuentz M Blood2012
Does the sickle cell trait (heterozygous carrier status) confer protection against malaria?Désidéri-Vaillant C, Sapin-Lory J, Di Costanzo L, Cano C, Lambrechts D, Le Mener S, Le Nestour K, Nicolas X Med Sante Trop2012
[BCL11A controls the expression of the human fetal hemoglobin].Labie D Med Sci (Paris)2012
A Phase 1 Study of Prasugrel in Patients with Sickle Cell Disease: Pharmacokinetics and Effects on ex Vivo Platelet Reactivity.Jakubowski JA, Zhou C, Small DS, Winters KJ, Lachno DR, Frelinger AL, Howard J, Mant TG, Jurcevic S, Payne CD Br J Clin Pharmacol2012
Sickle cell anaemia and malaria.Luzzatto L Mediterr J Hematol Infect Dis2012
Quality of life in patients with thalassemia major and intermedia in kerman-iran (I.R.).Safizadeh H, Farahmandinia Z, Nejad SS, Pourdamghan N, Araste M Mediterr J Hematol Infect Dis2012
Weisberg D, Balf-Soran G, Becker W, Brown SE, Sledge W J Hosp Med2012
Evaluation of microalbuminuria in relation to asymptomatic bacteruria in Nigerian patients with sickle cell anemia.Iwalokun BA, Iwalokun SO, Hodonu SO, Aina OA, Agomo PU Saudi J Kidney Dis Transpl2012
Evaluating iron status and the risk of anemia in young infants using erythrocyte parameters.Torsvik IK, Markestad T, Ueland PM, Nilsen RM, Midttun O, Bjørke Monsen AL Pediatr. Res.2012
Long-term treatment with high-dose of sildenafil in a thalassemic patient with pulmonary hypertension.Correale M, De Rosa F, Ieva R, Di Biase M, Brunetti ND Monaldi Arch Chest Dis2012
Quantitative MRI analysis of salivary glands in sickle cell disease.Liao J, Saito N, Ozonoff A, Jara H, Steinberg M, Sakai O Dentomaxillofac Radiol2012
The effects of chelators on zinc levels in patients with thalassemia major.Erdoğan E, Canatan D, Ormeci AR, Vural H, Aylak F J Trace Elem Med Biol2012
Molecular epidemiology of β-thalassemia in Pakistan: Far reaching implications.Ansari SH, Shamsi TS, Ashraf M, Farzana T, Bohray M, Perveen K, Erum S, Ansari I, Ahmed MN, Ahmed M, Raza F Indian J Hum Genet2012
Prevalence and hematological profile of β-thalassemia and sickle cell anemia in four communities of Surat city.Bhukhanvala DS, Sorathiya SM, Shah AP, Patel AG, Gupte SC Indian J Hum Genet2012
Micro mapping the frequencies of beta thalassemia and sickle cell anemia in India: A way forward to plan control strategies.Das R Indian J Hum Genet2012
Blood Erythrocyte and Hemoglobin Concentrations in Premature Adrenarche.Utriainen P, Jääskeläinen J, Voutilainen R J. Clin. Endocrinol. Metab.2012
Novel, High-Yield Red Blood Cell Production Methods from CD34-Positive Cells Derived from Human Embryonic Stem, Yolk Sac, Fetal Liver, Cord Blood, and Peripheral Blood.Olivier E, Qiu C, Bouhassira EE Stem Cells Transl Med2012
Differential plasma proteome profiles of mild versus severe β-thalassemia/Hb E.Hatairaktham S, Srisawat C, Siritanaratkul N, Chiangjong W, Fucharoen S, Thongboonkerd V, Kalpravidh RW Ann. Hematol.2012
Ogilvie's syndrome in sickle cell disease.Gürkan E Turk J Gastroenterol2012
Treosulfan-Thiotepa-Fludarabine-Based Conditioning Regimen for Allogeneic Transplantation in Patients with Thalassemia Major: A Single-Center Experience from North India.Choudhary D, Sharma SK, Gupta N, Kharya G, Pavecha P, Handoo A, Setia R, Katewa S Biol. Blood Marrow Transplant.2012
Antioxidant functions for the hemoglobin β93 cysteine residue in erythrocytes and in the vascular compartment in vivo.Vitturi DA, Sun CW, Harper VM, Thrash-Williams B, Cantu-Medellin N, Chacko BK, Peng N, Dai Y, Michael Wyss J, Townes T, Patel RP Free Radic. Biol. Med.2012
[Sickle cell disease and life-threatening acute chest syndrome: Interest of extracorporeal life support.]Grein E, Ducrocq N, Kimmoun A, Vanhuyse F, Gerard A, Levy B Ann Fr Anesth Reanim2012
CNTO 530 Increases Expression of HbA and HbF in Murine Models of β-Thalassemia and Sickle Cell Anemia.Makropoulos DA, Achuthanandam R, Avery J, Wilson K, Brosnan K, Miller A, Nesspor T, Chroscinski D, Walker M, Egenolf D, Huang C, Bugelski PJ Curr Pharm Biotechnol2012
L-arginine as an adjuvant drug in the treatment of sickle cell anaemia.Elias DB, Barbosa MC, Rocha LB, Dutra LL, Silva HF, Martins AM, Gonçalves RP Br. J. Haematol.2012
[Nutritional status in patients after gastrectomy due to gastric cancer]. Vopr Pitan2012
Managing acute painful sickle cell episodes in hospital.Howard J Nurs Times2012
The Other Side of Abnormal: A Case Series of Low Transcranial Doppler Velocities Associated With Stroke in Children With Sickle Cell Disease.Buchanan ID, James-Herry A, Osunkwo I J. Pediatr. Hematol. Oncol.2012
Effect of a group of genetic markers around the 5' regulatory regions of the β globin gene cluster linked to high HbF on the clinical severity of β thalassemia.Dabke P, Colah RB, Ghosh K, Nadkarni A Blood Cells Mol. Dis.2012
Pathophysiology and Clinical Manifestations of the β-Thalassemias.Nienhuis AW, Nathan DG Cold Spring Harb Perspect Med2012
Evolution of hemoglobin and its genes.Hardison RC Cold Spring Harb Perspect Med2012
The Switch from Fetal to Adult Hemoglobin.Sankaran VG, Orkin SH Cold Spring Harb Perspect Med2012
Correlates of steady-state haematocrit and hepatosplenomegaly in children with sickle cell disease in Western Nigeria.Brown BJ, Fatunde OJ, Sodeinde O West Afr J Med2012
Clinical features of sickle cell anaemia in northern nigerian children.Ambe JP, Mava Y, Chama R, Farouq G, Machoko Y West Afr J Med2012
Specific absorption spectra of hemoglobin at different PO2 levels: potential noninvasive method to detect PO2 in tissues.Liu P, Zhu Z, Zeng C, Nie G J Biomed Opt2012
Radiographic features in a rare case of sphenoid sinus extramedullary hematopoeisis in sickle cell disease.Sklar M, Rotaru C, Grynspan D, Bromwich M Int. J. Pediatr. Otorhinolaryngol.2012
A novel epsilon gamma delta beta thalassemia presenting with pregnancy complications and severe neonatal anemia.Shalev H, Landau D, Pissard S, Krasnov T, Kapelushnik J, Gilad O, Broides A, Dgany O, Tamary H Eur. J. Haematol.2012
Multiscale analysis of hypoxemia in methemoglobin anemia.Sanyal T, Chakraborty S Math Biosci2012
Oxidative stress-induced posttranslational modifications of human hemoglobin in erythrocytes.Xiang W, Weisbach V, Sticht H, Seebahn A, Bussmann J, Zimmermann R, Becker CM Arch. Biochem. Biophys.2012
Molecular Controls of the Oxygenation and Redox Reactions of Hemoglobin.Crumbliss AL, Bonaventura C, Henkens R, Alayash AI, Banerjee S Antioxid. Redox Signal.2012
Hospitalisations for sickle-cell disease in an Australian paediatric population.Teoh Y, Greenway A, Savoia H, Monagle P, Roy J, Barnes C J Paediatr Child Health2012
A Dual Reporter Mouse Model of the Human β-Globin Locus: Applications and Limitations.Papadopoulos P, Gutiérrez L, van der Linden R, Kong-A-San J, Maas A, Drabek D, Patrinos GP, Philipsen S, Grosveld F PLoS ONE2012
Advanced sickle cell associated interstitial lung disease presenting with cor pulmonale in a Nigerian.Fawibe AE, Kolo PM, Ogunmodede JA, Desalu OO, Salami KA Niger Med J2012
Acute massive splenic infarction with splenic vein thrombosis following altitude exposure of a sri lankan male with undetected sickle cell trait.Abeysekera WY, de Silva WD, Pinnaduwa SS, Banagala AS High Alt. Med. Biol.2012
Vitamin C Supplementation Does not Improve Hypoxia-Induced Erythropoiesis.Martinez-Bello VE, Sanchis-Gomar F, Martinez-Bello D, Olaso-Gonzalez G, Gomez-Cabrera MC, Viña J High Alt. Med. Biol.2012
Role of aquaporin-1 gene in erythroid differentiation of erythroleukemia K562 cells induced by retinoic acid.Wei M, Shi R, Jiang L, Wang NS, Ma WL Nan Fang Yi Ke Da Xue Xue Bao2012
Prenatal and post-natal screening of β-thalassemia and hemoglobin E genes in Thailand using denaturing high performance liquid chromatography.Prajantasen T, Fucharoen S, Fucharoen G, Siriratmanawong N, Pinmuang-Ngam C Mol. Biol. Rep.2012
Alpha-hemoglobin stabilizing protein (AHSP) markedly decreases the redox potential and reactivity of alpha subunits of human HbA with hydrogen peroxide.Mollan TL, Banerjee S, Wu G, Parker Siburt CJ, Tsai AL, Olson JS, Weiss MJ, Crumbliss AL, Alayash AI J. Biol. Chem.2012
Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins.Schaer DJ, Buehler PW, Alayash AI, Belcher JD, Vercellotti GM Blood2012
GWAS of Blood Cell Traits Identifies Novel Associated Loci and Epistatic Interactions in Caucasian and African American Children.Li J, Glessner JT, Zhang H, Hou C, Wei Z, Bradfield JP, Mentch FD, Guo Y, Kim C, Xia Q, Chiavacci RM, Thomas KA, Qiu H, Grant SF, Furth SL, Hakonarson H, Sleiman PM Hum. Mol. Genet.2012
Stromal Cell Mediated Inhibition of Erythropoiesis Can Be Attenuated by Sotatercept (ACE-011), an Activin Receptor Type II Ligand Trap.Iancu-Rubin C, Mosoyan G, Wang J, Kraus T, Sung V, Hoffman R Exp. Hematol.2012
Solenostemon monostachyus, Ipomoea involucrata and Carica papaya seed oil versus Glutathione, or Vernonia amygdalina: Methanolic extracts of novel plants for the management of sickle cell anemia disease.Afolabi IS, Osikoya IO, Fajimi OD, Usoro PI, Ogunleye DO, Bisi-Adeniyi T, Adeyemi AO, Adekeye BT BMC Complement Altern Med2012
Fulminant hepatic failure attributed to ackee fruit ingestion in a patient with sickle cell trait.Grunes DE, Scordi-Bello I, Suh M, Florman S, Yao J, Fiel MI, Thung SN Case Rep Transplant2012
Insights and hopes in umbilical cord blood stem cell transplantations.Shahrokhi S, Menaa F, Alimoghaddam K, McGuckin C, Ebtekar M J. Biomed. Biotechnol.2012
Sickle cell disease and racism: Real or false barriers?Thompson AA Pediatr Blood Cancer2012
High rates of recurrent biliary tract obstruction in children with sickle cell disease.Amoako MO, Casella JF, Strouse JJ Pediatr Blood Cancer2012
Hydroxyurea treatment decreases glomerular hyperfiltration in children with sickle cell anemia.Aygun B, Mortier NA, Smeltzer MP, Shulkin BL, Hankins JS, Ware RE Am. J. Hematol.2012
A Swiss (ϵγδβ)(0) -thalassemia patient with a novel 3-Mb deletion associated with mild mental impairment.Von Kanel T, Röthlisberger B, Schanz U, Dutly F, Huber AR, Saller E Am. J. Hematol.2012
Effect of propranolol as antiadhesive therapy in sickle cell disease.De Castro LM, Zennadi R, Jonassaint JC, Batchvarova M, Telen MJ Clin Transl Sci2012
Left ventricular myocardial performance assessed by 2-dimensional speckle tracking echocardiography in patients with sickle cell crisis.Sengupta SP, Jaju R, Nugurwar A, Caracciolo G, Sengupta PP Indian Heart J2012
A Preliminary Study of Psychiatric, Familial, and Medical Characteristics of High-utilizing Sickle Cell Disease Patients.Carroll PC, Haywood C, Hoot MR, Lanzkron S Clin J Pain2012
A novel approach to pain management in persons with sickle cell disease.Myers M, Eckes EJ Medsurg Nurs2012
Back to the basics.Khatri P, Wu BJ Conn Med2012
Sickle cell trait, exertion-related death and confounded estimates.Stovitz SD, Shrier I Br J Sports Med2012
Differential effects of the type of iron chelator on the absolute number of hematopoietic peripheral progenitors in patients with β-thalassemia major.Forni GL, Podesta' M, Musso M, Piaggio G, Musallam KM, Balocco M, Pozzi S, Rosa A, Frassoni F Haematologica2012
A proficiency testing program of hemoglobin analysis in prevention and control of severe hemoglobinopathies in Thailand.Karnpean R, Fucharoen G, Pansuwan A, Changtrakul D, Fucharoen S Clin. Chem. Lab. Med.2012
Cost-utility analysis of oral deferasirox versus infusional deferoxamine in transfusion-dependent β-thalassemia patients.Keshtkaran A, Javanbakht M, Salavati S, Mashayekhi A, Karimi M, Nuri B Transfusion2012
Jamaica, the Caribbean and sickle cell disease.Serjeant GR West Indian Med J2012
Normal muscle oxygen consumption and fatigability in sickle cell patients despite reduced microvascular oxygenation and hemorheological abnormalities.Waltz X, Pichon A, Lemonne N, Mougenel D, Lalanne-Mistrih ML, Lamarre Y, Tarer V, Tressières B, Etienne-Julan M, Hardy-Dessources MD, Hue O, Connes P PLoS ONE2012
Evidence for a Novel Mechanism Independent of Myocardial Iron in β-Thalassemia Cardiac Pathogenesis.Stoyanova E, Cloutier G, Felfly H, Lemsaddek W, Ah-Son N, Trudel M PLoS ONE2012
Mi2β Is Required for γ-Globin Gene Silencing: Temporal Assembly of a GATA-1-FOG-1-Mi2 Repressor Complex in β-YAC Transgenic Mice.Costa FC, Fedosyuk H, Chazelle AM, Neades RY, Peterson KR PLoS Genet.2012
Massive splenic infarction in an adolescent with hemoglobin S-HPFH.Whyte D, Forget B, Chui DH, Luo HY, Pashankar F Pediatr Blood Cancer2012
Potential role for statins in sickle cell disease.Adam SS, Hoppe C Pediatr Blood Cancer2012
Hemoglobin S and C affect the motion of Maurer's clefts in P. falciparum-infected erythrocytes.Kilian N, Dittmer M, Cyrklaff M, Ouermi D, Bisseye C, Simpore J, Frischknecht F, Sanchez CP, Lanzer M Cell. Microbiol.2012
Hydroxyurea therapy in sickle cell anemia patients aids to maintain oral fungal colonization balance.Salvia AC, Figueiredo MS, Braga JA, Pereira DF, Brighenti FL, Ito CY J. Oral Pathol. Med.2012
Antioxidant vitamins C and E supplementation increases markers of haemolysis in sickle cell anaemia patients: a randomized, double-blind, placebo-controlled trial.Arruda MM, Mecabo G, Rodrigues CA, Matsuda SS, Rabelo IB, Figueiredo MS Br. J. Haematol.2012
A randomized double-blind, placebo-controlled studyof therapeutic effects of silymarin in β-thalassemia major patients receiving desferrioxamine.Moayedi B, Gharagozloo M, Esmaeil N, Maracy MR, Hoorfar H, Jalaeikar M Eur. J. Haematol.2012
New optical coherence tomography fundus findings in a case of beta-thalassemia.Eleftheriadou M, Theodossiadis P, Rouvas A, Alonistiotis D, Theodossiadis G Clin Ophthalmol2012
Hemoglobin Allostery: New Views on Old Players.Miele AE, Bellelli A, Brunori M J. Mol. Biol.2012
Feasibility of early diagnosis and treatment of acute chest syndrome in sickle cell anaemia--a case report.Alli FO, Adebayo AK, Olowojolu OP, Daini OM, Osunkoya SA, Thomas BO Niger J Med2012
Causes of new cases of major thalassemia in sistan and balouchistan province in South-East of iran.Miri-Moghaddam E, Naderi M, Izadi S, Mashhadi M Iran. J. Public Health2012
Co-inheritance of sickle cell trait and thalassemia mutations in South central iran.Saleh-Gohari N, Mohammadi-Anaie M Iran. J. Public Health2012
Tissue Doppler echocardiographic findings of left ventricle in children with sickle-cell anemia.Ghaderian M, Keikhaei B, Heidari M, Salehi Z, Azizi Malamiri R J Tehran Heart Cent2012
Sickle Cell Disease (SCD), iNKT Cells, and Regadenoson Infusion.Nathan DG, Field J, Lin G, Neuberg D, Majerus E, Onyekwere O, Keefer J, Okam M, Ross A, Linden J Trans. Am. Clin. Climatol. Assoc.2012
Iron sucrose versus oral iron therapy in pregnancy anemia.Neeru S, Nair NS, Rai L Indian J Community Med2012
A novel deletion of -2.8 kb removing the entire alpha 2-globin gene observed in a Chinese patient with Hb H.Mo Z, Yu C, Hu Z, Feng W Clin. Lab.2012
Effect of hypertransfusion on extramedullary hematopoietic compression mass in thalassemia major: a case report.Emamhadi M, Alizadeh A Iran J Radiol2012
Views of patients about sickle cell disease management in primary care: a questionnaire-based pilot study.Aljuburi G, Okoye O, Majeed A, Knight Y, Green S, Banarsee R, Nkohkwo A, Ojeer P, Ndive C, Oni L, Phekoo K JRSM Short Rep2012
Quality of life of individuals with sickle cell disease followed at referral centers in Alagoas, Brazil.Vilela RQ, Cavalcante JC, Cavalcante BF, Araújo DL, Lôbo Mde M, Nunes FA Rev Bras Hematol Hemoter2012
Hematological differences between patients with different subtypes of sickle cell disease on hydroxyurea treatment.Neves F, Menezes Neto OA, Polis LB, Bassi SC, Brunetta DM, Silva-Pinto AC, Angulo IL Rev Bras Hematol Hemoter2012
The influence of hydroxyurea on oxidative stress in sickle cell anemia.Torres Lde S, da Silva DG, Belini Junior E, de Almeida EA, Lobo CL, Cançado RD, Ruiz MA, Bonini-Domingos CR Rev Bras Hematol Hemoter2012
Quality of life in sickle cell disease: assessments by the 36-item Short Form Health Survey Questionnaire and Beck Depression Inventory.Ivo ML, Ferreira Júnior MA Rev Bras Hematol Hemoter2012
Comment on "The influence of hydroxyurea on oxidative stress in sickle cell anemia"van Beers EJ, Kato GJ Rev Bras Hematol Hemoter2012
Splenic enlargement in adults with homozygous sickle cell disease: the Jamaican experience.Asnani MR, Williams A, Reid M Hematology2012
Iron-chelation therapy with oral chelators in patients with thalassemia major.Uygun V, Kurtoglu E Hematology2012
Beta-thalassemia in iran: new insight into the role of genetic admixture and migration.Rezaee AR, Banoei MM, Khalili E, Houshmand M ScientificWorldJournal2012
Transfusion practices in the management of sickle cell disease: a survey of Florida hematologists/oncologists.Dunbar LN, Coleman Brown L, Rivera DR, Hartzema AG, Lottenberg R ISRN Hematol2012
Comparative effects of three iron chelation therapies on the quality of life of greek patients with homozygous transfusion-dependent Beta-thalassemia.Goulas V, Kourakli-Symeonidis A, Camoutsis C ISRN Hematol2012
Differential impact of sickle cell trait on symptomatic and asymptomatic malaria.Shim E, Feng Z, Castillo-Chavez C Math Biosci Eng2012
Sickle retinopathy in a person with hemoglobin s/new york disease.Calder D, Etienne-Julan M, Romana M, Watkins N, Knight-Madden JM Case Rep Genet2012
Is sickle cell disease a hematologic disorder?Ballas SK J Natl Med Assoc2012
Kikuchi-Fugimoto's disease in sickle cell disease: report of 2 cases.Crawford RD, Kalhagen L, Wang E, Telen MJ J Natl Med Assoc2012
Sickle cell disease patients' perceptions of emergency department pain management.Porter J, Feinglass J, Artz N, Hafner J, Tanabe P J Natl Med Assoc2012
Exercise performance in thalassemia major: Correlation with cardiac iron burden.Sohn EY, Kato R, Noetzli LJ, Gera A, Coates T, Harmatz P, Keens TG, Wood JC Am. J. Hematol.2012
An unusual case of sarcoidosis in an adult patient with sickle cell disease: Management with methotrexate and low dose of steroid.Delmonte L, Zamo A, Cantini M, de Franceschi L Am. J. Hematol.2012
A method of HbF determination for potential use in underdeveloped countries.Schumacher SN, Randolph TR Clin Lab Sci2012
Study of behavioral problems in multi-transfused thalassemic children.Hongally C, Benakappa AD, Reena S Indian J Psychiatry2012
Activity and school attendance monitoring system for adolescents with Sickle cell disease.Venugopalan J, Brown C, Cheng C, Stokes TH, Wang MD Conf Proc IEEE Eng Med Biol Soc2012
Screening for thalassemia and other hemoglobinopathies in a tertiary care hospital of West Bengal: Implications for population screening.Jain BB, Roy RN, Ghosh S, Ghosh T, Banerjee U, Bhattacharya SK Indian J Public Health2012
Level of nitric oxide and antioxidant vitamins in sickle cell anaemia patients.Hundekar PS, Suryakar AN, Karnik AC, Katkam RV, Joshi NG, Ghone RA Indian J. Physiol. Pharmacol.2012
Comparison of biventricular dimensions and function between pediatric sickle-cell disease and thalassemia major patients without cardiac iron.Meloni A, Detterich J, Berdoukas V, Pepe A, Lombardi M, Coates TD, Wood JC Am. J. Hematol.2012
Biochemical features of hepatic dysfunction in Nigerians with Sickle Cell Anaemia.Yahaya IA Niger Postgrad Med J2012
Phenotype and genotype analysis of hemoglobin E.Li YQ, Huang HP, Qin GF, Yang WH, Lao ZC Zhonghua Xue Ye Xue Za Zhi2012
Analysis of hematological characteristics on the 79 co-inheritance of α-thalassemia and β-thalassemia carriers in Guangxi.Xiong F, Lou JW, Wei XF, Sun MN, Huang JW, Shang X, Zhang XH, Xu XM Zhonghua Xue Ye Xue Za Zhi2012
Genetic detection and enzymatic analyses in α-thalassaemia patients with pyrimidine 5' nucleotidase deficiency.Huang JB, Nie N, Shao YQ, Huang ZD, Zhang J, Zhang TL, Shi J, Zheng YZ Zhonghua Xue Ye Xue Za Zhi2012
Beta globin frameworks in thalassemia major patients from north iran.Akhavan-Niaki H, Banihashemi A, Azizi M Iran J Pediatr2012
Prevalance of iron deficiency in thalassemia minor: a study from tertiary hospital.Dolai TK, Nataraj KS, Sinha N, Mishra S, Bhattacharya M, Ghosh MK Indian J Hematol Blood Transfus2012
Distribution and ethnic variation of â-thalassemia mutations in Nepal.Mishra A, Mukherjee A, Roy A, Singh G, Shrestha P, Singh RR, Rohil V, Baral N, Majhi S, Dash D Nepal Med Coll J2012
Nineteen years study of beta-thalassaemia in Slovakia.Fábryová V, Babusík P, Laluhová-Striezencová Z, Drakulová M, Oslancová M, Macichová M, Sakalová A Cent. Eur. J. Public Health2012
Prevalence of Human Immunodeficiency Virus Transmission among Transfused Children with Sickle Cell Anemia in Enugu Nigeria.Ubesie A, Emodi I, Ikefuna A, Ilechukwu G, Ilechukwu G Ann Med Health Sci Res2012
Hemoglobin Pyrgos with hemoglobin H disease: new triple heterozygosity.Insiripong S, Jitpakdeebodin V, Jopang Y, Fucharoen S Southeast Asian J. Trop. Med. Public Health2012
Retinal impairment in young individuals with sickle cell anemia (hemoglobin SS disease) in university hospital in Northeastern of Brazil.Santos AM, Faro GB, Amaral MV, Mendonça Cde Q, Leal BC, Cipolotti R Arq Bras Oftalmol2012
Single-cell polymerase chain reaction-based pre-implantation genetic diagnosis using fragment analysis for β-thalassemia in an Indian couple with β-globin gene mutations.Saxena SG, Saranath D J Hum Reprod Sci2012
Haemoglobin SD disease--rare case of jaundice.Ghosh UC, Sen K, Narayan A, Banik KK, Saha PK J Indian Med Assoc2012
Co-inheritance of HbD (Iran)/Beta Thalassemia IVS1-5 (G > C) Trait in a Punjabi Lady with Diabetes.Bhat VS, Mandal AK, Mathew B Indian J Clin Biochem2012
Biochemical indicator of sickle cell disease: preliminary report from India.Pandey S, Sharma A, Dahia S, Shah V, Sharma V, Mishra RM, Pandey S, Saxena R Indian J Clin Biochem2012
Glomerular Hyperfiltration and Proteinuria in Transfusion-Independent Patients with β-Thalassemia Intermedia.Ziyadeh FN, Musallam KM, Mallat NS, Mallat S, Jaber F, Mohamed AA, Koussa S, Taher AT Nephron Clin Pract2012
Hypercoagulability in β-thalassemia: a status quo.Cappellini MD, Poggiali E, Taher AT, Musallam KM Expert Rev Hematol2012
How I treat transfusional iron overload.Hoffbrand AV, Taher A, Cappellini MD Blood2012
Longitudinal changes in serum ferritin levels correlate with measures of hepatic stiffness in transfusion-independent patients with β-thalassemia intermedia.Musallam KM, Motta I, Salvatori M, Fraquelli M, Marcon A, Taher AT, Cappellini MD Blood Cells Mol. Dis.2012
Mechanisms of renal disease in β-thalassemia.Musallam KM, Taher AT J. Am. Soc. Nephrol.2012
Hypercoagulability in non-transfusion-dependent thalassemia.Cappellini MD, Musallam KM, Poggiali E, Taher AT Blood Rev.2012
Iron overload in non-transfusion-dependent thalassemia: a clinical perspective.Musallam KM, Cappellini MD, Wood JC, Taher AT Blood Rev.2012
Recent advances and treatment challenges in patients with non-transfusion-dependent thalassemia.Taher AT, Cappellini MD, Musallam KM Blood Rev.2012
Deferasirox reduces iron overload significantly in nontransfusion-dependent thalassemia: 1-year results from a prospective, randomized, double-blind, placebo-controlled study.Taher AT, Porter J, Viprakasit V, Kattamis A, Chuncharunee S, Sutcharitchan P, Siritanaratkul N, Galanello R, Karakas Z, Lawniczek T, Ros J, Zhang Y, Habr D, Cappellini MD Blood2012
A puzzling mutation in congenital erythropoietic porphyria and an association with β-thalassaemia trait.Maakaron JE, Abdel Malak O, Itani S, Cappellini MD, Di Pierro E, Brancaleoni V, Granata F, Taher AT Br. J. Dermatol.2012
Deferasirox for up to 3 years leads to continued improvement of myocardial T2* in patients with β-thalassemia major.Pennell DJ, Porter JB, Cappellini MD, Chan LL, El-Beshlawy A, Aydinok Y, Ibrahim H, Li CK, Viprakasit V, Elalfy MS, Kattamis A, Smith G, Habr D, Domokos G, Roubert B, Taher A Haematologica2012
Fetal hemoglobin levels and morbidity in untransfused patients with β-thalassemia intermedia.Musallam KM, Sankaran VG, Cappellini MD, Duca L, Nathan DG, Taher AT Blood2012
Brain positron emission tomography in splenectomized adults with β-thalassemia intermedia: uncovering yet another covert abnormality.Musallam KM, Nasreddine W, Beydoun A, Hourani R, Hankir A, Koussa S, Haidar M, Taher AT Ann. Hematol.2012
Effort required to contact primary care providers after newborn screening identifies sickle cell trait.Christopher SA, Collins JL, Farrell MH J Natl Med Assoc2012
A Method to Identify California's Sickle-Cell Disease Population and its Linkage to the California Cancer Registry.Brown M, Brunson A, Wun T J Registry Manag2012
Safety and efficacy of iron chelation therapy with deferiprone in patients with transfusion-dependent thalassemia.Jamuar SS, Lai AH Ther Adv Hematol2012
Homozygous sickle cell disease in Uganda and Jamaica a comparison of Bantu and Benin haplotypes.Ndugwa C, Higgs D, Fisher C, Hambleton I, Mason K, Serjeant BE, Serjeant GR West Indian Med J2012
Survival in a large cohort of Greek patients with transfusion-dependent beta thalassaemia and mortality ratios compared to the general population.Ladis V, Chouliaras G, Berdoukas V, Chatziliami A, Fragodimitri C, Karabatsos F, Youssef J, Kattamis A, Karagiorga-Lagana MEur. J. Haematol.2011
Optimal management of β thalassaemia intermedia.Taher AT, Musallam KM, Cappellini MD, Weatherall DJBr. J. Haematol.2011
Normal pregnancy in a patient with β-thalassaemia major receiving iron chelation therapy with deferasirox (Exjade®).Vini D, Servos P, Drosou MEur. J. Haematol.2011
Genomic safe harbors permit high β-globin transgene expression in thalassemia induced pluripotent stem cells.Papapetrou EP, Lee G, Malani N, Setty M, Riviere I, Tirunagari LM, Kadota K, Roth SL, Giardina P, Viale A, Leslie C, Bushman FD, Studer L, Sadelain MNat. Biotechnol.2011
Reversal of cardiac iron loading and dysfunction in thalassemic mice by curcuminoids.Thephinlap C, Phisalaphong C, Lailerd N, Chattipakorn N, Winichagoon P, Vadolus J, Fucharoen S, Porter JB, Srichairatanakool SMed Chem2011
Occurrence of common and rare δ-globin gene defects in two multiethnic populations: thirteen new mutations and the significance of δ-globin gene defects in β-thalassemia diagnostics.Phylipsen M, Gallivan MV, Arkesteijn SG, Harteveld CL, Giordano PCInt J Lab Hematol2011
Genetic predisposition to β-thalassemia and sickle cell anemia in Turkey: a molecular diagnostic approach.Basak AN, Tuzmen SMethods Mol. Biol.2011
Continued improvement in myocardial T2* over two years of deferasirox therapy in β-thalassemia major patients with cardiac iron overload.Pennell DJ, Porter JB, Cappellini MD, Chan LL, El-Beshlawy A, Aydinok Y, Ibrahim H, Li CK, Viprakasit V, Elalfy MS, Kattamis A, Smith G, Habr D, Domokos G, Roubert B, Taher AHaematologica2011
Deferasirox, deferiprone and desferrioxamine treatment in thalassemia major patients: cardiac iron and function comparison determined by quantitative magnetic resonance imaging.Pepe A, Meloni A, Capra M, Cianciulli P, Prossomariti L, Malaventura C, Putti MC, Lippi A, Romeo MA, Bisconte MG, Filosa A, Caruso V, Quarta A, Pitrolo L, Missere M, Midiri M, Rossi G, Positano V, Lombardi M, Maggio AHaematologica2011
Quantitatively different red cell/nucleated cell chimerism in patients with long-term, persistent hematopoietic mixed chimerism after bone marrow transplantation for thalassemia major or sickle cell disease.Andreani M, Testi M, Gaziev J, Condello R, Bontadini A, Tazzari PL, Ricci F, De Felice L, Agostini F, Fraboni D, Ferrari G, Battarra M, Troiano M, Sodani P, Lucarelli GHaematologica2011
Full COLD-PCR protocol for noninvasive prenatal diagnosis of genetic diseases.Galbiati S, Brisci A, Lalatta F, Seia M, Makrigiorgos GM, Ferrari M, Cremonesi LClin. Chem.2011
Targeted massively parallel sequencing of maternal plasma DNA permits efficient and unbiased detection of fetal alleles.Liao GJ, Lun FM, Zheng YW, Chan KC, Leung TY, Lau TK, Chiu RW, Lo YMClin. Chem.2011
Bone disease and skeletal complications in patients with β thalassemia major.Haidar R, Musallam KM, Taher ATBone2011
β+-Thalassemia trait due to a novel mutation in the β-globin gene promoter: -26 (A>C) [HBB c.-76A>C].Waye JS, Nakamura-Garrett LM, Eng B, Kanavakis E, Traeger-Synodinos JHemoglobin2011
Novel and known microsatellite markers within the β-globin cluster to support robust preimplantation genetic diagnosis of β-thalassemia and sickle cell syndromes.Zachaki S, Vrettou C, Destouni A, Kokkali G, Traeger-Synodinos J, Kanavakis EHemoglobin2011
T-type calcium channel as a portal of iron uptake into cardiomyocytes of beta-thalassemic mice.Kumfu S, Chattipakorn S, Srichairatanakool S, Settakorn J, Fucharoen S, Chattipakorn NEur. J. Haematol.2011
Characterization of alpha thalassemic genotypes by multiplex ligation-dependent probe amplification in the Brazilian population.Suemasu CN, Kimura EM, Oliveira DM, Bezerra MA, Araújo AS, Costa FF, Sonati MFBraz. J. Med. Biol. Res.2011
Cell-free nucleic acids as potential markers for preeclampsia.Hahn S, Rusterholz C, Hösli I, Lapaire OPlacenta2011
Solving the problem of γ-retroviral vectors containing long terminal repeats.Persons DA, Baum CMol. Ther.2011
A systems approach to analyze transcription factors in mammalian cells.Soler E, Andrieu-Soler C, Boer E, Bryne JC, Thongjuea S, Rijkers E, Demmers J, Ijcken W, Grosveld FMethods2011
Early echocardiographic findings in β-thalassemia intermedia patients using standard and tissue Doppler methods.Amoozgar H, Farhani N, Karimi MPediatr Cardiol2011
Fok-I gene polymorphism of vitamin D receptor in patients with beta-thalassemia major and its effect on vitamin D status.Dimitriadou M, Christoforidis A, Fidani L, Economou M, Perifanis V, Tsatra I, Katzos G, Athanassiou-Metaxa MHematology2011
Seeking optimal relation between oxygen saturation and hemoglobin concentration in adults with cyanosis from congenital heart disease.Broberg CS, Jayaweera AR, Diller GP, Prasad SK, Thein SL, Bax BE, Burman J, Gatzoulis MAAm. J. Cardiol.2011
Systems biology and red cells.Weatherall DJN. Engl. J. Med.2011
Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort.Bernaudin F, Verlhac S, Arnaud C, Kamdem A, Chevret S, Hau I, Coïc L, Leveillé E, Lemarchand E, Lesprit E, Abadie I, Medejel N, Madhi F, Lemerle S, Biscardi S, Bardakdjian J, Galactéros F, Torres M, Kuentz M, Ferry C, Socié G, Reinert P, Delacourt CBlood2011
Hepcidin and disorders of iron metabolism.Ganz T, Nemeth EAnnu. Rev. Med.2011
Genetics of fetal hemoglobin in Tanzanian and British patients with sickle cell anemia.Makani J, Menzel S, Nkya S, Cox SE, Drasar E, Soka D, Komba AN, Mgaya J, Rooks H, Vasavda N, Fegan G, Newton CR, Farrall M, Thein SLBlood2011
Enhanced erythropoiesis in Hfe-KO mice indicates a role for Hfe in the modulation of erythroid iron homeostasis.Ramos P, Guy E, Chen N, Proenca CC, Gardenghi S, Casu C, Follenzi A, Van Rooijen N, Grady RW, de Sousa M, Rivella SBlood2011
Maternal and fetal circulating sKL and ET-1 levels as function of normal labor at term.Pappa KI, Anagnou NP, Daskalakis G, Ioannides I, Angelidou K, Antsaklis AJ. Matern. Fetal. Neonatal. Med.2011
Hb A2 Hong Kong - A novel δ-globin variant in a Chinese family masks the diagnosis of β-thalassemia trait.So CC, Chan AY, Luo HY, Verhovsek M, Chui DH, Ling SC, Chan LCHemoglobin2011
Hb Sheffield [β58(E2)Pro→His] in Oman: potential pitfall in genetic counseling.Al Zadjali S, Daar S, AlKindi S, Gravell D, Al Haddabi H, Berbar T, Krishnamoorthy RHemoglobin2011
Pulmonary hypertension associated with hemoglobinopathies: prevalent but overlooked.Farmakis D, Aessopos ACirculation2011
Hb Phimai [β72(E16)Ser→Thr]: a novel β-globin structural variant found in association with Hb constant spring in pregnancy.Singsanan S, Srivorakun H, Fucharoen G, Puangplruk R, Fucharoen SHemoglobin2011
Transcellular movement of hydroxyurea is mediated by specific solute carrier transporters.Walker AL, Franke RM, Sparreboom A, Ware REExp. Hematol.2011
Detection of Hb Setif in north Iran and the question of its origin: Iranian or multiethnic?Mahdavi MR, Karimi M, Yavarian M, Roshan P, Kosaryan M, Siami RHemoglobin2011
Hb Boskoop [HBA2c.112C>T p.Pro38Ser]: a new α2 chain variant observed in a Morrocan family.Versteegh FG, Arkesteijn SG, Bakker-Verweij M, Haanappel K, van Delft P, Phylipsen M, Kaufmann JO, Kok PJ, Lansbergen GW, Giordano PC, Harteveld CLHemoglobin2011
Clinical efficacy and safety evaluation of tailoring iron chelation practice in thalassaemia patients from Asia-Pacific: a subanalysis of the EPIC study of deferasirox.Viprakasit V, Ibrahim H, Ha SY, Ho PJ, Li CK, Chan LL, Chiu CF, Sutcharitchan P, Habr D, Domokos G, Roubert B, Xue HL, Bowden DK, Lin KHInt. J. Hematol.2011
Two new hemoglobin variants: Hb Aix-Les-Bains [β5(A2)Pro→Leu; HBB:c.17 C>T] and Hb Dubai [α122(H5)His→Leu (α2); HBA2:c.368 A>T].Joly P, Garcia C, Lacan P, Couprie N, Francina AHemoglobin2011
Identical mutations in the paralogous human γ-globin genes leading to hemoglobin variants and nondeletional hereditary persistence of fetal hemoglobin.Papachatzopoulou A, Patrinos GPHemoglobin2011
Oxidative stress-induced membrane shedding from RBCs is Ca flux-mediated and affects membrane lipid composition.Freikman I, Ringel I, Fibach EJ. Membr. Biol.2011
Value of black blood T2* cardiovascular magnetic resonance.Smith GC, Carpenter JP, He T, Alam MH, Firmin DN, Pennell DJJ Cardiovasc Magn Reson2011
Effectiveness of deferiprone in transfusion-independent beta-thalassemia/HbE patients.Akrawinthawong K, Chaowalit N, Chatuparisuth T, Siritanaratkul NHematology2011
Hb A2' (Hb B2) in the Omani population and diagnostic significance.Daar S, Al Zadjali S, Gravell D, Al Haddabi H, Al Riyami M, Al Belushi A, Berbar T, Krishnamoorthy RHemoglobin2011
Thalassemia and hemoglobinopathies in Southeast Asian newborns: diagnostic assessment using capillary electrophoresis system.Srivorakun H, Fucharoen G, Changtrakul Y, Komwilaisak P, Fucharoen SClin. Biochem.2011
Prenatal, noninvasive and preimplantation genetic diagnosis of inherited disorders: hemoglobinopathies.Traeger-Synodinos J, Vrettou C, Kanavakis EExpert Rev. Mol. Diagn.2011
Oxidative stress contributes to hemolysis in patients with hereditary spherocytosis and can be ameliorated by fermented papaya preparation.Ghoti H, Fibach E, Dana M, Abu Shaban M, Jeadi H, Braester A, Matas Z, Rachmilewitz EAnn. Hematol.2011
The global distribution of the Duffy blood group.Howes RE, Patil AP, Piel FB, Nyangiri OA, Kabaria CW, Gething PW, Zimmerman PA, Barnadas C, Beall CM, Gebremedhin A, Ménard D, Williams TN, Weatherall DJ, Hay SINat Commun2011
Health-related quality of life in adults with transfusion-independent thalassaemia intermedia compared to regularly transfused thalassaemia major: new insights.Musallam KM, Khoury B, Abi-Habib R, Bazzi L, Succar J, Halawi R, Hankir A, Koussa S, Taher ATEur. J. Haematol.2011
The surgeon and the patient with β-thalassaemia intermedia.Saad GS, Musallam KM, Taher ATBr J Surg2011
Safety of short-term valacyclovir as an anti-sickling agent in sickle-cell anemia.Ender KL, DeBellis RH, Erlanger BF, Billote GB, Brittenham GMPediatr Blood Cancer2011
Analyzing 5'HS3 and 5'HS4 LCR core regions and NF-E2 in Iranian thalassemia intermedia patients with normal or carrier status for beta-globin mutations.Neishabury M, Azarkeivan A, Oberkanins C, Abedini SS, Zamani S, Najmabadi HBlood Cells Mol. Dis.2011
Assessment of oxidative stress in patients with sickle cell disease: The glutathione system and the oxidant-antioxidant status.Gizi A, Papassotiriou I, Apostolakou F, Lazaropoulou C, Papastamataki M, Kanavaki I, Kalotychou V, Goussetis E, Kattamis A, Rombos I, Kanavakis EBlood Cells Mol. Dis.2011
Co-infusion of ex vivo-expanded, parental MSCs prevents life-threatening acute GVHD, but does not reduce the risk of graft failure in pediatric patients undergoing allogeneic umbilical cord blood transplantation.Bernardo ME, Ball LM, Cometa AM, Roelofs H, Zecca M, Avanzini MA, Bertaina A, Vinti L, Lankester A, Maccario R, Ringden O, Le Blanc K, Egeler RM, Fibbe WE, Locatelli FBone Marrow Transplant.2011
Gene test review. Alpha-thalassemia.Galanello R, Cao AGenet. Med.2011
The quest for accurate measurement of fetal DNA in maternal plasma.Lo YMClin. Chem.2011
Heterogeneity of hemoglobin H disease in childhood.Lal A, Goldrich ML, Haines DA, Azimi M, Singer ST, Vichinsky EPN. Engl. J. Med.2011
Therapeutic levels of fetal hemoglobin in erythroid progeny of β-thalassemic CD34+ cells after lentiviral vector-mediated gene transfer.Wilber A, Hargrove PW, Kim YS, Riberdy JM, Sankaran VG, Papanikolaou E, Georgomanoli M, Anagnou NP, Orkin SH, Nienhuis AW, Persons DABlood2011
Clinical management of cardiovascular complications in patients with thalassaemia major: a large observational multicenter study.Derchi G, Formisano F, Balocco M, Galanello R, Bina P, Dessì C, Piga A, Donato G, Cappellini MD, Cassinerio E, Quarta G, Melpignano A, Forni GLEur J Echocardiogr2011
Non-invasive prenatal diagnosis by fetal nucleic acid analysis in maternal plasma: the coming of age.Chiu RW, Lo YMSemin Fetal Neonatal Med2011
Neurocognitive deficits in children with sickle cell disease: a comprehensive profile.Hijmans CT, Fijnvandraat K, Grootenhuis MA, van Geloven N, Heijboer H, Peters M, Oosterlaan JPediatr Blood Cancer2011
Analytical evaluation of the Tosoh HLC-723 G8 automated HPLC analyzer for hemoglobin analysis in beta-thalassemia mode.Merono F, Agouti I, Bonello-Palot N, Paolasso C, Levy N, Badens CClin. Biochem.2011
Evidence for distinct pathways of hepcidin regulation by acute and chronic iron loading in mice.Ramos E, Kautz L, Rodriguez R, Hansen M, Gabayan V, Ginzburg Y, Roth MP, Nemeth E, Ganz THepatology2011
Biomarkers of splenic function in infants with sickle cell anemia: baseline data from the BABY HUG Trial.Rogers ZR, Wang WC, Luo Z, Iyer RV, Shalaby-Rana E, Dertinger SD, Shulkin BL, Miller JH, Files B, Lane PA, Thompson BW, Miller ST, Ware RE, Blood2011
On T2* magnetic resonance and cardiac iron.Carpenter JP, He T, Kirk P, Roughton M, Anderson LJ, de Noronha SV, Sheppard MN, Porter JB, Walker JM, Wood JC, Galanello R, Forni G, Catani G, Matta G, Fucharoen S, Fleming A, House MJ, Black G, Firmin DN, St Pierre TG, Pennell DJCirculation2011
The genetic heterogeneity of β-globin gene defects in Sicily reflects the historic population migrations of the island.Giambona A, Vinciguerra M, Cannata M, Cassarà F, Fiorentino G, Leto F, Gioco PL, Renda D, Passarello C, Maggio ABlood Cells Mol. Dis.2011
Thalassemia intermedia is associated with a proatherogenic biochemical phenotype.Lai ME, Vacquer S, Carta MP, Spiga A, Cocco P, Angius F, Mandas A, Dessì SBlood Cells Mol. Dis.2011
Hydroxyurea for sickle cell anemia: what have we learned and what questions still remain?McGann PT, Ware RECurr. Opin. Hematol.2011
Transcriptional regulation of fetal to adult hemoglobin switching: new therapeutic opportunities.Wilber A, Nienhuis AW, Persons DABlood2011
Uptake of non-transferrin iron by erythroid cells.Prus E, Fibach EAnemia2011
Long-term results using hydroxyurea/phlebotomy for reducing secondary stroke risk in children with sickle cell anemia and iron overload.Greenway A, Ware RE, Thornburg CDAm. J. Hematol.2011
Transplantation for liver failure in patients with sickle cell disease: challenging but feasible.Hurtova M, Bachir D, Lee K, Calderaro J, Decaens T, Kluger MD, Zafrani ES, Cherqui D, Mallat A, Galactéros F, Duvoux CLiver Transpl.2011
Clinical follow-up of hydroxyurea-treated adults with sickle cell disease.Nzouakou R, Bachir D, Lavaud A, Habibi A, Lee K, Lionnet F, Hulin A, Jouault H, Préhu C, Roudot-Thoraval F, Girot R, Galactéros FActa Haematol.2011
Thrombosis and sickle cell disease.De Franceschi L, Cappellini MD, Olivieri OSemin. Thromb. Hemost.2011
Global gene expression analysis of human erythroid progenitors.Merryweather-Clarke AT, Atzberger A, Soneji S, Gray N, Clark K, Waugh C, McGowan SJ, Taylor S, Nandi AK, Wood WG, Roberts DJ, Higgs DR, Buckle VJ, Robson KJBlood2011
Participation of Mac-1, LFA-1 and VLA-4 integrins in the in vitro adhesion of sickle cell disease neutrophils to endothelial layers, and reversal of adhesion by simvastatin.Canalli AA, Proença RF, Franco-Penteado CF, Traina F, Sakamoto TM, Saad ST, Conran N, Costa FFHaematologica2011
Cardiac iron and cardiac disease in males and females with transfusion-dependent thalassemia major: a T2* magnetic resonance imaging study.Marsella M, Borgna-Pignatti C, Meloni A, Caldarelli V, Dell'Amico MC, Spasiano A, Pitrolo L, Cracolici E, Valeri G, Positano V, Lombardi M, Pepe AHaematologica2011
A phase 1 dose-escalation study: safety, tolerability, and pharmacokinetics of FBS0701, a novel oral iron chelator for the treatment of transfusional iron overload.Rienhoff HY, Viprakasit V, Tay L, Harmatz P, Vichinsky E, Chirnomas D, Kwiatkowski JL, Tapper A, Kramer W, Porter JB, Neufeld EJHaematologica2011
Improvements in haemolysis and indicators of erythrocyte survival do not correlate with acute vaso-occlusive crises in patients with sickle cell disease: a phase III randomized, placebo-controlled, double-blind study of the Gardos channel blocker senicapoc (ICA-17043).Ataga KI, Reid M, Ballas SK, Yasin Z, Bigelow C, James LS, Smith WR, Galacteros F, Kutlar A, Hull JH, Stocker JW, Br. J. Haematol.2011
Red cell alloimmunization in a diverse population of transfused patients with thalassaemia.Thompson AA, Cunningham MJ, Singer ST, Neufeld EJ, Vichinsky E, Yamashita R, Giardina P, Kim HY, Trachtenberg F, Kwiatkowski JL, Br. J. Haematol.2011
The effect of reducing repetition time TR on the measurement of liver R2 for the purpose of measuring liver iron concentration.Pavitt HL, Aydinok Y, El-Beshlawy A, Bayraktaroglu S, Ibrahim AS, Hamdy MM, Pang W, Sharples C, St Pierre TGMagn Reson Med2011
A pilot study of the short-term use of simvastatin in sickle cell disease: effects on markers of vascular dysfunction.Hoppe C, Kuypers F, Larkin S, Hagar W, Vichinsky E, Styles LBr. J. Haematol.2011
Pulmonary function test in transfusion-dependent β-thalassemia major patients: a pilot study.Alyasin S, Moghtaderi M, Amin R, Kashef S, Karimi MPediatr Hematol Oncol2011
Determination of fetal chromosome aberrations from fetal DNA in maternal blood: has the challenge finally been met?Hahn S, Lapaire O, Tercanli S, Kolla V, Hösli IExpert Rev Mol Med2011
Hematopoietic stem cell transplantation for thalassemia.Gaziev J, Lucarelli GCurr Stem Cell Res Ther2011
Compound heterozygosity for KLF1 mutations associated with remarkable increase of fetal hemoglobin and red cell protoporphyrin.Satta S, Perseu L, Moi P, Asunis I, Cabriolu A, Maccioni L, Demartis FR, Manunza L, Cao A, Galanello RHaematologica2011
A 3-bp deletion in the HBS1L-MYB intergenic region on chromosome 6q23 is associated with HbF expression.Farrell JJ, Sherva RM, Chen ZY, Luo HY, Chu BF, Ha SY, Li CK, Lee AC, Li RC, Li CK, Yuen HL, So JC, Ma ES, Chan LC, Chan V, Sebastiani P, Farrer LA, Baldwin CT, Steinberg MH, Chui DHBlood2011
Rapid and reliable β-globin gene cluster haplotyping of sickle cell disease patients by FRET Light Cycler and HRM assays.Joly P, Lacan P, Garcia C, Delasaux A, Francina AClin. Chim. Acta2011
Severity ranking of non-deletional alpha thalassemic alleles: insights from an Omani family study.Wali Y, Zadjali SA, Elshinawy M, Beshlawi I, Fawaz N, Alkindi S, Rawas A, Alsinani S, Daar S, Krishnamoorthy REur. J. Haematol.2011
A case of well-tolerated and safe deferasirox administration during the first trimester of a spontaneous pregnancy in an advanced maternal age thalassemic patient.Ricchi P, Costantini S, Spasiano A, Di Matola T, Cinque P, Prossomariti LActa Haematol.2011
Anemia, iron deficiency and thalassemia among adolescents in Northeast Thailand: results from two independent surveys.Pansuwan A, Fucharoen G, Fucharoen S, Himakhun B, Dangwiboon SActa Haematol.2011
Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG).Wang WC, Ware RE, Miller ST, Iyer RV, Casella JF, Minniti CP, Rana S, Thornburg CD, Rogers ZR, Kalpatthi RV, Barredo JC, Brown RC, Sarnaik SA, Howard TH, Wynn LW, Kutlar A, Armstrong FD, Files BA, Goldsmith JC, Waclawiw MA, Huang X, Thompson BW, Lancet2011
Characterization of low bone mass in young patients with thalassemia by DXA, pQCT and markers of bone turnover.Fung EB, Vichinsky EP, Kwiatkowski JL, Huang J, Bachrach LK, Sawyer AJ, Zemel BSBone2011
Sox2 cooperates with Chd7 to regulate genes that are mutated in human syndromes.Engelen E, Akinci U, Bryne JC, Hou J, Gontan C, Moen M, Szumska D, Kockx C, van Ijcken W, Dekkers DH, Demmers J, Rijkers EJ, Bhattacharya S, Philipsen S, Pevny LH, Grosveld FG, Rottier RJ, Lenhard B, Poot RANat. Genet.2011
3-years experience review of neonatal screening for hemoglobin disorders using tandem mass spectrometry.Boemer F, Cornet Y, Libioulle C, Segers K, Bours V, Schoos RClin. Chim. Acta2011
Endocrine histology findings in a prepubertal thalassemic girl with multiple endocrine complications secondary to iron overload.De Sanctis V, Giovannini MGeorgian Med News2011
Genetic Analysis in Translational Medicine: The 2010 GOLDEN HELIX Symposium.Patrinos GP, Innocenti F, Cox N, Fortina PHum. Mutat.2011
Sequential alternating deferiprone and deferoxamine treatment compared to deferiprone monotherapy: main findings and clinical follow-up of a large multicenter randomized clinical trial in -thalassemia major patients.Pantalone GR, Maggio A, Vitrano A, Capra M, Cuccia L, Gagliardotto F, Filosa A, Romeo MA, Magnano C, Caruso V, Argento C, Gerardi C, Campisi S, Violi P, Malizia R, Cianciulli P, Rizzo M, D'Ascola DG, Quota A, Prossomariti L, Fidone C, Rigano P, Pepe A, D'Amico G, Morabito A, Gluud CHemoglobin2011
Efficacy, compliance and toxicity factors are affecting the rate of normalization of body iron stores in thalassemia patients using the deferiprone and deferoxamine combination therapy.Kolnagou A, Kleanthous M, Kontoghiorghes GJHemoglobin2011
Ancestry of African Americans with sickle cell disease.Solovieff N, Hartley SW, Baldwin CT, Klings ES, Gladwin MT, Taylor JG, Kato GJ, Farrer LA, Steinberg MH, Sebastiani PBlood Cells Mol. Dis.2011
Transcriptional regulation and pharmacogenomics.Georgitsi M, Zukic B, Pavlovic S, Patrinos GPPharmacogenomics2011
Blood transfusion usage among adults with sickle cell disease - a single institution experience over ten years.Drasar E, Igbineweka N, Vasavda N, Free M, Awogbade M, Allman M, Mijovic A, Thein SLBr. J. Haematol.2011
Involvement of phosphatases in proliferation, maturation, and hemoglobinization of developing erythroid cells.Fibach EJ Signal Transduct2011
The effects of hydroxycarbamide and magnesium on haemoglobin SC disease: results of the multi-centre CHAMPS trial.Wang W, Brugnara C, Snyder C, Wynn L, Rogers Z, Kalinyak K, Brown C, Qureshi A, Bigelow C, Neumayr L, Smith-Whitley K, Chui DH, Delahunty M, Woolson R, Steinberg M, Telen M, Kesler KBr. J. Haematol.2011
Detection of α-thalassemia-1 Southeast Asian and Thai type deletions and β-thalassemia 3.5-kb deletion by single-tube multiplex real-time PCR with SYBR Green1 and high-resolution melting analysis.Pornprasert S, Wiengkum T, Srithep S, Chainoi I, Singboottra P, Wongwiwatthananukit SKorean J Lab Med2011
Recent advances in β-thalassemias.Cao A, Moi P, Galanello RPediatr Rep2011
Evaluation of safety and pharmacokinetics of sodium 2,2 dimethylbutyrate, a novel short chain fatty acid derivative, in a phase 1, double-blind, placebo-controlled, single-dose, and repeat-dose studies in healthy volunteers.Perrine SP, Wargin WA, Boosalis MS, Wallis WJ, Case S, Keefer JR, Faller DV, Welch WC, Berenson RJJ Clin Pharmacol2011
Impaired bone formation and osteopenia in heterozygous β(IVSII-654) knockin thalassemic mice.Thongchote K, Svasti S, Sa-ardrit M, Krishnamra N, Fucharoen S, Charoenphandhu NHistochem. Cell Biol.2011
Placental microparticles, DNA, and RNA in preeclampsia.Rusterholz C, Messerli M, Hoesli I, Hahn SHypertens Pregnancy2011
Fetal hemoglobin in sickle cell anemia.Akinsheye I, Alsultan A, Solovieff N, Ngo D, Baldwin CT, Sebastiani P, Chui DH, Steinberg MHBlood2011
A hemodynamic study of pulmonary hypertension in sickle cell disease.Parent F, Bachir D, Inamo J, Lionnet F, Driss F, Loko G, Habibi A, Bennani S, Savale L, Adnot S, Maitre B, Yaïci A, Hajji L, O'Callaghan DS, Clerson P, Girot R, Galacteros F, Simonneau GN. Engl. J. Med.2011
Comparison of the region-based and pixel-wise methods for cardiac T2* analysis in 50 transfusion-dependent Thai thalassemia patients.Saiviroonporn P, Viprakasit V, Boonyasirinant T, Khuhapinant A, Wood JC, Krittayaphong RJ Comput Assist Tomogr2011
The management of iron chelation therapy: preliminary data from a national registry of thalassaemic patients.Ceci A, Mangiarini L, Felisi M, Bartoloni F, Ciancio A, Capra M, D'Ascola D, Cianciulli P, Filosa AAnemia2011
Generation of bivalent chromatin domains during cell fate decisions.De Gobbi M, Garrick D, Lynch M, Vernimmen D, Hughes JR, Goardon N, Luc S, Lower KM, Sloane-Stanley JA, Pina C, Soneji S, Renella R, Enver T, Taylor S, Jacobsen SE, Vyas P, Gibbons RJ, Higgs DREpigenetics Chromatin2011
Darbepoetin alfa for the treatment of anaemia in alpha- or beta- thalassaemia intermedia syndromes.Singer ST, Vichinsky EP, Sweeters N, Rachmilewitz EBr. J. Haematol.2011
Molecular characterization of two new mutations of α° thalassemia in two Spanish families (mutation --(ED) and --(GP))Villegas A, Ropero P, Anguita E, Hernández A, Polo M, Ataúlfo González FMed Clin (Barc)2011
Paraplegia in a thalassaemic patient with short stature.Campisi S, Mangiagli A, De Sanctis V, Giovannini MPediatr Endocrinol Rev2011
Case report: thalassemia intermedia patient with hypertension non-responsive to combined medical treatment.Lai ME, Vacquer S, Carta MP, Corrias C, Spiga APediatr Endocrinol Rev2011
Adrenal incidentaloma in thalassemia: a case report and literature review.Gamberini MR, Prandini N, Chiodi E, Farneti C, Garani MCPediatr Endocrinol Rev2011
Myocardial iron loading in patients with thalassemia major in Turkey and the potential role of splenectomy in myocardial siderosis.Aydinok Y, Bayraktaroglu S, Yildiz D, Alper HJ. Pediatr. Hematol. Oncol.2011
Papillary thyroid cancer in thalassaemia.Govoni MR, Sprocati M, Fabbri E, Zanforlin N, De Sanctis VPediatr Endocrinol Rev2011
Impact of magnetic resonance imaging on cardiac mortality in thalassemia major.Chouliaras G, Berdoukas V, Ladis V, Kattamis A, Chatziliami A, Fragodimitri C, Karabatsos F, Youssef J, Karagiorga-Lagana MJ Magn Reson Imaging2011
β-thalassemia and thyroid failure: is there a role for thyroid autoimmunity?Mariotti S, Pigliaru F, Cocco MC, Spiga A, Vaquer S, Lai MEPediatr Endocrinol Rev2011
Bone disease in thalassaemia major: recent advances in pathogenesis and clinical aspects.Skordis N, Toumba MPediatr Endocrinol Rev2011
Glomerular hyperfiltration and albuminuria in children with sickle cell anemia.Aygun B, Mortier NA, Smeltzer MP, Hankins JS, Ware REPediatr. Nephrol.2011
Growth hormone and adrenal response to intramuscular glucagon test and its relationship to IGF-1 production and left ventricular ejection fraction in adult B-thalassemia major patients.De Sanctis V, Skordis N, Galati MC, Raiola G, Giovannini M, Candini G, Kaffe K, Savvides I, Christou SPediatr Endocrinol Rev2011
Complex interaction of hemoglobin (Hb) Nakhon Ratchasima [α63(E12)Ala→Val], a novel α2-globin chain variant with Hb E [β26(B8)Glu→Lys] and a deletional α(+)-thalassemia.Srivorakun H, Fucharoen G, Puangplruk R, Kheawon N, Fucharoen SEur. J. Haematol.2011
The multifactorial origin of growth failure in thalassaemia.Skordis N, Kyriakou APediatr Endocrinol Rev2011
Pathophysiology of beta thalassaemia.Origa R, Galanello RPediatr Endocrinol Rev2011
Presumptive diagnosis of common haemoglobinopathies in Southeast Asia using a capillary electrophoresis system.Fucharoen G, Srivorakun H, Singsanan S, Fucharoen SInt J Lab Hematol2011
Interference of hemoglobin Hope on beta-thalassemia diagnosis by the capillary electrophoresis Method.Panyasai S, Sukunthamala K, Jaiping K, Wongwiwatthananukit S, Singboottra P, Pornprasert SAm. J. Clin. Pathol.2011
Nuclear receptors TR2 and TR4 recruit multiple epigenetic transcriptional corepressors that associate specifically with the embryonic β-type globin promoters in differentiated adult erythroid cells.Cui S, Kolodziej KE, Obara N, Amaral-Psarris A, Demmers J, Shi L, Engel JD, Grosveld F, Strouboulis J, Tanabe OMol. Cell. Biol.2011
Iron chelation with deferasirox in adult and pediatric patients with thalassemia major: efficacy and safety during 5 years' follow-up.Cappellini MD, Bejaoui M, Agaoglu L, Canatan D, Capra M, Cohen A, Drelichman G, Economou M, Fattoum S, Kattamis A, Kilinc Y, Perrotta S, Piga A, Porter JB, Griffel L, Dong V, Clark J, Aydinok YBlood2011
Switching globin, raising red cells.Perrine SPBlood2011
A novel deletion/insertion caused by a replication error in the β-globin gene locus control region.Joly P, Lacan P, Garcia C, Meley R, Pondarré C, Francina AHemoglobin2011
Sickle cell/β0-thalassemia associated with the 1393 bp deletion can be associated with a severe phenotype.Daniel Y, Hill K, Inusa B, Thein SL, Howard JHemoglobin2011
Pomalidomide augments fetal hemoglobin production without the myelosuppressive effects of hydroxyurea in transgenic sickle cell mice.Meiler SE, Wade M, Kutlar F, Yerigenahally SD, Xue Y, Moutouh-de Parseval LA, Corral LG, Swerdlow PS, Kutlar ABlood2011
Comparison between capillary electrophoresis and high performance liquid chromatography for detection and quantification of Hb constant spring [Hb CS; α142, Term→Gln (TAA>CAA IN α2)].Waneesorn J, Panyasai S, Kongthai K, Singboottra P, Pornprasert SHemoglobin2011
Pancreatic exocrine function and cardiac iron in patients with iron overload and with thalassemia.Yamamura J, Grosse R, Jarisch A, Janka GE, Nielsen P, Adam G, Fischer RPediatr Blood Cancer2011
Effect of deferiprone or deferoxamine on right ventricular function in thalassemia major patients with myocardial iron overload.Smith GC, Alpendurada F, Carpenter JP, Alam MH, Berdoukas V, Karagiorga M, Ladis V, Piga A, Aessopos A, Gotsis ED, Tanner MA, Westwood MA, Galanello R, Roughton M, Pennell DJJ Cardiovasc Magn Reson2011
Cross-sectional study of pulmonary function and MRI-derived liver and myocardial iron content in young patients with β-thalassemia major.Dimitriadou M, Christoforidis A, Bourli E, Perifanis V, Economou M, Teli A, Pataka A, Stanopoulos I, Argyropoulou P, Athanassiou-Metaxa MEur. J. Haematol.2011
Changing patterns of splenectomy in transfusion-dependent thalassemia patients.Piga A, Serra M, Longo F, Forni G, Quarta G, Cappellini MD, Galanello RAm. J. Hematol.2011
Molecular analysis of globin gene expression in different thalassaemia disorders: individual variation of β(E) pre-mRNA splicing determine disease severity.Tubsuwan A, Munkongdee T, Jearawiriyapaisarn N, Boonchoy C, Winichagoon P, Fucharoen S, Svasti SBr. J. Haematol.2011
Evidence for a proatherogenic biochemical phenotype in beta thalassemia minor and intermedia.Lai ME, Vacquer S, Carta MP, Spiga A, Cocco P, Abete C, Dessì S, Mandas AActa Haematol.2011
Marked impact of IL28B genotype in the natural clearance of hepatitis C virus in patients with haemoglobinopathies.Renda MC, Ruggeri RF, Piazza A, Fecarotta E, Renda D, Pantalone GR, Madonia S, Cottone M, Maggio ABr. J. Haematol.2011
Chelation treatment in sickle-cell-anaemia: much ado about nothing?Lucania G, Vitrano A, Filosa A, Maggio ABr. J. Haematol.2011
Histone deacetylase inhibitors reverse CpG methylation by regulating DNMT1 through ERK signaling.Sarkar S, Abujamra AL, Loew JE, Forman LW, Perrine SP, Faller DVAnticancer Res.2011
Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study.Schrappe M, Valsecchi MG, Bartram CR, Schrauder A, Panzer-Grümayer R, Möricke A, Parasole R, Zimmermann M, Dworzak M, Buldini B, Reiter A, Basso G, Klingebiel T, Messina C, Ratei R, Cazzaniga G, Koehler R, Locatelli F, Schäfer BW, Aricò M, Welte K, van Dongen JJ, Gadner H, Biondi A, Conter VBlood2011
Fok-I polymorphism of vitamin D receptor gene and the presence of renal dysfunction in patients with β-thalassemia major.Dimitriadou M, Christoforidis A, Economou M, Teli A, Printza N, Tzimouli V, Tsatra I, Fidani L, Papachristou F, Athanassiou-Metaxa MPediatr Hematol Oncol2011
In vitro and in vivo properties of distinct populations of amniotic fluid mesenchymal progenitor cells.Roubelakis MG, Bitsika V, Zagoura D, Trohatou O, Pappa KI, Makridakis M, Antsaklis A, Vlahou A, Anagnou NPJ. Cell. Mol. Med.2011
Hemoglobinopathies: clinical manifestations, diagnosis, and treatment.Kohne EDtsch Arztebl Int2011
Derivation of genetically modified human pluripotent stem cells with integrated transgenes at unique mapped genomic sites.Papapetrou EP, Sadelain MNat Protoc2011
Chronic IFN-γ production in mice induces anemia by reducing erythrocyte life span and inhibiting erythropoiesis through an IRF-1/PU.1 axis.Libregts SF, Gutiérrez L, de Bruin AM, Wensveen FM, Papadopoulos P, van Ijcken W, Ozgür Z, Philipsen S, Nolte MABlood2011
Generation of transgene-free human induced pluripotent stem cells with an excisable single polycistronic vector.Papapetrou EP, Sadelain MNat Protoc2011
Progress in understanding the hemoglobin switch.Forget BGN. Engl. J. Med.2011
A functional element necessary for fetal hemoglobin silencing.Sankaran VG, Xu J, Byron R, Greisman HA, Fisher C, Weatherall DJ, Sabath DE, Groudine M, Orkin SH, Premawardhena A, Bender MAN. Engl. J. Med.2011
Absolute quantification of the alleles in somatic point mutations by bioluminometric methods based on competitive polymerase chain reaction in the presence of a locked nucleic acid blocker or an allele-specific primer.Iliadi A, Petropoulou M, Ioannou PC, Christopoulos TK, Anagnostopoulos NI, Kanavakis E, Traeger-Synodinos JAnal. Chem.2011
The DNA binding factor Hmg20b is a repressor of erythroid differentiation.Esteghamat F, van Dijk TB, Braun H, Dekker S, van der Linden R, Hou J, Fanis P, Demmers J, van IJcken W, Ozgür Z, Horos R, Pourfarzad F, von Lindern M, Philipsen SHaematologica2011
Urgency of emergency department visits by children with sickle cell disease: a comparison of 3 chronic conditions.Bundy DG, Strouse JJ, Casella JF, Miller MRAcad Pediatr2011
Long-term safety and efficacy of deferasirox (Exjade) for up to 5 years in transfusional iron-overloaded patients with sickle cell disease.Vichinsky E, Bernaudin F, Forni GL, Gardner R, Hassell K, Heeney MM, Inusa B, Kutlar A, Lane P, Mathias L, Porter J, Tebbi C, Wilson F, Griffel L, Deng W, Giannone V, Coates TBr. J. Haematol.2011
Mortality and causes of death in children with sickle cell disease in the Netherlands, before the introduction of neonatal screening.van der Plas EM, van den Tweel XW, Geskus RB, Heijboer H, Biemond BJ, Peters M, Fijnvandraat KBr. J. Haematol.2011
Reproductive capacity in iron overloaded women with thalassemia major.Singer ST, Vichinsky EP, Gildengorin G, van Disseldorp J, Rosen M, Cedars MIBlood2011
How I treat thalassemia.Rachmilewitz EA, Giardina PJBlood2011
Peripheral vasoconstriction and abnormal parasympathetic response to sighs and transient hypoxia in sickle cell disease.Sangkatumvong S, Khoo MC, Kato R, Detterich JA, Bush A, Keens TG, Meiselman HJ, Wood JC, Coates TDAm. J. Respir. Crit. Care Med.2011
Importance of optimal dosing ≥ 30 mg/kg/d during deferasirox treatment: 2.7-yr follow-up from the ESCALATOR study in patients with β-thalassaemia.Taher A, Elalfy MS, Al Zir K, Daar S, Al Jefri A, Habr D, Kriemler-Krahn U, El-Ali A, Roubert B, El-Beshlawy AEur. J. Haematol.2011
Achieving treatment goals of reducing or maintaining body iron burden with deferasirox in patients with β-thalassaemia: results from the ESCALATOR study.Taher A, Elalfy MS, Al Zir K, Daar S, Al Jefri A, Habr D, Kriemler-Krahn U, Roubert B, El-Beshlawy AEur. J. Haematol.2011
Changing pattern of hospital admissions of children with sickle cell disease over the last 50 years.Day TG, Thein SL, Drasar E, Dick MC, Height SE, O'Driscoll S, Rees DCJ. Pediatr. Hematol. Oncol.2011
Transient receptor potential vanilloid 1 mediates pain in mice with severe sickle cell disease.Hillery CA, Kerstein PC, Vilceanu D, Barabas ME, Retherford D, Brandow AM, Wandersee NJ, Stucky CLBlood2011
Evaluation of myocardial iron overload using cardiovascular magnetic resonance imaging.Mavrogeni S, Pepe A, Lombardi MHellenic J Cardiol2011
Mechanisms of slower nitric oxide uptake by red blood cells and other hemoglobin-containing vesicles.Azarov I, Liu C, Reynolds H, Tsekouras Z, Lee JS, Gladwin MT, Kim-Shapiro DBJ. Biol. Chem.2011
Strategies to optimize the outcome of children given T-cell depleted HLA-haploidentical hematopoietic stem cell transplantation.Locatelli F, Vinti L, Palumbo G, Rossi F, Bertaina A, Mastronuzzi A, Bernardo ME, Rutella S, Dellabona P, Giorgiani G, Moretta A, Moretta LBest Pract Res Clin Haematol2011
Hematopoietic stem cell transplantation for people with ß-thalassaemia major.Jagannath VA, Fedorowicz Z, Al Hajeri A, Hu N, Sharma ACochrane Database Syst Rev2011
Hemoglobin Lepore EF Bart's disease: a molecular, hematological, and diagnostic aspects.Chaibunruang A, Fucharoen G, Jetsrisuparb A, Fucharoen SAnn. Hematol.2011
Reliable detection of paternal SNPs within deletion breakpoints for non-invasive prenatal exclusion of homozygous α-thalassemia in maternal plasma.Yan TZ, Mo QH, Cai R, Chen X, Zhang CM, Liu YH, Chen YJ, Zhou WJ, Xiong F, Xu XMPLoS ONE2011
Alloimmunization to red cells in thalassemics: emerging problem and future strategies.Gupta R, Singh DK, Singh B, Rusia UTransfus. Apher. Sci.2011
Increased oxidative metabolism is associated with erythroid precursor expansion in β0-thalassaemia/Hb E disease.Leecharoenkiat A, Wannatung T, Lithanatudom P, Svasti S, Fucharoen S, Chokchaichamnankit D, Srisomsap C, Smith DRBlood Cells Mol. Dis.2011
TNF-alpha and IL-8: serum levels and gene polymorphisms (-308G>A and -251A>T) are associated with classical biomarkers and medical history in children with sickle cell anemia.Cajado C, Cerqueira BA, Couto FD, Moura-Neto JP, Vilas-Boas W, Dorea MJ, Lyra IM, Barbosa CG, Reis MG, Goncalves MSCytokine2011
Iron chelation therapy in thalassemia major: a systematic review with meta-analyses of 1520 patients included on randomized clinical trials.Maggio A, Filosa A, Vitrano A, Aloj G, Kattamis A, Ceci A, Fucharoen S, Cianciulli P, Grady RW, Prossomariti L, Porter JB, Iacono A, Cappellini MD, Bonifazi F, Cassarà F, Harmatz P, Wood J, Gluud CBlood Cells Mol. Dis.2011
Dynamics of the epigenetic landscape during erythroid differentiation after GATA1 restoration.Wu W, Cheng Y, Keller CA, Ernst J, Kumar SA, Mishra T, Morrissey C, Dorman CM, Chen KB, Drautz D, Giardine B, Shibata Y, Song L, Pimkin M, Crawford GE, Furey TS, Kellis M, Miller W, Taylor J, Schuster SC, Zhang Y, Chiaromonte F, Blobel GA, Weiss MJ, Hardison RCGenome Res.2011
Portacaths are safe for long-term regular blood transfusion in children with sickle cell anaemia.Bartram JL, O'Driscoll S, Kulasekararaj AG, Height SE, Dick M, Patel S, Rees DCArch. Dis. Child.2011
MYH9 and APOL1 are both associated with sickle cell disease nephropathy.Ashley-Koch AE, Okocha EC, Garrett ME, Soldano K, De Castro LM, Jonassaint JC, Orringer EP, Eckman JR, Telen MJBr. J. Haematol.2011
The β-globin promoter -71 C>T mutation is a β+ thalassemic allele.Al Zadjali S, Wali Y, Al Lawatiya F, Gravell D, Alkindi S, Al Falahi K, Krishnamoorthy R, Daar SEur. J. Haematol.2011
Acquired alpha thalassemia myelodyslastic/myeloproliferative syndrome (ATMDS): evolution on hypomethylating agent therapy.Rose C, Fournier M, Nibourel O, Herbaux C, Charpentier A, Renneville A, Pissard S, Badens C, Preudhomme CLeuk. Res.2011
Erythroblast enucleation.Keerthivasan G, Wickrema A, Crispino JDStem Cells Int2011
Distribution and shedding of the membrane phosphatidylserine during maturation and aging of erythroid cells.Freikman I, Fibach EBiochim. Biophys. Acta2011
Targeting microRNAs involved in human diseases: a novel approach for modification of gene expression and drug development.Gambari R, Fabbri E, Borgatti M, Lampronti I, Finotti A, Brognara E, Bianchi N, Manicardi A, Marchelli R, Corradini RBiochem. Pharmacol.2011
Pulmonary hypertension in sickle cell disease.Gladwin MT, Machado RFN. Engl. J. Med.2011
Evaluation of hepatic iron overload in Chinese children with β-thalassemia major.Xu LH, Fang JP, Xu HG, Weng WJPediatr Hematol Oncol2011
In silico analysis of single nucleotide polymorphism (SNPs) in human β-globin gene.Alanazi M, Abduljaleel Z, Khan W, Warsy AS, Elrobh M, Khan Z, Al Amri A, Bazzi MDPLoS ONE2011
Application of SNP array method in prenatal diagnosisBecvárová V, Hynek M, Putzová M, Soldátová I, Horácek J, Smetanová D, Kulovaný E, Matousková M, Krutílková V, Hlavová E, Rasková D, Hejtmánková M, Cutka K, Cutka D, Stejskal D, Mihalová R, Trková MCeska Gynekol2011
Zfp281 functions as a transcriptional repressor for pluripotency of mouse embryonic stem cells.Fidalgo M, Shekar PC, Ang YS, Fujiwara Y, Orkin SH, Wang JStem Cells2011
Recent patents on therapeutic applications of the transcription factor decoy approach.Gambari RExpert Opin Ther Pat2011
KLF1 gene mutations cause borderline HbA(2).Perseu L, Satta S, Moi P, Demartis FR, Manunza L, Sollaino MC, Barella S, Cao A, Galanello RBlood2011
Production of embryonic and fetal-like red blood cells from human induced pluripotent stem cells.Chang CJ, Mitra K, Koya M, Velho M, Desprat R, Lenz J, Bouhassira EEPLoS ONE2011
TMPRSS6 rs855791 modulates hepcidin transcription in vitro and serum hepcidin levels in normal individuals.Nai A, Pagani A, Silvestri L, Campostrini N, Corbella M, Girelli D, Traglia M, Toniolo D, Camaschella CBlood2011
β-thalassemia: a model for elucidating the dynamic regulation of ineffective erythropoiesis and iron metabolism.Ginzburg Y, Rivella SBlood2011
Ontogeny stage-independent and high-level clonal expansion in vitro of mouse hematopoietic stem cells stimulated by an engineered NUP98-HOX fusion transcription factor.Sekulovic S, Gasparetto M, Lecault V, Hoesli CA, Kent DG, Rosten P, Wan A, Brookes C, Hansen CL, Piret JM, Smith C, Eaves CJ, Humphries RKBlood2011
Thalassemia-like phenotype in a novel complex hemoglobinopathy with α, β, δ globin chain abnormalities.Sabio H, Dixon N, Patel N, Obiaga C, Zhuang L, Meiler SE, Kutlar A, Kutlar FJ. Pediatr. Hematol. Oncol.2011
Pharmacokinetics, pharmacodynamics, and pharmacogenetics of hydroxyurea treatment for children with sickle cell anemia.Ware RE, Despotovic JM, Mortier NA, Flanagan JM, He J, Smeltzer MP, Kimble AC, Aygun B, Wu S, Howard T, Sparreboom ABlood2011
T cell-depleted hla-haploidentical stem cell transplantation in thalassemia young patients.Sodani P, Isgrò A, Gaziev J, Paciaroni K, Marziali M, Simone MD, Roveda A, De Angelis G, Gallucci C, Torelli F, Isacchi G, Zinno F, Landi F, Adorno G, Lanti A, Testi M, Andreani M, Lucarelli GPediatr Rep2011
Eliminating cells gone astray.Sadelain MN. Engl. J. Med.2011
The complex transcription regulatory landscape of our genome: control in three dimensions.Splinter E, de Laat WEMBO J.2011
Alterations in cell maturity and serum survival factors may modulate neutrophil numbers in sickle cell disease.Almeida CB, Favero ME, Pereira-Cunha FG, Lorand-Metze I, Saad ST, Costa FF, Conran NExp. Biol. Med. (Maywood)2011
Echocardiographic markers of elevated pulmonary pressure and left ventricular diastolic dysfunction are associated with exercise intolerance in adults and adolescents with homozygous sickle cell anemia in the United States and United Kingdom.Sachdev V, Kato GJ, Gibbs JS, Barst RJ, Machado RF, Nouraie M, Hassell KL, Little JA, Schraufnagel DE, Krishnamurti L, Novelli EM, Girgis RE, Morris CR, Rosenzweig EB, Badesch DB, Lanzkron S, Castro OL, Taylor JG, Hannoush H, Goldsmith JC, Gladwin MT, Gordeuk VR, Circulation2011
Response of iron overload to deferasirox in rare transfusion-dependent anaemias: equivalent effects on serum ferritin and labile plasma iron for haemolytic or production anaemias.Porter JB, Lin KH, Beris P, Forni GL, Taher A, Habr D, Domokos G, Roubert B, Thein SL, Eur. J. Haematol.2011
Deferasirox effectively decreases iron burden in patients with double heterozygous HbS/β-thalassemia.Voskaridou E, Plata E, Douskou M, Sioni A, Mpoutou E, Christoulas D, Dimopoulou M, Terpos EAnn. Hematol.2011
Activation of mononuclear phagocytes and its relationship to asplenia and phosphatidylserine exposing red blood cells in hemoglobin E/β-thalassemia patients.Banyatsuppasin W, Butthep P, Atichartakarn V, Thakkinstian A, Archararit N, Pattanapanyasat K, Chuncharunee SAm. J. Hematol.2011
Transition from pediatric to adult care in sickle cell disease: establishing evidence-based practice and directions for research.Treadwell M, Telfair J, Gibson RW, Johnson S, Osunkwo IAm. J. Hematol.2011
Pharmacokinetics of deferiprone in patients with β-thalassaemia: impact of splenectomy and iron status.Limenta LM, Jirasomprasert T, Jittangprasert P, Wilairat P, Yamanont P, Chantharaksri U, Fucharoen S, Morales NPClin Pharmacokinet2011
The proceedings of the 19Th international conference on chelation held in London, United Kingdom: major changes in iron chelation therapy in the last 25 years using deferiprone (L1) has resulted in the complete treatment of iron overload.Kontoghiorghes GJHemoglobin2011
Interactions of hydroxycarbamide (hydroxyurea) with iron and copper: implications on toxicity and therapeutic strategies.Konstantinou E, Pashalidis I, Kolnagou A, Kontoghiorghes GJHemoglobin2011
Challenges of adherence and persistence with iron chelation therapy.Porter JB, Evangeli M, El-Beshlawy AInt. J. Hematol.2011
Abnormal haemoglobins: detection & characterization.Wajcman H, Moradkhani KIndian J. Med. Res.2011
Past, present & future scenario of thalassaemic care & control in India.Verma IC, Saxena R, Kohli SIndian J. Med. Res.2011
The proinflammatory cytokine GM-CSF downregulates fetal hemoglobin expression by attenuating the cAMP-dependent pathway in sickle cell disease.Ikuta T, Adekile AD, Gutsaeva DR, Parkerson JB, Yerigenahally SD, Clair B, Kutlar A, Odo N, Head CABlood Cells Mol. Dis.2011
Haemoglobinopathies in southeast Asia.Fucharoen S, Winichagoon PIndian J. Med. Res.2011
Accounting for artifactually elevated HbA2 in cases of Hb hope when measured by capillary electrophoresis.Keren DF, Sample LRAm. J. Clin. Pathol.2011
Forced TR2/TR4 expression in sickle cell disease mice confers enhanced fetal hemoglobin synthesis and alleviated disease phenotypes.Campbell AD, Cui S, Shi L, Urbonya R, Mathias A, Bradley K, Bonsu KO, Douglas RR, Halford B, Schmidt L, Harro D, Giacherio D, Tanimoto K, Tanabe O, Engel JDProc. Natl. Acad. Sci. U.S.A.2011
Improved hybridization probe method for genetic analysis of beta-thalassemiaYamashiro Y, Hattori Y, Hino M, Furuya C, Fukamitu A, Suehisa YRinsho Byori2011
Levels of growth differentiation factor-15 are high and correlate with clinical severity in transfusion-independent patients with β thalassemia intermedia.Musallam KM, Taher AT, Duca L, Cesaretti C, Halawi R, Cappellini MDBlood Cells Mol. Dis.2011
Mutagen-specific mutation signature determines global microRNA binding.Greenberg E, Rechavi G, Amariglio N, Solomon O, Schachter J, Markel G, Eyal EPLoS ONE2011
Heterozygous β thalassemia with triplication of the α globin geneConstanço MC, Rocha P, Bento C, Silva HMActa Med Port2011
Efficacy and safety of Iranian made Deferasirox (Osveral®) in Iranian major thalassemic patients with transfusional iron overload: A one year prospective multicentric open-label non-comparative study.Eshghi P, Farahmandinia Z, Molavi M, Naderi M, Jafroodi M, Hoorfar H, Davari K, Azarkeivan A, Keikhaie B, Ansari S, Arasteh MDaru2011
Combined α-thalassemia and Hemoglobin J-Iran (β77 His → Asp). A Family Study in southern Iran.Dehghani SJ, Amiri Dashtarzhen A, Nasirabadi Sh, Dehbozorgian J, Afrasiabi AR, Morshedi N, Imanifard J, Mehrpoor Sh, Gerdabi J, Karimi MIran Red Crescent Med J2011
Pneumonia due to Hemophilus influenzae fin a child with sickle cell disease.Kalpatthi R, Panchoosingh H, Rao S J S C Med Assoc2011
Sickle cell protection from malaria.Eridani S Hematol Rep2011
Prevalence of sickle cell disease and sickle cell trait in national neonatal screening studies.Lervolino LG, Baldin PE, Picado SM, Calil KB, Viel AA, Campos LA Rev Bras Hematol Hemoter2011
Brazilian Guidelines for transcranial doppler in children and adolescents with sickle cell disease.Lobo CL, Cançado RD, Leite AC, Dos Anjos AC, Pinto AC, Matta AP, Silva CM, Silva GS, Friedrisch JR, Braga JA, Lange MC, Figueiredo MS, Rugani MÁ, Veloso O, Moura PG, Cortez PI, Adams R, Gualandro SF, de Castilho SL, Thomé U, Zetola VF Rev Bras Hematol Hemoter2011
Resting blood lactate in individuals with sickle cell disease.Petto J, de Jesus JB, Vasques LM, Pinheiro RL, Oliveira AM, Spinola KA, Silva Wdos S Rev Bras Hematol Hemoter2011
Sickle cell disease: from the beginning until it was recognized as a public health disease.Naoum PC Rev Bras Hematol Hemoter2011
Risk factors for pulmonary hypertension in patients with β thalassemia intermedia.Karimi M, Musallam KM, Cappellini MD, Daar S, El-Beshlawy A, Belhoul K, Saned MS, Temraz S, Koussa S, Taher AT Eur. J. Intern. Med.2011
Brain magnetic resonance angiography in splenectomized adults with β-thalassemia intermedia.Musallam KM, Beydoun A, Hourani R, Nasreddine W, Raad R, Koussa S, Taher AT Eur. J. Haematol.2011
Thrombosis in thalassemia: why are we so concerned?Musallam KM, Taher AT Hemoglobin2011
Elevated liver iron concentration is a marker of increased morbidity in patients with β thalassemia intermedia.Musallam KM, Cappellini MD, Wood JC, Motta I, Graziadei G, Tamim H, Taher AT Haematologica2011
Thalassemia and venous thromboembolism.Succar J, Musallam KM, Taher AT Mediterr J Hematol Infect Dis2011
Iron-chelating therapy for transfusional iron overload.Musallam KM, Taher AT N. Engl. J. Med.2011
Nontransferrin-bound iron in transfused patients with sickle cell disease.Inati A, Musallam KM, Cappellini MD, Duca L, Taher AT Int J Lab Hematol2011
Deferiprone or deferasirox for cardiac siderosis in beta-thalassemia major.Musallam KM, Taher AT Haematologica2011
Library of variants (LOV) v. 1.0: an help for the interpretation of the phenotypic haemoglobin data obtained with liquid chromatography Bio-Rad devicesJoly P, Wajcman H, Francina AAnn. Biol. Clin. (Paris)2010
Functional analysis of the role of the TPMT gene promoter VNTR polymorphism in TPMT gene transcription.Zukic B, Radmilovic M, Stojiljkovic M, Tosic N, Pourfarzad F, Dokmanovic L, Janic D, Colovic N, Philipsen S, Patrinos GP, Pavlovic SPharmacogenomics2010
Regulation of the human HBA genes by KLF4 in erythroid cell lines.Marini MG, Porcu L, Asunis I, Loi MG, Ristaldi MS, Porcu S, Ikuta T, Cao A, Moi PBr. J. Haematol.2010
alpha-thalassaemia masked by beta gene defects and a new polyadenylation site mutation on the alpha2-globin gene.Harteveld CL, Oosterhuis WP, Schoenmakers CH, Ananta H, Kos S, Bakker Verweij M, van Delft P, Arkesteijn SG, Phylipsen M, Giordano PCEur. J. Haematol.2010
Effect of human beta-globin bacterial artificial chromosome transgenesis on embryo cryopreservation in mouse models.Boonkusol D, Dinnyes A, Faisaikarm T, Sangsuwan P, Pratipnatalang N, Sa-Ardrit M, Saikhun K, Svasti S, Vadolas J, Winichagoon P, Fucharoen S, Kitiyanant YReprod. Fertil. Dev.2010
Rapid diagnosis of alpha-thalassemia by melting curve analysis.Munkongdee T, Vattanaviboon P, Thummarati P, Sewamart P, Winichagoon P, Fucharoen S, Svasti SJ Mol Diagn2010
Genetic modifiers of Hb E/beta0 thalassemia identified by a two-stage genome-wide association study.Sherva R, Sripichai O, Abel K, Ma Q, Whitacre J, Angkachatchai V, Makarasara W, Winichagoon P, Svasti S, Fucharoen S, Braun A, Farrer LABMC Med. Genet.2010
Two new alpha1-globin gene point mutations: Hb Nedlands (HBA1:c.86C>T) [alpha28(B9)Ala-->Val] and Hb Queens Park (HBA1:c.98T>A) [alpha32(B13)Met-->Lys].Phylipsen M, Prior JF, Lim E, Lingam N, Finlayson J, Arkesteijn SG, Harteveld CL, Giordano PCHemoglobin2010
Hb Valletta [beta87(F3)Thr-->Pro] and Hb Marseille/Long Island [beta2(NA2)His-->Pro; (-1)Met-(+1)Val-(+2)Pro-Leu], in a unique compound heterozygote with a normal hemoglobin phenotype.Galdies R, Cassar W, Pizzuto M, Scerri CA, Felice N, Cassar OA, Buttigieg G, Felice AEHemoglobin2010
Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias.Cappellini MD, Porter J, El-Beshlawy A, Li CK, Seymour JF, Elalfy M, Gattermann N, Giraudier S, Lee JW, Chan LL, Lin KH, Rose C, Taher A, Thein SL, Viprakasit V, Habr D, Domokos G, Roubert B, Kattamis A, Haematologica2010
Beta-globin gene cluster haplotypes in Yemeni children with sickle cell disease.Al-Saqladi AW, Brabin BJ, Bin-Gadeem HA, Kanhai WA, Phylipsen M, Harteveld CLActa Haematol.2010
beta-Globin gene cluster haplotypes of Hb D-Punjab.Atalay EOHemoglobin2010
Extended molecular spectrum of beta- and alpha-thalassemia in Oman.Hassan SM, Hamza N, Jaffer Al-Lawatiya F, Jaffer Mohammed A, Harteveld CL, Rajab A, Giordano PCHemoglobin2010
Improved treatment satisfaction and convenience with deferasirox in iron-overloaded patients with beta-Thalassemia: Results from the ESCALATOR Trial.Taher A, Al Jefri A, Elalfy MS, Al Zir K, Daar S, Rofail D, Baladi JF, Habr D, Kriemler-Krahn U, El-Beshlawy AActa Haematol.2010
The inherited diseases of hemoglobin are an emerging global health burden.Weatherall DJBlood2010
Evaluation of a panel of circulating DNA, RNA and protein potential markers for pathologies of pregnancy.Galbiati S, Causarano V, Pinzani P, Francesca S, Orlando C, Smid M, Pasi F, Castiglioni MT, Cavoretto P, Rovere-Querini P, Pedroni S, Calza S, Ferrari M, Cremonesi LClin. Chem. Lab. Med.2010
Alpha-hemoglobin stabilizing protein (AHSP), a kinetic scheme of the action of a human mutant, AHSPV56G.Brillet T, Baudin-Creuza V, Vasseur C, Domingues-Hamdi E, Kiger L, Wajcman H, Pissard S, Marden MCJ. Biol. Chem.2010
Phenotypic expression and origin of the rare beta-thalassemia splice site mutation HBB:c.315 + 1G>T.Broquere C, Brudey K, Harteveld CL, Saint-Martin C, Elion J, Giordano PC, Romana MHemoglobin2010
Combined chelation therapy in thalassemia major with deferiprone and desferrioxamine: a retrospective study.Ricchi P, Ammirabile M, Spasiano A, Costantini S, Cinque P, Di Matola T, Pagano L, Prossomariti LEur. J. Haematol.2010
Alpha-thalassaemia.Harteveld CL, Higgs DROrphanet J Rare Dis2010
Beta-thalassemia.Galanello R, Origa ROrphanet J Rare Dis2010
The importance of micromapping the gene frequencies for the common inherited disorders of haemoglobin.Weatherall DJBr. J. Haematol.2010
ETHNOS : A versatile electronic tool for the development and curation of national genetic databases.van Baal S, Zlotogora J, Lagoumintzis G, Gkantouna V, Tzimas I, Poulas K, Tsakalidis A, Romeo G, Patrinos GPHum. Genomics2010
Hb Charlieu [alpha106(G13)Leu-->Pro (alpha1)]: a new phenotypically silent hemoglobin variant associated with a mild alpha-thalassemia phenotype.Joly P, Szymanowicz A, Neyron MJ, Zine A, Wajcman H, Francina AHemoglobin2010
Codon 24 (TAT>TAG) and codon 32 (ATG>AGG) (Hb Rotterdam): two novel alpha2 gene mutations associated with mild alpha-thalassemia found in the same family after newborn screening.Giordano PC, Cnossen MH, Joosten AM, Jansen CA, Hakvoort TE, Bakker-Verweij M, Arkesteijn SG, van Delft P, Waye JS, Bouva MJ, Harteveld CLHemoglobin2010
Genetic databases and their potential in pharmacogenomics.Lagoumintzis G, Poulas K, Patrinos GPCurr. Pharm. Des.2010
Region-specific genetic heterogeneity of HBB mutation distribution in South-Western Greece.Papachatzopoulou A, Kourakli A, Stavrou EF, Fragou E, Vantarakis A, Patrinos GP, Athanassiadou AHemoglobin2010
Hepatocellular carcinoma in patients with thalassaemia syndromes: clinical characteristics and outcome in a long term single centre experience.Restivo Pantalone G, Renda D, Valenza F, D'Amato F, Vitrano A, Cassarà F, Rigano P, Di Salvo V, Giangreco A, Bevacqua E, Maggio ABr. J. Haematol.2010
Implementing neonatal screening for haemoglobinopathies in the Netherlands.Bouva MJ, Mohrmann K, Brinkman HB, Kemper-Proper EA, Elvers B, Loeber JG, Verheul FE, Giordano PCJ Med Screen2010
Haploinsufficiency for the erythroid transcription factor KLF1 causes hereditary persistence of fetal hemoglobin.Borg J, Papadopoulos P, Georgitsi M, Gutiérrez L, Grech G, Fanis P, Phylactides M, Verkerk AJ, van der Spek PJ, Scerri CA, Cassar W, Galdies R, van Ijcken W, Ozgür Z, Gillemans N, Hou J, Bugeja M, Grosveld FG, von Lindern M, Felice AE, Patrinos GP, Philipsen SNat. Genet.2010
Age-related complications in treatment-naïve patients with thalassaemia intermedia.Taher AT, Musallam KM, El-Beshlawy A, Karimi M, Daar S, Belhoul K, Saned MS, Graziadei G, Cappellini MDBr. J. Haematol.2010
New golden era of chelation therapy in thalassaemia: the achievement and maintenance of normal range body iron stores.Kolnagou A, Kontoghiorghes GJBr. J. Haematol.2010
Binding patterns of BCL11A in the globin and GATA1 loci and characterization of the BCL11A fetal hemoglobin locus.Jawaid K, Wahlberg K, Thein SL, Best SBlood Cells Mol. Dis.2010
Expression of microRNA-451 in normal and thalassemic erythropoiesis.Svasti S, Masaki S, Penglong T, Abe Y, Winichagoon P, Fucharoen S, Umemura TAnn. Hematol.2010
Fetal globin gene inducers: novel agents and new potential.Perrine SP, Castaneda SA, Chui DH, Faller DV, Berenson RJ, Siritanaratku N, Fucharoen SAnn. N. Y. Acad. Sci.2010
Deferiprone.Piga A, Roggero S, Salussolia I, Massano D, Serra M, Longo FAnn. N. Y. Acad. Sci.2010
Hematopoietic stem cell mobilization strategies for gene therapy of beta thalassemia and sickle cell disease.Yannaki E, Stamatoyannopoulos GAnn. N. Y. Acad. Sci.2010
Thalassemia as a global health problem: recent progress toward its control in the developing countries.Weatherall DJAnn. N. Y. Acad. Sci.2010
Treatment options for thalassemia patients with osteoporosis.Terpos E, Voskaridou EAnn. N. Y. Acad. Sci.2010
Hepcidin and Hfe in iron overload in beta-thalassemia.Gardenghi S, Ramos P, Follenzi A, Rao N, Rachmilewitz EA, Giardina PJ, Grady RW, Rivella SAnn. N. Y. Acad. Sci.2010
Emerging insights in the management of hemoglobin E beta thalassemia.Olivieri NF, Thayalsuthan V, O'Donnell A, Premawardhena A, Rigobon C, Muraca G, Fisher C, Weatherall DJAnn. N. Y. Acad. Sci.2010
A preclinical approach for gene therapy of beta-thalassemia.Breda L, Kleinert DA, Casu C, Casula L, Cartegni L, Fibach E, Mancini I, Giardina PJ, Gambari R, Rivella SAnn. N. Y. Acad. Sci.2010
Magnetic resonance assessment of iron overload by separate measurement of tissue ferritin and hemosiderin iron.Wu EX, Kim D, Tosti CL, Tang H, Jensen JH, Cheung JS, Feng L, Au WY, Ha SY, Sheth SS, Brown TR, Brittenham GMAnn. N. Y. Acad. Sci.2010
Strategy for a multicenter phase I clinical trial to evaluate globin gene transfer in beta-thalassemia.Sadelain M, Rivière I, Wang X, Boulad F, Prockop S, Giardina P, Maggio A, Galanello R, Locatelli F, Yannaki EAnn. N. Y. Acad. Sci.2010
The role of antioxidants and iron chelators in the treatment of oxidative stress in thalassemia.Fibach E, Rachmilewitz EAAnn. N. Y. Acad. Sci.2010
The natural history of thalassemia intermedia.Borgna-Pignatti C, Marsella M, Zanforlin NAnn. N. Y. Acad. Sci.2010
Progress in hematopoietic stem cell transplantation as allogeneic cellular gene therapy in thalassemia.Isgrò A, Gaziev J, Sodani P, Lucarelli GAnn. N. Y. Acad. Sci.2010
Better survival and less cardiac morbidity in female patients with thalassemia major: a review of the literature.Marsella M, Pepe A, Borgna-Pignatti CAnn. N. Y. Acad. Sci.2010
Combined iron chelation therapy.Galanello R, Agus A, Campus S, Danjou F, Giardina PJ, Grady RWAnn. N. Y. Acad. Sci.2010
Iron metabolism and ineffective erythropoiesis in beta-thalassemia mouse models.Ramos P, Melchiori L, Gardenghi S, Van-Roijen N, Grady RW, Ginzburg Y, Rivella SAnn. N. Y. Acad. Sci.2010
Pathogenesis and management of iron toxicity in thalassemia.Hershko CAnn. N. Y. Acad. Sci.2010
Metabolic disorders associated with chronic hepatitis C: impact of genotype and ethnicity.Sersté T, Nkuize M, Moucari R, Van Gossum M, Reynders M, Scheen R, Vertongen F, Buset M, Mulkay JP, Marcellin PLiver Int.2010
Flowcharts for the diagnosis and the molecular characterization of hemoglobinopathiesAguilar-Martinez P, Badens C, Bonello-Palot N, Cadet E, Couque N, Ducrocq R, Elion J, Francina A, Joly P, Pissard S, Rochette J, Ann. Biol. Clin. (Paris)2010
Hydroxyurea therapy requires HbF induction for clinical benefit in a sickle cell mouse model.Lebensburger JD, Pestina TI, Ware RE, Boyd KL, Persons DAHaematologica2010
Amelioration of oxidative stress in red blood cells from patients with beta-thalassemia major and intermedia and E-beta-thalassemia following administration of a fermented papaya preparation.Fibach E, Tan ES, Jamuar S, Ng I, Amer J, Rachmilewitz EAPhytother Res2010
Education and employment status of children and adults with thalassemia in North America.Pakbaz Z, Treadwell M, Kim HY, Trachtenberg F, Parmar N, Kwiatkowski JL, Cunningham MJ, Martin M, Sweeters N, Neufeld EJ, Giardina PJ, Olivieri N, Yamashita RC, Vichinsky EPediatr Blood Cancer2010
Embryo-fetal erythroid megaloblasts in the human coelomic cavity.Renda MC, Giambona A, Fecarotta E, Leto F, Makrydimas G, Renda D, Damiani G, Jakil MC, Picciotto F, Piazza A, Valtieri M, Maggio AJ. Cell. Physiol.2010
Relation of chelation regimes to cardiac mortality and morbidity in patients with thalassaemia major: an observational study from a large Greek Unit.Ladis V, Chouliaras G, Berdoukas V, Moraitis P, Zannikos K, Berdoussi E, Kattamis CEur. J. Haematol.2010
Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia.Cavazzana-Calvo M, Payen E, Negre O, Wang G, Hehir K, Fusil F, Down J, Denaro M, Brady T, Westerman K, Cavallesco R, Gillet-Legrand B, Caccavelli L, Sgarra R, Maouche-Chrétien L, Bernaudin F, Girot R, Dorazio R, Mulder GJ, Polack A, Bank A, Soulier J, Larghero J, Kabbara N, Dalle B, Gourmel B, Socie G, Chrétien S, Cartier N, Aubourg P, Fischer A, Cornetta K, Galacteros F, Beuzard Y, Gluckman E, Bushman F, Hacein-Bey-Abina S, Leboulch PNature2010
A new sickling variant 'Hb S-Wake β[(Glu6Val-Asn139 Ser)]' found in a compound heterozygote with Hb S β(Glu6Val) coinherited with homozygous α-thalassemia-2: phenotype and molecular characteristics.Kutlar F, Redding-Lallinger R, Meiler SE, Bakanay SM, Borders L, Kutlar AActa Haematol.2010
The impact of previous or concomitant IFN therapy on deferiprone-induced agranulocytosis and neutropenia: a retrospective study.Ricchi P, Ammirabile M, Costantini S, Cinque P, Lanza AG, Spasiano A, Di Matola T, Di Costanzo G, Pagano L, Prossomariti LExpert Opin Drug Saf2010
Reconstructing blood from induced pluripotent stem cells.Papapetrou EP, Sadelain MF1000 Med Rep2010
Immunohematologic reconstitution in pediatric patients after T cell-depleted HLA-haploidentical stem cell transplantation for thalassemia.Isgrò A, Marziali M, Sodani P, Gaziev J, Erer B, Polchi P, Paciaroni K, Roveda A, De Angelis G, Gallucci C, Alfieri C, Simone MD, Zinno F, Isacchi G, Adorno G, Lanti A, Leti W, Aiuti F, Fraboni D, Andreani M, Lucarelli GBiol. Blood Marrow Transplant.2010
The effect of UGT1A1 promoter polymorphism on bilirubin response to hydroxyurea therapy in hemoglobinopathies.Italia KY, Jijina FF, Jain D, Merchant R, Nadkarni AH, Mukherjee M, Ghosh K, Colah RBClin. Biochem.2010
Pregnancy in sickle cell disease: maternal and fetal outcomes in a population receiving prophylactic partial exchange transfusions.Ngô C, Kayem G, Habibi A, Benachi A, Goffinet F, Galactéros F, Haddad BEur. J. Obstet. Gynecol. Reprod. Biol.2010
Secondary erythrocytosis caused by hemoglobin Tak/(δβ)0-thalassemia syndrome.Prakobkaew N, Singsanan S, Fucharoen G, Surapot S, Fucharoen SActa Haematol.2010
Molecular basis and hematological features of hemoglobin variants in Southern Thailand.Saechan V, Nopparatana C, Nopparatana C, Fucharoen SInt. J. Hematol.2010
Red blood cell generation from human induced pluripotent stem cells: perspectives for transfusion medicine.Lapillonne H, Kobari L, Mazurier C, Tropel P, Giarratana MC, Zanella-Cleon I, Kiger L, Wattenhofer-Donzé M, Puccio H, Hebert N, Francina A, Andreu G, Viville S, Douay LHaematologica2010
Experimental generation of SNP haplotype signatures in patients with sickle cell anaemia.Menzel S, Qin J, Vasavda N, Thein SL, Ramakrishnan RPLoS ONE2010
Benefits of utilizing gene-modified iPSCs for clinical applications.Ellis J, Baum C, Benvenisty N, Mostoslavsky G, Okano H, Stanford WL, Porteus M, Sadelain MCell Stem Cell2010
Gene therapy for β-thalassaemia: the continuing challenge.Yannaki E, Emery DW, Stamatoyannopoulos GExpert Rev Mol Med2010
Major challenges for gene therapy of thalassemia and sickle cell disease.Papanikolaou E, Anagnou NPCurr Gene Ther2010
One-third of the new paediatric patients with sickle cell disease in The Netherlands are immigrants and do not benefit from neonatal screening.Peters M, Fijnvandraat K, van den Tweel XW, Garre FG, Giordano PC, van Wouwe JP, Pereira RR, Verkerk PHArch. Dis. Child.2010
Haemoglobin Bonn in a Chinese family as a cause of spurious hypoxaemia measured by pulse oximetry.So CC, Chan AY, Chow EY, Lin SY, Yip SF, Szeto SC, Chan LCJ. Clin. Pathol.2010
Analysis of alpha hemoglobin stabilizing protein overexpression in murine β-thalassemia.Nasimuzzaman M, Khandros E, Wang X, Kong Y, Zhao H, Weiss D, Rivella S, Weiss MJ, Persons DAAm. J. Hematol.2010
Development and validation of a pediatric severity index for sickle cell patients.van den Tweel XW, van der Lee JH, Heijboer H, Peters M, Fijnvandraat KAm. J. Hematol.2010
Leg ulcers in sickle cell disease.Minniti CP, Eckman J, Sebastiani P, Steinberg MH, Ballas SKAm. J. Hematol.2010
Homozygous deletion of the major alpha-globin regulatory element (MCS-R2) responsible for a severe case of hemoglobin H disease.Sollaino MC, Paglietti ME, Loi D, Congiu R, Podda R, Galanello RBlood2010
Decreased sickle red blood cell adhesion to laminin by hydroxyurea is associated with inhibition of Lu/BCAM protein phosphorylation.Bartolucci P, Chaar V, Picot J, Bachir D, Habibi A, Fauroux C, Galactéros F, Colin Y, Le Van Kim C, El Nemer WBlood2010
Crosstalk between Erythropoiesis and Iron Metabolism.Rivella S, Nemeth E, Miller JLAdv Hematol2010
Thalassemia and iron deficiency in a group of northeast Thai school children: relationship to the occurrence of anemia.Panomai N, Sanchaisuriya K, Yamsri S, Sanchaisuriya P, Fucharoen G, Fucharoen S, Schelp FPEur. J. Pediatr.2010
Reduction of body iron stores to normal range levels in thalassaemia by using a deferiprone/deferoxamine combination and their maintenance thereafter by deferiprone monotherapy.Kolnagou A, Kleanthous M, Kontoghiorghes GJEur. J. Haematol.2010
SYTO9 and SYBR GREEN1 with a high-resolution melting analysis for prenatal diagnosis of β⁰-thalassemia/hemoglobin-E.Pornprasert S, Sukunthamala KEur. J. Haematol.2010
Future challenges in the use of magnetic resonance imaging for the diagnosis of iron overload.Kolnagou A, Kontoghiorghes GJBlood Transfus2010
Endocrine and bone disease in appropriately treated adult patients with beta-thalassemia major.Baldini M, Forti S, Marcon A, Ulivieri FM, Orsatti A, Tampieri B, Airaghi L, Zanaboni L, Cappellini MDAnn. Hematol.2010
Splenectomy and thrombosis: the case of thalassemia intermedia.Taher AT, Musallam KM, Karimi M, El-Beshlawy A, Belhoul K, Daar S, Saned M, Cesaretti C, Cappellini MDJ. Thromb. Haemost.2010
Global distribution of the sickle cell gene and geographical confirmation of the malaria hypothesis.Piel FB, Patil AP, Howes RE, Nyangiri OA, Gething PW, Williams TN, Weatherall DJ, Hay SINat Commun2010
Aggregation of mononuclear and red blood cells through an {alpha}4{beta}1-Lu/basal cell adhesion molecule interaction in sickle cell disease.Chaar V, Picot J, Renaud O, Bartolucci P, Nzouakou R, Bachir D, Galactéros F, Colin Y, Le Van Kim C, El Nemer WHaematologica2010
ATR-X syndrome protein targets tandem repeats and influences allele-specific expression in a size-dependent manner.Law MJ, Lower KM, Voon HP, Hughes JR, Garrick D, Viprakasit V, Mitson M, De Gobbi M, Marra M, Morris A, Abbott A, Wilder SP, Taylor S, Santos GM, Cross J, Ayyub H, Jones S, Ragoussis J, Rhodes D, Dunham I, Higgs DR, Gibbons RJCell2010
Distribution of cardiac iron measured by magnetic resonance imaging (MRI)-R*2.Yamamura J, Grosse R, Graessner J, Janka GE, Adam G, Fischer RJ Magn Reson Imaging2010
The diagnostic dilemma of congenital unstable hemoglobinopathies.Yates AM, Mortier NA, Hyde KS, Hankins JS, Ware REPediatr Blood Cancer2010
The safety, tolerability, and efficacy of a liquid formulation of deferiprone in young children with transfusional iron overload.ElAlfy MS, El Alfy M, Sari TT, Lee CL, Tricta F, El-Beshlawy AJ. Pediatr. Hematol. Oncol.2010
Habitual physical activity and endothelial activation in sickle cell trait carriers.Aufradet E, Monchanin G, Oyonno-Engelle S, Feasson L, Messonnier L, Francina A, Bezin L, Serpero LD, Gozal D, Dodogba M, Wouassi D, Banimbeck V, Djoda B, Thiriet P, Martin CMed Sci Sports Exerc2010
Management of chronic viral hepatitis in patients with thalassemia: recommendations from an international panel.Di Marco V, Capra M, Angelucci E, Borgna-Pignatti C, Telfer P, Harmatz P, Kattamis A, Prossamariti L, Filosa A, Rund D, Gamberini MR, Cianciulli P, De Montalembert M, Gagliardotto F, Foster G, Grangè JD, Cassarà F, Iacono A, Cappellini MD, Brittenham GM, Prati D, Pietrangelo A, Craxì A, Maggio A, , Blood2010
A calcified mass in the spinal canal of a patient with β-thalassemia major.Borgna-Pignatti C, Turlá G, Zanforlin N, Marsella M, Gentile MP, Maida G, Fainardi EJ. Pediatr. Hematol. Oncol.2010
Cardiac magnetic resonance in transfusion dependent thalassaemia: assessment of iron load and relationship to left ventricular ejection fraction.Chouliaras GL, Kattamis A, Berdoukas V, Gotsis ED, Mavrogeni S, Ladis VBr. J. Haematol.2010
Unexpectedly low pulse oximetry measurements associated with variant hemoglobins: a systematic review.Verhovsek M, Henderson MP, Cox G, Luo HY, Steinberg MH, Chui DHAm. J. Hematol.2010
Osteoporosis syndrome in thalassaemia major: an overview.Toumba M, Skordis NJ Osteoporos2010
Molecular medicine; the road to the better integration of the medical sciences in the twenty-first century.Weatherall DJNotes Rec R Soc Lond2010
Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice.Gardenghi S, Ramos P, Marongiu MF, Melchiori L, Breda L, Guy E, Muirhead K, Rao N, Roy CN, Andrews NC, Nemeth E, Follenzi A, An X, Mohandas N, Ginzburg Y, Rachmilewitz EA, Giardina PJ, Grady RW, Rivella SJ. Clin. Invest.2010
The need for genetically engineering therapeutic pluripotent stem cells.Sadelain MMol. Ther.2010
Analysis of real-time PCR cycle threshold of alpha-thalassemia-1 Southeast Asian type deletion using fetal cell-free DNA in maternal plasma for noninvasive prenatal diagnosis of Bart's hydrops fetalis.Pornprasert S, Sukunthamala K, Kunyanone N, Sittiprasert S, Thungkham K, Junorse S, Pongsawatkul K, Pattanaporn W, Jitwong C, Sanguansermsri TJ Med Assoc Thai2010
CTCF regulates the local epigenetic state of ribosomal DNA repeats.van de Nobelen S, Rosa-Garrido M, Leers J, Heath H, Soochit W, Joosen L, Jonkers I, Demmers J, van der Reijden M, Torrano V, Grosveld F, Delgado MD, Renkawitz R, Galjart N, Sleutels FEpigenetics Chromatin2010
Molecular screening of the Hbs Constant Spring (codon 142, TAA>CAA, α2) and Paksé (codon 142, TAA>TAT, α2) mutations in Thailand.Pichanun D, Munkongdee T, Klamchuen S, Butthep P, Winichagoon P, Fucharoen S, Svasti SHemoglobin2010
Double disadvantage: a case control study on health-related quality of life in children with sickle cell disease.Hijmans CT, Fijnvandraat K, Oosterlaan J, Heijboer H, Peters M, Grootenhuis MAHealth Qual Life Outcomes2010
Anemia, ineffective erythropoiesis, and hepcidin: interacting factors in abnormal iron metabolism leading to iron overload in β-thalassemia.Gardenghi S, Grady RW, Rivella SHematol. Oncol. Clin. North Am.2010
The population genetics and dynamics of the thalassemias.Weatherall DJ, Williams TN, Allen SJ, O'Donnell AHematol. Oncol. Clin. North Am.2010
Allogeneic cellular gene therapy for hemoglobinopathies.Gaziev J, Lucarelli GHematol. Oncol. Clin. North Am.2010
Renal complications in transfusion-dependent beta thalassaemia.Ponticelli C, Musallam KM, Cianciulli P, Cappellini MDBlood Rev.2010
Clinical, hematologic and molecular variability of sickle cell-β thalassemia in western India.Mukherjee MB, Nadkarni AH, Gorakshakar AC, Ghosh K, Mohanty D, Colah RBIndian J Hum Genet2010
Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus.Lo YM, Chan KC, Sun H, Chen EZ, Jiang P, Lun FM, Zheng YW, Leung TY, Lau TK, Cantor CR, Chiu RWSci Transl Med2010
Redefining thalassemia as a hypercoagulable state.Cappellini MD, Motta I, Musallam KM, Taher ATAnn. N. Y. Acad. Sci.2010
Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study.Taher AT, Musallam KM, Karimi M, El-Beshlawy A, Belhoul K, Daar S, Saned MS, El-Chafic AH, Fasulo MR, Cappellini MDBlood2010
Absence of cardiac siderosis despite hepatic iron overload in Italian patients with thalassemia intermedia: an MRI T2* study.Roghi A, Cappellini MD, Wood JC, Musallam KM, Patrizia P, Fasulo MR, Cesaretti C, Taher ATAnn. Hematol.2010
Asymptomatic brain magnetic resonance imaging abnormalities in splenectomized adults with thalassemia intermedia.Taher AT, Musallam KM, Nasreddine W, Hourani R, Inati A, Beydoun AJ. Thromb. Haemost.2010
Efficacy of deferasirox in reducing and preventing cardiac iron overload in beta-thalassemia.Pennell DJ, Porter JB, Cappellini MD, El-Beshlawy A, Chan LL, Aydinok Y, Elalfy MS, Sutcharitchan P, Li CK, Ibrahim H, Viprakasit V, Kattamis A, Smith G, Habr D, Domokos G, Roubert B, Taher ABlood2010
Deferasirox (Exjade) significantly improves cardiac T2* in heavily iron-overloaded patients with beta-thalassemia major.Pathare A, Taher A, Daar SAnn. Hematol.2010
Iron chelation therapy for patients with sickle cell disease and iron overload.Inati A, Khoriaty E, Musallam KM, Taher ATAm. J. Hematol.2010
Magnetic resonance evaluation of hepatic and myocardial iron deposition in transfusion-independent thalassemia intermedia compared to regularly transfused thalassemia major patients.Taher AT, Musallam KM, Wood JC, Cappellini MDAm. J. Hematol.2010
The IVS1-2A>G mutation in the SRD5A2 gene predominates in Cypriot patients with 5α reductase deficiency.Skordis N, Neocleous V, Kyriakou A, Efstathiou E, Sertedaki A, Philibert P, Phylactou LA, Lumbroso S, Sultan CJ. Endocrinol. Invest.2010
NOD2/CARD15, ATG16L1 and IL23R gene polymorphisms and childhood-onset of Crohn's disease.Gazouli M, Pachoula I, Panayotou I, Mantzaris G, Chrousos G, Anagnou NP, Roma-Giannikou EWorld J. Gastroenterol.2010
The antioxidant effect of erythropoietin on thalassemic blood cells.Amer J, Dana M, Fibach EAnemia2010
Novel human pathological mutations. Gene symbol: UROD. Disease: porphyria, cutanea tarda.Brancaleoni V, Di Pierro E, Moriondo V, Borghi A, Sardini C, Ventura P, Cappellini MDHum. Genet.2010
Rapid iron loading in heart and liver in a patient with transfusion dependent thalassaemia after brief poor compliance with iron chelation therapy.Daar S, Ahmed S, Berdoukas VSultan Qaboos Univ Med J2010
Serum lipid profiles in patients with beta-thalassemia major and intermedia in southern Iran.Haghpanah S, Davani M, Samadi B, Ashrafi A, Karimi MJ Res Med Sci2010
Pregnant women affected by thalassemia major: a controlled study of traits and personality.Messina G, Colombo E, Cassinerio E, Cesaretti C, Marcon A, Zanaboni L, Baldini M, Cappellini MDJ Res Med Sci2010
The Diagnosis of α-Thalassaemia: A Case of Hemoglobin H -α Deletion.Bhat VS, Dewan KK, Krishnaswamy PRIndian J Clin Biochem2010
Adaptation to anemia in hemoglobin E-ß thalassemia.Allen A, Fisher C, Premawardhena A, Peto T, Allen S, Arambepola M, Thayalsutha V, Olivieri N, Weatherall DBlood2010
Systematic identification of placental epigenetic signatures for the noninvasive prenatal detection of Edwards syndrome.Tsui DW, Lam YM, Lee WS, Leung TY, Lau TK, Lau ET, Tang MH, Akolekar R, Nicolaides KH, Chiu RW, Lo YM, Chim SSPLoS ONE2010
A descriptive profile of β-thalassaemia mutations in India, Pakistan and Sri Lanka.Black ML, Sinha S, Agarwal S, Colah R, Das R, Bellgard M, Bittles AHJ Community Genet2010
Covert brain ischaemia in splenectomised adults with thalassemia intermedia: An emerging entity.Taher AT, Musallam KM, Nasreddine W, Beydoun A Thromb. Haemost.2010
The role of liver iron in hepatitis C antiviral treatment.Musallam KM, Sharara AI, Inati A, Taher AT Eur J Gastroenterol Hepatol2010
Paraspinal extramedullary hematopoiesis in patients with thalassemia intermedia.Haidar R, Mhaidli H, Taher AT Eur Spine J2010
A computed tomography Iron Index.Isma'eel H, Musallam KM, Budoff M, Taher AT Eur J Radiol2010
Clinicovirologic analysis of hepatitis C infection in transfusion-dependent beta-thalassemia major children.Ragab L, Helal S, Zaghloul N, El-Raziky M, Afifi R, Musallam KM, Taher AT Int J Lab Hematol2010
A new scientific journal linked to a genetic database: towards a novel publication modality.Patrinos GP, Petricoin EFHum Genomics Proteomics2009
Absence of cardiac siderosis by MRI T2* despite transfusion burden, hepatic and serum iron overload in Lebanese patients with sickle cell disease.Inati A, Musallam KM, Wood JC, Sheikh-Taha M, Daou L, Taher ATEur. J. Haematol.2009
Levels of non-transferrin-bound iron as an index of iron overload in patients with thalassaemia intermedia.Taher A, Musallam KM, El Rassi F, Duca L, Inati A, Koussa S, Cappellini MDBr. J. Haematol.2009
Efficacy and safety of deferasirox doses of >30 mg/kg per d in patients with transfusion-dependent anaemia and iron overload.Taher A, Cappellini MD, Vichinsky E, Galanello R, Piga A, Lawniczek T, Clark J, Habr D, Porter JBBr. J. Haematol.2009
Reduction in labile plasma iron during treatment with deferasirox, a once-daily oral iron chelator, in heavily iron-overloaded patients with beta-thalassaemia.Daar S, Pathare A, Nick H, Kriemler-Krahn U, Hmissi A, Habr D, Taher AEur. J. Haematol.2009
Efficacy and safety of deferasirox, an oral iron chelator, in heavily iron-overloaded patients with beta-thalassaemia: the ESCALATOR study.Taher A, El-Beshlawy A, Elalfy MS, Al Zir K, Daar S, Habr D, Kriemler-Krahn U, Hmissi A, Al Jefri AEur. J. Haematol.2009
Hematopoietic stem cell transplantation in thalassemia and sickle cell disease. Unicenter experience in a multi-ethnic population.Marziali M, Isgrò A, Gaziev J, Lucarelli GMediterr J Hematol Infect Dis2009
Thalassaemia and aberrations of growth and puberty.Kyriakou A, Skordis NMediterr J Hematol Infect Dis2009
Screening and genetic diagnosis of hemoglobinopathies in southern and northern europe: two examples.Amato A, Giordano PCMediterr J Hematol Infect Dis2009
Gene therapy in thalassemia and hemoglobinopathies.Breda L, Gambari R, Rivella SMediterr J Hematol Infect Dis2009
Hb H disease resulting from the association of an α-thalassemia allele [-(α)] with an unstable α-globin variant [Hb Icaria]: First report on the occurrence in Brazil.Kimura EM, Oliveira DM, Fertrin K, Pinheiro VR, Jorge SE, Costa FF, de Fátima Sonati MGenet. Mol. Biol.2009
Unexpected myocarditis in thalassaemia major patient screened for iron load cardiomyopathy.Roghi A, Dellegrottaglie S, Pedrotti P, Pedretti S, Cassinerio E, Cappellini MDBMJ Case Rep2009
Gene symbol: HBD. Disease: Thalassaemia delta.Refaldi C, Cappellini MDHum. Genet.2008
Challenges associated with prolonged survival of patients with thalassemia: transitioning from childhood to adulthood.Musallam K, Cappellini MD, Taher APediatrics2008
Transcription Regulation by Class III Histone Deacetylases (HDACs)-Sirtuins.Dai Y, Faller DVTransl Oncogenomics2008
Sickle-β(+) thalassemia with splenic calcification and bone marrow infarction: a case report.Kar R, Das R, Saxena A, Chawla Y, Ahluwalia JIndian J Hematol Blood Transfus2008
Mutational spectrum of thalassemias in India.Panigrahi I, Marwaha RKIndian J Hum Genet2007
Diagnosis of Beta-thalassaemia carriers in the sultanate of oman.Daar S, Gravell DSultan Qaboos Univ Med J2006
Hemoglobinopathies : community clues to mutation detection.Old JMMethods Mol. Med.1996
Noninvasive prenatal diagnosis using fetal cells in maternal blood.Lo YMMethods Mol. Med.1996
Induction of Erythroid-Specific Expression in Murine Erythroleukemia (MEL) Cell Lines.Antoniou MMethods Mol. Biol.1991
Sickle cell anemia a molecular disease.PAULING L, ITANO HA Science1949
[Not Available].HORLEIN H, WEBER G Dtsch. Med. Wochenschr.1948
back to top

Future events

  • 2nd EPIRARE Meeting
  • 23th Regional Congress of the ISBT
  • 17th International Conference on Prenatal Diagnosis and Therapy
  • 4th International Conference RAHMS: Recent Advances in Health and Medical Sciences
  • European Human Genetics Conference 2013

View all events

Supported By

Find Us